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ABSTRACT OF DISSERTATION 
 
 
KEY ROLES OF SUB-CELLULAR MEMBRANES AND CO-CHAPERONE IN 
TOMBUSVIRUS REPLICATION 
 
 
 Positive strand RNA viruses, inculding tombusviruses, are known to utilize 
cellular membranes to assemble their replicase complexes (VRCs). Two tombusviruses , 
Tomato bushy stunt virus (TBSV) and Carnation Italian ringspot virus (CIRV), replicate 
on different organellar membranes, peroxisomes or endoplasmic reticulum (ER)  for 
TBSV and mitochodria outer membranes in case of CIRV. I showed that both TBSV and 
CIRV replicase proteins could assemble VRCs and replicate viral RNA on purified 
microsomes (ER) and mitochondria. Different efficiencies of assembly was shown 
determined by multiple domains on TBSV or CIRV replication proteins. 
 
 To study why VRC assembly could occur on an alternative organellar 
membranes, I focused on the phospholipids, key lipid components in ER or mitochondria 
membranes. Phospholipids directly interact with viral replicases, however, their specific 
roles during (+)RNA virus replication are far less understood. I used TBSV as a model 
(+) RNA virus, and established a cell-free TBSV replication system using artificial 
membranes prepared from different phospholipids. I showed that 
phosphatidylethanolamine (PE) is required for full cycle replication of the viral 
RNA.Moreover, PE is enriched at the sites of TBSV replication in plant and yeast cells, 
and was up-regulated during TBSV replication. Furthermore, up-regulation of total 
cellular PE content in yeast due to deletion of CHO2 leads to dramatically stimulated 
TBSV replication. Overall, I identified PE as the key lipid component of membranes 
required for TBSV replication, and my data highlighted that PE, an abundant 
phospholipid in all eukaryotic cells, not only serves as a structural component of 
membrane bilayers, its interaction with the viral replication proteins also stimulates 
(+)RNA virus replication. Further experiments indicated both early secretory pathway 
and endocytic pathway are involved in PE re-distribution to site of replication. 
 
 In addition to lipids and subcellular membranes, certain host proteins are also 
involved in (+) RNA virus replication and VRC assembly. I identified Hop-like stress-
inducible protein 1 (Sti1p), which interacts with heat shock protein 70, is required for the
inhibition of CIRV replication. My findings indicate that Hop/Sti1 co-chaperone could 
act as a virus restriction factor in case of mitochondrial CIRV, but not against 
peroxisomal tombusvirus. 
 
KEY WORDS: Positive strand RNA virus, phospholipids, phosphatidylethanolamine, 
subcellular membrane, Sti1p 
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Chapter 1 
INTRODUCTION 
1.1 Tombusviruses 
 
The group of tombusvirus belongs to positive strand RNA virus that replicate their 
genomes in a wild range of plant hosts (1). Tomato bushy stunt virus (TBSV) is the 
prototypical species in the Tombusvirus genus and tombusviridae family. TBSV has a 
single-stranded positive-sense RNA genome of ~4800 nucleotides long(1). Its RNA 
genome is highly structured with 5' non-capped end, 3' non-polyadenylated end, as well 
as many internal RNA elements which functions in viral protein translation enhancement, 
viral replicase complex assembly and replication (1-4). 
 TBSV encodes five viral proteins (1), the replication proteins p33 and p92; a 
capside protein p42, movement protein p22 and a suppressor of gene silencing p19. p33 
and p92 are both required for viral replication (1). The sequence of p33 overlaps with N-
terminal part of p92, and functions as auxiliary replication cofactor (5, 6), which is 
involved in template RNA recruitment(3) and replicase complex assembly (4) with RNA 
chaperone function (7). The p92 protein is a read-through product of p33, and has RNA 
dependent RNA polymerase (RdRp) activity. Both p33 and p92 have two trans-
membrane domains(8, 9), which are predicted to be inserted into sub-cellular membranes 
and expose the N-terminal and C-terminal, including RdRp, regions of replication 
proteins to the cytosolic side of membranes. Besides association with the membrane, p33 
and p92 could interact with each other through S1 and S2 p33:p33/p92 interaction 
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domains. This interaction leads to multimerization of replication proteins which is 
important for TBSV replication (10, 11). 
 Tombusviruses have been developed as model viruses for studies of (+)RNA 
virus replication in yeast (5, 12, 13). The tombusvirus system is based on trans-
replication of a defective interfering (DI) RNAs in the presence of replication proteins 
p33/p92. DI RNAs are defective viral RNAs containing noncontiguous regions of the 
viral RNA genome due to recombination events (5, 14-17). In the yeast system, p33 and 
p92 are expressed from plasmids and support the replication of DI-72, the model replicon 
(13). 
 Carnation italian ringspot virus (CIRV) is another tombusvirus in the same genus 
and shows high sequence similarity with TBSV (14). Unlike TBSV, which use 
peroxisome membrane for replicase assembly(18), CIRV assembles its replicase complex 
on mitochondrial outer membrane (9, 19). Studies revealed that short motifs in TBSV and 
CIRV replication proteins p33/p92 (TBSV) or p36/p95 (CIRV) are required for replicase 
targeting to peroxisome (18) or mitochondria (19). 
 
1.2 Subcellular locations of positive strand RNA virus replication 
 
Positive strand RNA viruses are the largest group among the seven virus genetic classes 
(20). They cause many diseases in human history. Egyptian tombstone as early as 1500 
BC recorded a priest having typical poliovirus infection syndrome of poliomyelitis (21). 
Recent epidemic of hepatitis C virus (22-25), dengue virus (26), West Nile virus (27, 28), 
severe acute respiratory syndrome (SARS) virus (29, 30) and many economically 
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important animal and plant viruses highlight the importance of understanding the positive 
strand RNA virus life cycle, and urgency of the discovery of novel medicines for curing 
viral diseases. 
 Positive strand RNA viruses share some common features: i) single-stranded 
RNA genome harboring ORFs on the sense-polarity (20, 31); ii) RNA genome replication 
occurs within specific sub-cellular membrane compartments of their eukaryotic host cells 
(15, 18, 20, 31-33); iii) Virion assembly often couples with genome replication (34-36). 
iv) Use of (-)RNA only as a template for asymmetrical replication. (37) 
 Despite the common feature of membrane association of (+)RNA viruses, 
subcellular locations of (+)RNA virus replication vary drastically throughout the whole 
endomembrane systems, including endoplasmic reticulum (ER) or ER derived replication 
organelles for bromovirus (38), potyvirus (38), flavivirus (34, 39, 40), arterivirus (41) and 
coronavirus (35); ER-Golgi intermediate compartment (ERGIC) for enterovirus (33); 
endosome for alphavirus (42); vacuole for Alfamovirus (43, 44) and tobamovirus (45); 
peroxisome for tombusvirus (18); mitochondria for nodavirus (46), carmovirus (47) and 
tombusvirus (48). 
 Questions were raised for these many replication sites. Why do (+)RNA viruses 
need to explore so many different locations for replication? Are selection of these sites 
random events during evolution, or some specific protein or lipid factors are determinants 
of subcellular membrane selectivity of different (+)RNA viruses? Is there any common 
pathway connecting different replication sites of (+)RNA viruses? 
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 Tombusviruses are used as model viruses to address these questions. As two 
closely related viruses in genus of tombusvirus, TBSV and CIRV replicate in distinct 
subcellular locations (peroxisome and ER for TBSV, mitochondria for CIRV) (9).  
 In a host cell, due to post-translational targeting of viral replication proteins, 
TBSV replicase may already evolved to be peroxisome targeting and does not have a 
chance to meet other sub-cellular membrane, like mitochondria. However, in cell-free 
environment, viral protein and membrane may have a chance to interact, simply by 
diffusion of molecules. Could TBSV replicate on mitochondrial membranes in a cell-free 
environment? Or could CIRV replicate on ER or peroxisome membrane? To address 
these questions, an cell-free system was established for TBSV replication using yeast 
extract (49), which contains cytosolic proteins as well as total cellular membranes, 
including peroxisome, ER or mitochondria membranes. 
 In Chapter 2, a further modification of yeast cell-free extract will be used to 
explore sub-cellular membrane requirements of TBSV and CIRV replication. This study 
leads to a deeper understanding of (+)RNA virus replication sites. The method developed 
in chapter 2 was also used for identification and characterization of an inhibitory host 
factor, stress induced protein 1 (Sti1) co-chaperone, of CIRV replication. Results with 
Sti1 in tombusvirus replication will be discussed in Chapter 3. 
 
1.3 Requirements of specific lipids for positive strand RNA virus replication 
 
Although (+)RNA viruses adapted different subcellular locations for their replication, 
membranes of these organelles have one common feature: mainly composed of 
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phospholipids, among which glycerophospholipids are most abundant (50-53), while 
sphingolipids mostly occur in Golgi and the endosomal membranes count about 10% of 
total phospholipid content (51). Major glycerolphospholipids in eukaryotic cells include: 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), 
phosphatidylinositol (PI) and phosphatidylglycerol (PG). PC is the most abundant 
phospholipids in eukaryotic cells (54), and it has an almost cylindrical shape which 
favors the organization of stable planar bilayer (51, 55). While PE is usually the second 
most abundant phospholipid species (54), it possesses a conical molecular structure (51, 
55), which could introduce negative curvature when incorporated into stable bilayer and 
promotes membrane fusion (55-57). Other than PC and PE, which are neutral 
phosholipids, negatively charged phospholipids, such as PS, PG, PI or phosphorylated 
forms of PI, namely PIPs, bring negative charge to where they are enriched and could 
attract protein effectors specifically or non-specifically (58), like Rho GTPase (59), 
protein kinase C (60), SNARE protein vam7p (61) , which are involved in different 
cellular pathways. Since different phospholipids involve in regulating different cellular 
processes, they may regulate (+)RNA virus replication through their interactions with 
viral replication proteins. 
 Elevation of overall fatty acid synthesis was shown to facilitate many (+)RNA 
virus replication, including members of enterovirus, poliovirus (62) and coxsackievirus 
B3 (CVB3) (63), and members flavivirus, Dengue virus (64) and West Nile virus (65). 
Lipidomics analysis conducted with cells infected with Dengue virus and Hepatitis C 
virus (66, 67) suggest that viruses induce new lipids biosynthesis, and virus infection 
changes the global lipid profile of the host cell. These changes add a new level of 
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complexity of virus-host interaction. However, the question remains if specific lipid 
species or total lipids  are more important to viruses? 
 In the past decade, virologists made different approaches to reveal interactions 
between specific phospholipid species and (+)RNA viruses. Enterovirus is among the 
most intensively studied viruses in this area. Phosphatidylinositol-4-phosphate (PI4P) 
was shown to be enriched with CVB3 (enterovirus, picornaviridae) replication proteins. 
RNA polymerase 3Dpol  of poliovirus (PV, enterovirus, picornaviridae) selectively binds 
to PI4P (33), suggesting a PI4P-rich micro-environment is the site for enterovirus 
replication. Down-regulation of PI4P by Phosphatidylinositol-4-phosphate kinase (PI4K) 
inhibitor or knock-down of PI4K by PI4K specific siRNA reduced the cellular PI4P 
content as well as inhibited enterovirus replication. It was proposed that interaction of 
PI4P with enterovirus replication proteins is required for enterovirus replication. Recent 
findings (68, 69) showed that a mutant CVB3 with mutation in viral protein 3A could 
bypass the requirement of PI4P or PI4Ks without lost fitness and virulence (68), 
suggesting that PI4P is not required for the mutant CVB3 replication. It is interesting to 
note that RNA polymerase 3Dpol  was not mutated in the mutant CVB3 and still kept the 
ability to interact specifically with PI4P, but the mutant virus did not require PI4P for 
replication, suggesting other lipids, if any, may be responsible for enterovirus replication. 
Nchoutmboube, J. et al. pulse-labeled PV infected HeLa cells with fluorescent fatty acid 
(bodipy-FA) and found that bodipy-FA was mostly converted to newly synthesized lipids 
which co-localized with PV replication proteins. Among the newly synthesized lipids, PC 
was the most abundant, suggesting that bodipy-FA labeled PC enriched at the site of PV 
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replication (62). Whether PC was enriched due to its abundant nature in the cell or 
because PV replication specifically requires PC is current not clear. 
 Hepatitis C Virus, hepacivirus genus, a member of Flaviviridae family, has been 
shown to require PI4P-enriched micro-environment for efficient replication (33, 70). 
While West Nile virus (WNV), flavivirus genus, a member of Flaviviridae family, does 
not require PI4P for its replication (65).  
 Besides phospholipids which form lipid bilayers needed for viral replicase 
assembly, sterols could also be important. Sterols affect lipid bilayer fluidity and are 
enriched within  West Nile virus (71) and enterovirus (72) replication organelles and are 
required for efficient Dengue virus and enterovirus replication. Are phospholipids species 
less important for the virus than sterols? We don't know yet, but at least sterols cannot 
stably exist without being inserted into lipid bilayers. 
 In Chapter 4, a novel method of cell-free TBSV replication assay using artificial 
vesicles made from phospholipids will be shown to study phospholipids and TBSV-
specific interaction. Then the findings of my research will be added to the discussion of 
previously raised questions, and shed new lights on this unexplored virology area. In 
Chapter 5 and 6, cellular pathways and mechanism of viral utilization of 
phosphatidylethanolamine will be discussed. 
 
 
 
Copyright © Kai Xu 2014 
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Chapter 2 
AUTHENTIC IN VITRO REPLICATION OF TWO TOMBUSVIRUSES IN 
ISOLATED MITOCHONDRIAL AND ENDOPLASMIC RETICULUM 
MEMBRANES 
(This chapter was published on Journal of Virology, December 2012 vol. 86 no. 23 
12779-12794., Copyright © American Society for Microbiology) 
 
2.1 Introduction 
 
Replication of plus-stranded (+)RNA viruses takes place in membrane-bound viral 
replicase complexes (VRCs) in the cytoplasm of infected cells (13, 39, 73-79). Various 
(+)RNA viruses usurp different intracellular membranes, including ER, mitochondria, 
peroxisomes or endosomal membranes to aid the replication process. Other viruses induce 
the formation of “viral replication organelles” or “membranous web” made from various 
intracellular membranes (33, 39, 77, 79, 80). The recruited membranes are thought to 
facilitate virus replication by (i) providing surfaces to assemble the VRCs; (ii) 
sequestering and concentrating viral and host components; (iii) protecting the viral RNA 
and proteins from nucleases and proteases (81); and (iv) facilitating regulated RNA 
synthesis by harboring the (-)RNA template for production of abundant (+)RNA progeny.  
 The emerging picture with several (+)RNA viruses is that their replication proteins bind 
to different lipids and recruit a number of host proteins, which are involved in lipid 
synthesis, or modification, to the site of replication (33, 79, 82, 83). In addition, (+)RNA 
 9 
 
virus replication is also dependent on bending intracellular membranes that form 
characteristic viral structures, such as spherules (vesicles with narrow openings) or 
vesicles (76). Therefore, (+)RNA viruses likely recruit host proteins affecting membrane 
curvature, as shown for ESCRT, reticulon and amphiphysin proteins in case of 
tombusviruses, Brome mosaic virus and Semliki Forest virus (81, 84-86). Lipids also 
affect membrane curvature and fluidity. Indeed, replication of several viruses has been 
shown to be affected by sterols, fatty acids and phospholipids (31, 71, 87-90). 
 Tomato bushy stunt virus (TBSV) is a small (+)RNA virus that has emerged as a 
model virus to study virus replication, recombination, and virus - host interactions due to 
the development of yeast (Saccharomyces cerevisiae) as a model host (1, 5, 79, 91, 92). 
Over 400 host genes/proteins that affected either TBSV replication or recombination have 
been identified via genome-wide screens of yeast genes or global proteomics approaches 
(12, 93-96). The highly purified tombusvirus replicase complex (VRC) is known to 
contain the two viral replication proteins (i.e., p33 and p92pol) and 6-10 host proteins (97-
99). These host proteins have different functions during TBSV replication. For example, 
heat shock protein 70 (Hsp70), eukaryotic elongation factor 1A (eEF1A) and the ESCRT 
(endosomal sorting complexes required for transport) family of host proteins are involved 
in the assembly of the VRC (75, 81, 86, 100-103). In addition, eEF1A and eEF1Bγ 
facilitate (-)strand synthesis (103, 104); glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) and Ded1 DEAD-box helicase have been shown to promote viral (+)RNA 
synthesis (37, 105, 106); while Pex19 shuttle protein is involved in targeting of the 
replication proteins to peroxisomes, the sites of replication (107).  
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 The auxiliary p33 replication protein, which has RNA chaperone function, is an 
abundant protein and is essential for replication of TBSV in both yeast and plants (3, 7, 
10, 32). The tombusvirus p33 is an integral membrane protein that has been shown to 
recruit the TBSV (+)RNA into replication. The current picture is that the p33 replication 
protein is the master regulator of TBSV replication by interacting with the viral RNA, 
p92pol and numerous host proteins and host membranes. The host also targets p33 or the 
viral RNA via nucleolin, cyclophilins or WW-domain proteins to limit tombusvirus 
infections (108-112). On the other hand, the viral p92pol, which is a translational 
readthrough product containing the p33 sequence at its N-terminus and a unique RdRp 
domain at the C-terminus, is present in a lesser amount (1). Interaction between p92pol and 
p33 replication proteins is required for assembling the functional VRC (2, 10, 49, 92). 
Interestingly, the activation of the RdRp function of p92pol protein requires not only p33, 
cis-acting sequences present in the viral (+)RNA and host factors, but also host 
membranes (2-4, 92). This complex VRC assembly process and the many factors needed 
for the RdRp activation opens the exciting questions whether tombusviruses could utilize 
different cellular membranes or if various heterologous combinations of tombusvirus 
replication proteins are functional.   
Most tombusviruses, including TBSV, Cucumber necrosis virus (CNV), and 
Cymbidium ringspot virus (CymRSV), show preference for peroxisomal membranes (10, 
18, 113). Interestingly, these viruses can also replicate efficiently on the ER membrane in 
the absence of peroxisomes, suggesting flexibility in intracellular membrane utilization 
(15, 32, 107). Another tombusvirus, Carnation Italian ringspot virus (CIRV), however, 
prefers to use mitochondrial membrane for replication (19, 48). Artificial retargeting of 
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the CIRV replication proteins to the peroxisomes or CymRSV to the mitochondria via 
chimeric constructs also supported CIRV and CymRSV replication (114), suggesting that 
these viruses could utilize more than one intracellular environment for their replication.    
To analyze if tombusviruses are indeed capable of utilizing various intracellular 
membranes for their replication, we used in vitro approaches with recombinant viral 
proteins and isolated intracellular organelles/membranes. Interestingly, we found that 
TBSV, which originally uses the peroxisomal membrane, could also utilize ER and 
mitochondrial membranes for replication in vitro. On the other hand, CIRV, which 
originally utilizes the mitochondrial membranes, replicated on the isolated mitochondrial 
membranes, while it could use the ER membrane less efficiently in vitro. Using 
heterologous combinations of replication proteins and chimeric constructs, we identified 
that multiple domains in the replication proteins are determinants of membrane 
preference for tombusvirus replication. Altogether, the current paper promotes the idea 
that TBSV is less restricted, while CIRV is more restricted in utilizing various 
intracellular membranes for replication. 
 
2.2 Materials And Methods 
 
Yeast strains and expression plasmids. Saccharomyces cerevisiae strain  
Saccharomyces cerevisiae strain BY4741 (MATa his3∆1 leu2∆0 met15∆0 ura3∆0) and 
single-gene deletion strains pex3∆ were obtained from Open Biosystems. Constructs 
pMAL-p33 and pMAL-p92, to express TBSV p33 (renamed here as T33) and p92 (re-
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named as T92) as fusion proteins to the C-terminus of MBP were described previously 
(102).  
To generate the E. coli expression constructs pMAL-p36, pMAL-p95, pMAL-
C36-T92, pMAL-T33-C95, pMAL-T33c, pMAL-T92c, pMAL-T33tc, and pMAL-T92tc, 
we used the following approaches: The CIRV p36 sequence was amplified from CIRV 
full-length cDNA (obtained from A. White, York University, Canada) with primers #642 
(5’-GTATTTGACACCGAGGG-3’) and #3230 
(CCGCTCGAGCTATTTGACACCGAGGGATT). The CIRV p95 sequence was 
obtained by blunt-end ligation of PCR product of C36 amplified by primer #642 and 
#643 (GGAGGCCTAGTGCGTCTAC) from CIRV cDNA and the C95 C-terminal 
sequence was amplified by PCR using primers # 644 
(GGAGCTCGAGCTATTTGACACCCAGGGAC) and #970 
(CCTAGGGAAAAACTGTCGGTA) and CIRV cDNA. C36-T92 chimeric sequence 
was obtained by blunt-end ligation of PCR product of C36 sequence PCR-amplified with 
primers #642 and #643 using CIRV full-length cDNA, and T92 C-terminal sequence was 
amplified by PCR with primers #6 (GGAGGCCTAGTACGTCTAC) and #826 
(GATTACATTGTCCCTCTATCT) using TBSV full-length cDNA. T33-C95 chimeric 
sequence was obtained by blunt-end ligation of PCR products of T33 [generated by PCR 
with primers #473 (GAGGAATTCGAGACCATCAAGAGAATG) and #3960 
(GTATTTGACACCCAGGGAC)] and C-terminal sequence of C95 (generated by PCR 
with primers #644 and #970). The T33c sequence was obtained by blunt-end ligation of 
PCR product using primers #642 and #4102 amplified from CIRV cDNA and PCR 
product using primers #4099 and #810 amplified from TBSV cDNA. The T92c sequence 
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was obtained by blunt-end ligation of T33c (generated by PCR with primers #642 and 
#3960) and T92 C-terminal sequence. The T33tc sequence was obtained by blunt-end 
ligation of PCR product using primers #642 and  #4090 
(ACGAGCCACACCCCGTTTAGC) and CIRV cDNA and the PCR-product generated 
by using primer #4087 (GATTACATTGTCCCTCTATCT) and #810 
(CCCGCTCGAGTCAAGCTACGGCGGAGTCGAGGA) and TBSV cDNA. The T92tc 
sequence was obtained by blunt-end ligation of T33tc (generated by PCR using primers 
#642 and #3960) and the PCR-amplified C-terminal sequence of T92. All the above PCR 
products were digested by EcoRI and XhoI restriction enzymes and inserted into pMAL-
c2X (New England BioLabs). 
To generate N-terminal GST-His6 fusion proteins, the C-terminal sequence of 
TBSV p33 was PCR-amplified using primers #633 
(GGAGGAATTCATGGAGGGTTTGAAGGC) and #1593 
(CGGCTCGAGCTATTTGACACCCAGGGACTCCTGT) and TBSV cDNA. The C-
terminal sequence of CIRV p36 was PCR-amplified using primers #633 
(GGAGGAATTCATGGAGGGTTTGAAGGC) and #3230 
(CCGCTCGAGCTATTTGACACCGAGGGATT) and CIRV cDNA. The PCR products 
were digested with BamHI and XhoI and cloned into BamHI/XhoI digested pGEX-His 
(111).  
To generate pGD-L-T33, pGD-L-T92, pGD-L-C36, pGD-L-95 constructs for 
agro-infiltration in plants, the PCR product of TBSV p33 sequence  [using primers: #788 
(GGAGCTCGAGTCAAGCTACGGCGGAGTC)/ #810 
(CCCGCTCGAGTCAAGCTACGGCGGAGTCGAGGA)] was digested with BamHI 
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and XhoI; the TBSV p92 sequence [obtained using primers: #4000 
(CCAGAGATCTATGGAGACCATCAAGAGAATG) / #826 
(GATTACATTGTCCCTCTATCT)] was digested with BglII and XhoI, the PCR product 
of CIRV p36 sequence [obtained using primers: #900 
(ACGAGCCACACCCCGTTTAGC) / #3230 
(CCGCTCGAGCTATTTGACACCGAGGGATT)] was digested with BamHI and XhoI, 
while the PRC product of CIRV p95 sequence [obtained using primers: #900 
(ACGAGCCACACCCCGTTTAGC) / #970 (CCTAGGGAAAAACTGTCGGTA)] was 
digested with BamHI and XhoI. Then, the above PCR products were separately inserted 
into pGD-L (81), which was digested with BamHI and XhoI, generating transient 
expression vectors for agro-infiltration. 
For the imaging experiments, we have constructed the following plasmids: pESC-
T33/DI72, pESC-C36/DI72, pYES-T92 and pYES-C95. For this, sequences of full-
length TBSV p33 (primers: #788/#810), CIRV p36 (primers: #900/#3230) and p95 
(primers: #900/#970) were PCR-amplified and digested with BamHI and XhoI, while the 
PCR-amplified sequence of TBSV p92 (primers: #4000/#826) were digested with BglII 
and XhoI. Digested PCR products were then inserted into pESC-HisCNVp33-DI72, or 
pYES-CNVp92 digested with BamHI/XhoI. 
To track viral protein localization in yeast cells, we cloned rsGFP (red-shifted) sequence 
upstream of the N-terminus of TBSV p33/p92, and CIRV p36/p95. The rsGFP sequence 
was PCR-amplified with primers #1262 
(CGGCGGATCCGGTAAAGGAGAAGAACTTTTCACT) and #1263 
(CGGCGGATCCGAGTCCGGACTTGTATAGTTCA) using pGDG vector as a template 
 15 
 
[provided by Dr. M. Goodin (115)], followed by digestion with BamHI and inserted into 
pESC-C36/DI72 or pYES-C95 digested with BamHI, generating pESC-rsGFP-C36/DI72 
and pYES-rsGFP/C95. The cDNA sequence of TBSV p33 was PCR-amplified using 
primers #4000/#810, while the cDNA sequence of TBSV p92 was PCR-amplified with 
primers #4000/#826. The obtained PRC products were digested with BglII, followed by 
ligation with the PCR-amplified rsGFP sequence digested with BamHI, generating the 
cDNAs of rsGFP-T33 and rsGFP-T92. Then, the cDNAs of rsGFP-T33 and rsGFP-T92 
were digested with BamHI and XhoI, and inserted into pESC-C36/DI72 or pYES-C95 
digested with BamHI/XhoI, resulting in pESC-rsGFP-T33/DI72 and pYES-rsGFP-T92 
expression plasmids. 
 
Agroinfiltration and RNA extraction. N. benthamiana leaves were agroinfiltrated with 
A. tumefaciens cultures containing combinations of pGD-L-T33, pGD-L-T92, pGD-L-
C36 or pGD-L-C95 as well as pGD-DI72sat and pGD-p19 as described (81).  After 3.5 
days post infiltration, agro-infiltrated leaves were collected, total RNA was extracted and 
subjected for Northern blot analysis as described (81). 
 
Preparation of CFE and soluble fraction (S100). The yeast CFE from BY4741yeast 
strain was prepared as described (49). For production of S100 soluble fraction, yeast CFE 
was further centrifuged at 100,000 g for 1 hour, and the supernatant (S100) was carefully 
collected without disturbing the pellet, and then stored at –80°C. 
 
Purification of yeast microsomal membranes. Yeast microsomes were prepared as 
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previously described (116), except that yeast microsomes were washed in 30 mM 
HEPES-KOH, pH 7.4, 150 mM potassium acetate, 2 mM magnesium acetate, containing 
complete mini Protease Inhibitor Cocktail (Roche applied science). The protein 
concentration of obtained yeast microsomal membranes was 4 mg/ml. 
 
Purification of intact yeast mitochondria. Yeast intact mitochondria were purified 
according to REF.: (117). Briefly, yeast cells were made into spheroplasts by incubating 
with 5 mg/g (wet weight) Zymolyase-20T (Seikagaku, America), and then the 
spheroplasts were homogenized and lysed with glass Dounce homogenizer in ice-cold 
homogenization buffer (0.6 M sorbitol, 10 mM Tris-HCl, pH 7.4, 1 mM PMSF, 0.2% 
(w/v) BSA). Then, the homogenized spheroplasts were centrifuged at 3,000 g for 5 min at 
4°C and the supernatant was subjected to additional centrifugation at 12,000 g for 15 min 
to obtain the crude mitochondria preparation. To further remove contaminating 
membranes, the crude mitochondrial preparation was subjected to two sequential 
centrifugations at 134,000 g on a sucrose gradient (0.7 ml 60%, 1.5 ml 32%, 0.7 ml 23% 
and 0.7 ml 15% (w/v) sucrose with 1mM EDTA and 10 mM MOPS-KOH). The purified 
mitochondrial preparation was recovered between the 60% / 32% sucrose gradient 
interface and stored in SEM buffer [250 mM sucrose, 1 mM EDTA, 10 mM MOPS-
KOH, pH 7.2, containing complete mini Protease Inhibitor Cocktail (Roche applied 
science)] at -80°C. The protein concentration was about 3 mg/ml. 
 
Isolation of oleate-induced peroxisomes using sucrose gradients. The isolation of 
peroxisomes was according to REF.: (118). Yeast was grown in peroxisome induction 
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medium containing 0.12% (w/v) oleic acid, 0.2% Tween 40, 0.5% Bacto peptone and 
0.3% yeast extract till 1.0 OD600. Cell wall was digested with Zymolyase to generate 
spheroplasts in MES buffer (5 mM MES pH5.5, 1 mM EDTA, 1 mM KCl) with 1.2 M 
sorbitol, and homogenized by gradually adding MES buffer until sorbitol concentration 
reached to 0.65 M. Unlysed cells and cell debris were removed by centrifuging at 2,000 
g, and crude peroxisome preparations were collected via centrifugation at 20,000 g. The 
crude peroxisome preparations were applied to a linear sucrose gradient (10%-80%) 
using Beckman VTi 50 rotor at 34,500 g for 2.5 hours. Fractions were collected and 
stored at -80°C.  Before in vitro replicase assembly assay, each membrane fraction (100 
µl) was thawed on ice and diluted 5x with 30% sucrose/MES buffer, followed by 
centrifugation at 20,000 g for 30 min. Then, the pellets of each fraction were carefully 
suspended into 10 µl of 30% sucrose/MES buffer. The protein density in peroxisome 
fractions #11 to #16 was about 1 mg/ml. 
 
In vitro replication assay. The yeast CFE-based replication assay was modified from Ref: 
(54) to study TBSV and CIRV replication using the isolated organelle preparations. The 
yeast cell extract (2 µl) or purified membrane fractions (1 µl) together with S100 soluble 
fraction (1 µl) was incubated at 25°C water bath for 1 hour in 8 µl cell-free replication 
buffer A containing 30 mM HEPES-KOH, pH 7.4, 150 mM potassium acetate, 5 mM 
magnesium acetate, 0.6 M sorbitol, as well as 15 mM creatine phosphate; 1 mM ATP, 
CTP, GTP and 0.025 mM UTP; 0.1 µl of [32P]UTP, 0.1 mg/ml creatine kinase, 0.1 µl of 
RNase inhibitor, 10 mM dithiothreitol, 0.5 µg DI-72 RNA transcript and 0.5 μg 
recombinant MBP-fused viral proteins. Then the volume of reaction was adjusted by 
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adding 16 l cell-free replication buffer B containing 30 mM HEPES-KOH, pH 7.4, 150 
mM potassium acetate, 5 mM magnesium acetate, together with 15 mM creatine 
phosphate; 1 mM ATP, CTP, GTP and 0.025 mM UTP; 0.2 µl of [32P]UTP, 0.1 mg/ml 
creatine kinase, 0.2 µl of RNase inhibitor, 10 mM dithiothreitol, 0.05 mg/ml actinomycin 
D. The reaction mixture was incubated at 25°C for 3 h. The reaction was terminated by 
adding 110 µl stop buffer (1% sodium dodecyl sulfate [SDS] and 0.05 M EDTA, pH 8.0), 
followed by phenol-chloroform extraction, isopropanol-ammonium acetate precipitation, 
and a washing step with 70% ethanol. RNA samples were electrophoresed in denaturing 
gel (5% PAGE containing 8 M urea) and analyzed by phosphorimager(Typhoon; GE). 
To test the effect of sorbitol on in vitro tombusvirus replication, the purified membrane 
preparations (1 µl) together with S100 fraction (1 µl) was incubated at 25 °C water bath 
for 4 hour in 24 l of modified cell-free replication buffer A containing 0, 0.2 and 0.6 M 
sorbitol. 
 
Micrococcal nuclease treatment of the in vitro replication assay mixture. The The 
replication assay was conducted as described above, except that at different time points of 
the reaction, each sample was treated with 0.25 U/µl micrococcal nuclease and 1 mM 
CaCl2 at different time point after staring of the incubation in the replication buffer A as 
described previously (54). 2.5 mM EGTA was added to each sample after 15 min 
incubation of micrococcal nuclease to stop the nuclease digestion. 
 
Replication assay to determine viral (+)RNA/(−)RNA ratio. This assay was done as 
described in a previous publication (95). Briefly, 2 µg of in vitro transcripts of minus-
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strand and plus-strand DI-72 RNAs were separately dot blotted onto a Hybond XL 
membrane (Amersham) followed by UV cross-linking. In vitro replication products were 
hybridized to the blots in ULTRAhyb solution (Ambion) at 68°C and quantified after 
washing. 
 
Western blotting. Western blotting of yeast membrane proteins was done according to 
REF.: (100). The following antibodies were used: anti-porin, anti-ALP, anti-PGK and 
anti-dpm1 (purchased from Invitrogen, CA, USA). Sec61p antibody was provided by Dr. 
Tom Rapoport from Harvard Medical School. Fox3p antibody was provided by Dr. 
Daniel J. Klionsky from University of Michigan. 
 
In vitro membrane association assay. [35S]methionine-labeled TBSV p33 and CIRV 
p36 were obtained in nuclease-treated rabbit reticulocyte lysates (Promega) in the 
presence of 400 µCi/ml [35S]methionine. 1 l of translation mixture was incubated at 
25°C for 1 hour with 2 l purified yeast microsomes or purified yeast mitochondrial 
preparations and 2 l S100 fraction in 40 l reaction containing cell-free replication 
buffer A (30 mM HEPES-KOH, pH 7.4, 150 mM potassium acetate, 5 mM magnesium 
acetate, 0.6 M sorbitol) as well as 15 mM creatine phosphate; 1 mM rNTP; 0.1 mg/ml 
creatine kinase, 0.1 µl of RNase inhibitor, 10 mM dithiothreitol, 0.5 µg DI-72 RNA 
transcript. Each reaction mixture was diluted 3 times with the cell-free reaction buffer A, 
followed by incubation on ice for 30 min. The samples were centrifuged at 100,000 g for 
2 hours. Pellet was dissolved in SDS-PAGE sample buffer. Proteins from the supernatant 
fractions were precipitated in 10% trichloroacetic acid (TCA) and dissolved in SDS-
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PAGE sample buffer. Samples were separated by SDS-PAGE. 
 
In vitro MBP pulldown assay. MBP-tagged TBSV T33 (p33), T92 (p92), CIRV C36, 
C95 and GST- His6-tagged TBSV p33C and CIRV p36C were expressed in E. coli, 
transformed with one of the following plasmids: pMAL-T33, pMAL-T92, pMAL-C36, 
pMAL-C95, pGEX-his-T33C, pGEX-his-C36C. E. coli cultures were lysed by sonication, 
followed by affinity-purification via amylose columns and washed with cold column 
buffer with high salt (10 mM Tris-Cl, pH 7.4; 1 mM EDTA, 200 mM NaCl, 10 mM 2-
mercaptoethanol) as described (119). The GST-His6-tagged p33C, GST-His6-p36C or 
GST-His6 (negative control) were incubated with the MBP-tagged proteins for 1 hour at 
4 °C and washed by column buffer with high salt. The bound proteins were eluted with 
column buffer with high salt supplemented with 10 mM maltose (119). The presence of 
GST-tagged proteins was analyzed by SDS-PAGE and Western blotting using an anti-
GST antibody. 
 
Confocal laser microscopy. Visualization of Pho86-CFP ER marker protein and various 
combination of tagged viral proteins in live yeast cells were as described previously (32, 
107). To visualize yeast mitochondrial distribution of various viral proteins, we 
transformed yeast with combinations of plasmids: pESC-GFP-T33/DI72, pESC-GFP-
C36/DI72, pYES-GFP-T92 or pYES-GFP-C95 with pESC-T33/DI72, pESC-C36/DI72, 
pYES-T92 and pYES-C95 as described in the legend to Fig. 2.9. Transformed yeast were 
grown at 23°C in minimal media supplemented with 2% galactose, and then we used 
Rhodamine B (hexyl ester-perchlorate, a mitochondria-specific dye used in yeast, Catalog 
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# R-648MP, Invitrogen, CA, USA) to visualize yeast mitochondria (120-122) with an 
Olympus FV1000 microscope (Olympus America Inc., Melville, New York). 
 
2.3 Results 
CIRV replication proteins support RNA replication in yeast cell-free preparations in 
vitro. We have previously shown that TBSV can efficiently replicate in cell-free extracts 
(CFE) prepared from yeast (4, 49, 102). The CFE-based TBSV replication assay 
contained purified recombinant TBSV p33 and p92pol replication proteins and T7 
polymerase-made DI-72 (+)-stranded replicon (rep)RNA transcripts. The CFE supported 
one single cycle of replication, starting with (-)RNA synthesis on the added (+)repRNA 
transcripts, followed by robust synthesis of (+)repRNA progeny (4, 49, 102). The CFE-
based assay recapitulated the known features of TBSV replication, including the 
requirement of cis-acting viral RNA elements, dependence on viral and host factors and 
the need for both membranous and soluble fractions of CFE. Other features of the assay 
included asymmetrical replication, leading to 10-to-40-fold more (+) than (-)RNA; 
association of the VRCs with membranes that led to protection against ribonucleases and 
proteases after the assembly of VRCs; the release of (+)repRNA progeny to the soluble 
fraction during the reaction, while retaining the (-)repRNA in the VRCs (4, 49, 102).  
 To test if CIRV replication proteins, which are originally associated with 
mitochondrial membranes (19, 48), could support repRNA replication in the CFE-based 
assay, we added purified recombinant p36 and p95pol (called C36 and C95 in this paper to 
discriminate them form the homologous TBSV p33 and p92pol, named T33 and T92) in 
combination with the TBSV-derived DI-72(+) repRNA to yeast CFE. Interestingly, we 
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observed the replication of repRNA in samples containing both C36 and C95 (Fig. 2.1A, 
lane 7), which reached about 10% of that supported by T33/T92 (lane 1). No replication 
was observed when C95 protein was omitted from the CFE-based assay (Fig. 2.1A, lane 
8), confirming that both CIRV replication proteins are required for repRNA replication. 
The supernatant or membrane fractions of CFE alone or the Triton X100-treated CFE 
could not support repRNA replication in the presence of C36 and C95 (Fig. 2.1A, lanes 
10-12), similar to that observed with T33/T92 (lanes 4-6). Thus, these experiments 
showed that the CIRV C36/C95 replication proteins could support repRNA replication in 
CFE, albeit with reduced efficiency when compared with the TBSV T33/T92 replication 
proteins.  
 To further test the CIRV replication process in the yeast CFE, we estimated the 
ratio of newly made (+)-strand versus (-)-strand repRNA levels in the replication assay 
(Fig. 2.1C). This showed that, similar to the TBSV replication proteins, the CIRV 
replication proteins also performed asymmetrical viral RNA synthesis by producing ~10 
times more new (+)-strands than (-)-strands in the yeast CFE (Fig. 2.1C).    
 Since the repRNA was the TBSV-derived DI-72 in the above assays, it is possible 
that the reduced replication was due to the less efficient utilization of the heterologous 
repRNA by the CIRV replication proteins in comparison with repRNA replication 
supported by the homologous TBSV replication proteins. To test this possibility, we also 
used the CIRV-derived DI-1 repRNA (14) in the CFE-based assay. These experiments 
revealed that both repRNAs were used more efficiently by T33/T92 than C36/C95 in 
vitro (Fig. 2.1B, and D, lanes 1-2 versus 3-4). Thus, the viral replication proteins 
determine the efficiency of repRNA replication in this assay. 
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Heterologous combinations of replication proteins supports RNA replication in yeast 
cell-free preparations in vitro and in planta. To test if the heterologous combinations of 
tombusvirus replication proteins could support repRNA replication, we used the CFE-
based assay with the purified recombinant proteins. The CFE-based assay revealed that 
the heterologous combinations of replication proteins did support repRNA replication 
(Fig. 2.1B and D, lanes 5-8), albeit less efficiently than T33/T92 (Fig. 2.1B and D, lanes 
1-2). Moreover, we observed that the viral RdRp protein was the major factor controlling 
the efficiency of repRNA replication. Accordingly, the homologous combination of 
T33/T92 (Fig 2.1B and D, lanes 1-2) or the heterologous combination of C36/T92 (lanes 
5-6) supported more efficient replication than C36/C95 (lanes 3-4) or T33/C95 (lanes 7-
8). Thus, it seems that T92 RdRp protein is ~6-20-fold more active in the CFE-based 
assay than C95 RdRp. However, the small replication protein also affected the efficiency 
of replication since the combinations of replication proteins that included T33 supported 
up to ~3-fold more replication than C36 in a complex with the RdRp protein (compare 
T33/T92 versus C36/T92; Fig. 2.1B and D, lanes 1-2 versus 5-6). 
 To test if the tombusvirus replication proteins behave similarly in plant cells, we 
used an agro-infiltration-based approach to express the TBSV and CIRV replication 
proteins and DI-72 repRNA in Nicotiana benthamiana. These experiments also revealed 
that T33/T92 combination supported repRNA replication more efficiently (Fig. 2.2, lanes 
1-4) than C36/C95 (lanes 5-8). However, the use of heterologous combination of 
tombusvirus replication proteins revealed that T33 replication protein and not the T92 
replication protein is responsible for the enhanced level of replication in plants (Fig. 2.2). 
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This difference between in vitro and in planta data could be due to the ability of T33 or 
C36 to induce membrane proliferation in plant cells that promote more efficient 
replication (these features cannot manifest in the CFE). Nevertheless, the in planta 
experiments demonstrated that the heterologous combinations of tombusvirus replication 
proteins are functional in supporting repRNA replication.  
 Tombusvirus replication depends on the interaction between the S1/S2 
subdomains common in the T33/C36 RNA chaperone and T92/C95 RdRp proteins, 
which is needed for the assembly of the functional VRC (11). The above observations 
that the heterologous combinations of tombusvirus replication proteins support 
tombusvirus RNA replication in the CFE assay and in planta suggest that the 
heterologous replication proteins likely interact with one another. To test the 
heterologous interactions, we performed pull-down assay with immobilized MBP-tagged 
viral replication proteins and the GST-tagged T33C (the C-terminal half, p33C) or GST-
C36C (the C-terminal half, p36C). This assay confirmed interaction between the 
heterologous replication proteins that were comparable with the interaction between the 
homologous replication proteins (Fig. 2.2B). 
 
Tombusviruses can replicate in microsomal and mitochondrial preparations in vitro. 
To better understand the role of different subcellular membranes in tombusvirus 
replication and to test what subcellular membranes can be used for repRNA replication 
by TBSV and CIRV replication proteins in vitro, we isolated microsomal (representing 
the ER membrane), peroxisomal and mitochondrial fractions from yeast, followed by in 
vitro replication assay with purified recombinant tombusvirus replication proteins (Fig. 
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2.3A). Interestingly, we found that the microsomal preps, which lacked detectable 
peroxisomal and mitochondrial marker proteins (Fig. 2.3B, bottom panels), supported 
repRNA replication ~16-fold more efficiently in the presence of T33/T92 than C36/C95 
and the S100 fraction of CFE (the membrane-free supernatant that provides essential 
soluble host proteins) (Fig. 2.3B, lane 1 versus 2). These data suggest that the isolated ER 
membrane can support the assembly of both TBSV and CIRV VRCs, although the CIRV 
replication proteins show poor activity in this environment. 
 To test if viral RNA synthesis includes the full cycle of replication in the 
microsomal preparations, we estimated the ratio of newly made (+)-strand versus (-)-
strand repRNA levels in the in vitro replication assay (Fig. 2.3C). Interestingly, both 
TBSV and CIRV replication proteins supported asymmetrical viral RNA synthesis by 
producing ~11-14 times more new (+)-strands than (-)-strands in the microsomal 
preparations (Fig. 2.3C). Thus, even CIRV replication proteins are capable of supporting 
full replication, albeit less efficiently than the TBSV replication proteins, in the 
microsomal preparations.  
 Similar experiments with purified mitochondrial preparations revealed that both 
TBSV and CIRV replication proteins supported repRNA replication in vitro (Fig. 2.3D). 
Thus, unlike with the microsomal preparations, the CIRV replication proteins are fully 
active on the mitochondrial membrane, which is also used by CIRV in yeast and plants 
(19, 48). Both TBSV and CIRV replication proteins supported asymmetrical viral RNA 
synthesis by producing ~9-10 times more new (+)-strands than (-)-strands in the 
mitochondrial preparations (Fig. 2.3E). Thus, these data indicate that the mitochondrial 
membrane can support full TBSV and CIRV replication in vitro. 
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 Unfortunately, the isolated oleate-induced peroxisomal preparations did not 
support repRNA replication with TBSV and CIRV replication proteins (not shown). 
Therefore, we decided to test tombusvirus RNA replication using sucrose-gradient 
fractionated crude mitochondrial and peroxisomal preparations (Fig. 2.4). We found that 
fractions 12 to 16 of the crude peroxisomal preparation (obtained from yeast after 
induction with oleic acid), which had the highest concentration of Fox3 peroxisomal 
marker (Fig. 2.4A, lanes 12-16), while contained Sec61 ER marker or porin 
mitochondrial marker proteins in small amounts, did not support repRNA replication by 
C36/C95 and T33/T92. The only repRNA replication with C36/C95 and T33/T92 was 
seen with fractions 3-to-11, which contained the highest amount of contaminating ER and 
mitochondrial membranes (based on the presence of Sec61 ER and porin mitochondrial 
marker proteins in these fractions) (Fig. 2.4A, lanes 3-11). Based on these data, we 
conclude that the peroxisomal preparations obtained from yeast induced by oleic acid 
cannot support tombusvirus replication in vitro. This could be due to the fragile nature of 
the peroxisomes during the isolation procedure or other unknown factors. 
 In contrast, fractions 17 and 18 of the crude mitochondrial preparation (after high 
speed centrifugation in sucrose-gradient) supported repRNA replication by C36/C95 and 
T33/T92 at the highest efficiency (Fig. 2.4B, lanes 17-20). These fractions were enriched 
for mitochondria since they had the porin mitochondrial marker protein in the highest 
concentration, but contained Sec61 ER marker or peroxisomal, vauolar and cytosolic 
markers at low levels These data confirmed that the enriched mitochondrial membrane 
could provide suitable environment for tombusvirus VRC assembly and repRNA 
replication in vitro. 
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 Since the ER membrane has been shown to support efficient TBSV replication in 
yeast (32, 107), we decided to use both the purified microsomal and mitochondrial 
preparations for the follow up experiments. Accordingly, to further test if the microsomal 
and mitochondrial preparations could assemble authentic tombusvirus VRCs, we 
performed time-course experiments with micrococcal nuclease, which digests the 
unprotected viral RNA (Fig. 2.5A) (49, 102). Interestingly, similar to CFE (49, 102), both 
microsomal and mitochondrial preparations with C36/C95 and T33/T92 replication 
proteins protected ~15-24% of the newly made 32P-labeled repRNA (representing the 
minus- and plus-stranded replication products) if added 60 min after the start of the assay 
(Fig. 2.5B-C, lanes 5 and 15). The addition of micrococcal nuclease during the first 15 
min of the assay eliminated repRNA synthesis (Fig. 2.5B-C, lanes 2 and 12), likely due to 
the lack (or incomplete) of VRC assembly, which takes 30-60 min in vitro (49, 102). 
Altogether, we observed that the recruited repRNA becomes nuclease-protected after 30-
45 min in the microsome preparation in the presence of the viral replication proteins (Fig. 
2.5B, lanes 3 and 13), while it takes 45-60 min in the mitochondrial preparation to 
assemble VRC and protect the recruited repRNA from micrococcal nuclease (Fig. 2.5C, 
lanes 4-5 and 14-15). These data suggest that both microsomal and mitochondrial 
preparations with C36/C95 and T33/T92 replication proteins could assemble authentic 
VRCs that protect the VRC-bound viral RNA from nucleases. In addition, it seems that 
the VRC assembly with C36/C95 and T33/T92 replication proteins is faster in the 
microsomal than in the mitochondrial preparations. 
 Osmotic pressure is important during the isolation of pure and intact mitochondria 
(117). To test if the osmotic pressure is important during tombusvirus replication in vitro 
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in microsomal or mitochondrial membranes, we compared the effect of different 
concentrations of sorbitol in the assay buffer. We found that in the absence of sorbitol in 
the assay buffer, neither TBSV nor CIRV could replicate in microsomal or mitochondrial 
preparations (Fig. 2.5D, lanes 3 and 7). These data suggest that intact microsomal or 
mitochondrial membranes should be maintained to support viral VRC assembly or 
replication. On the other hand, the purified tombusvirus replicase does not require 
sorbitol for RNA synthesis in vitro (2, 92), excluding that the replicase depends on 
sorbitol for function. We propose that the sorbitol is needed in the assay buffer to keep 
the organellar membranes intact and functional during the assay. 
 
Multiple domains within the replication proteins are responsible for different level of 
tombusvirus replication in ER or mitochondrial membranes. To test what domain of the 
tombusvirus replication proteins is responsible for the observed differences between the 
TBSV and CIRV in utilizing microsomal and mitochondrial membranes, first we used 
heterologous combinations of CIRV and TBSV replication proteins to support RNA 
replication in vitro based on microsomal and mitochondrial preparations. Interestingly, 
the heterologous combination of C36/T92 supported repRNA replication almost as 
efficiently as the homologous combination of T33/T92 (Fig. 2.6A, lanes 5-6 versus 1-2) 
in the microsomal preparation, while combinations of C36/C95 and T33/C95 replication 
proteins supported repRNA replication only at ~10-15% level of T33/T92 (Fig. 2.6A, 
lanes 3-4, and 7-8 versus 1-2). Thus, we conclude that the T92 RdRp protein is far more 
active than the C95 RdRp protein and T92 is the major determinant of the efficient use of 
the ER membrane for in vitro repRNA replication. In addition, we note that T33 
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replication cofactor has a better stimulatory effect on the activity of the tombusvirus 
replicase than C36 replication cofactor in case of the ER membrane. 
 The picture was different with the mitochondrial preparation because of the 
improved stimulatory effect of the C36 replication cofactor on the activity of the 
tombusvirus replicase (Fig. 2.6B). Accordingly, high replication level was supported by 
C36/T92 and C36/C95 combinations (Fig. 2.6B). While the homologous combination of 
T33/T92 supported high level replication (Fig. 2.6B, lanes 1-2), the heterologous 
combination of T33 and C95 supported the lowest level of repRNA replication (Fig. 2.6B, 
lanes 7-8), suggesting that the T33 protein is less efficient than C36 in the mitochondrial 
membrane. The observed differences between T33 and C36 is unlikely due to differences 
in membrane associations, since we found that both T33 and C36 replication proteins 
associated with microsomal and mitochondrial membranes efficiently in vitro (Fig. 2.6C-
D).  
 Since the tombusvirus RdRp proteins have two major domains (Fig. 2.7A), we 
have made chimeric constructs between the TBSV T92 and CIRV C95 proteins as shown 
in Fig. 2.7B. The N-terminal domain of the TBSV T92 and CIRV C95 RdRp proteins is 
identical with the T33 or C36 co-factor proteins (Fig. 2.7A), while the C-terminal domain 
harbors the highly conserved RdRp functional motifs. Testing the chimeric RdRp 
proteins in microsomal preparations revealed that C36-T92 (in combination with C36 co-
factor), carrying the RdRp domain of the TBSV T92 and the N-terminal C36 domain, 
supported repRNA replication up to 40% level of combination of T33 co-factor and T92 
RdRp (Fig. 2.7C, lanes 7-8 versus 1-2). In contrast, the chimeric T33-C95 RdRp protein 
(in combination with T33 co-factor) supported repRNA replication poorly in microsomal 
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preparations (lanes 5-6). Thus, these experiments indicate that the C-terminal RdRp 
domain in T92 is responsible for the efficient utilization of the ER membrane, while the 
homologous RdRp domain of C95 is less efficient in this environment. The data also 
support that T33 over-lapping domain within the RdRp protein is more active in the ER 
than the C36 over-lapping domain. 
 Similar experiments with mitochondrial preparations revealed that the RdRp 
domain of the TBSV T92 is still ~3-fold more active than the corresponding domain of 
the CIRV C95 (compare the chimeric C36-T92 RdRp with C95 RdRp in combination 
with C36 co-factor, lanes 7-8 versus 3-4, Fig. 2.7D). However, we also observed a ~2-
fold stimulatory effect of C36 over-lapping domain when present in the RdRp protein 
(compare the chimeric C36-T92 RdRp with T92 RdRp, lanes 7-8 versus 1-2, Fig. 2.7D). 
In addition, T33 co-factor and T33-C95 RdRp combination supported low level of 
repRNA replication, demonstrating that the T33 over-lapping domain is poorly adapted to 
the mitochondrial membrane, as noted above with the heterologous combination of 
replication proteins (Fig. 2.6B, lanes 7-8). 
 Since it seems that the T33 protein and the T33 over-lapping domain when 
present in the RdRp protein is not well suited to support RNA replication in the 
mitochondrial membrane when compared with C36 cofactor, we made chimeras between 
T33 and C36 and their corresponding domains in the RdRp proteins as shown in Fig. 
2.8A, D. We have divided T33 and C36 sequences into three subdomains: the N-terminal 
subdomain known to be involved in intracellular localization of T33 and C36 cofactors 
(10, 18, 48); the central subdomain that includes the two trans-membrane sequences 
(TMD); and the C-terminal subdomain involved in protein-RNA and protein-protein 
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interactions (11, 119, 123).  
 Testing the chimeric constructs in the mitochondrial preps revealed that replacing 
the N and TMD subdomains of T33 with those of C36 in T33 cofactor and T92 RdRp 
resulted in a highly active chimera (T33c and T92c), which replicated the most efficiently 
(Fig. 2.8C, lanes 5-6 versus 1-2). This chimera, however, replicated the repRNA more 
efficiently even in the microsome preparations (Fig. 2.8B, lanes 5-6 versus 1-2), 
suggesting that chimeric tombusviruses might have increased potential to replicate in 
various intracellular membranes. These observations could be relevant for the evolution 
of tombusviruses (see Discussion). 
 
Combinations of heterologous replication proteins show both ER and mitochondrial 
localization in yeast. The in vitro data show that TBSV can efficiently replicate in both 
ER and mitochondrial membranes, while the CIRV replication proteins favor the 
mitochondrial membrane over the ER membrane to support viral repRNA replication. To 
test if the tombusvirus replication proteins can indeed utilize these membranes in cells, 
we performed localization studies with GFP-, YFP- and CFP-tagged proteins in yeast 
using homologous and heterologous combinations of the tombusvirus replication proteins.  
 As expected, the homologous combination of T33/T92 localized mostly in the ER 
membrane in yeast (in pex3∆ yeast to mimic the in vitro situation with isolated 
microsomal preparations by using yeast lacking peroxisomes) based on the Pho86 ER 
protein, while only a small fraction of C36 and C95 localized to the ER membrane, albeit 
these proteins were frequently located in the vicinity of the ER (Fig. 2.9A). On the 
contrary, the homologous combination of C36 and C95 localized mostly in the 
 32 
 
mitochondrial membranes in yeast based on Rhodamine B-staining (a mitochondrial dye 
used in yeast) (120-122), while only a small fraction of T33 and T92 localized in the 
mitochondrial membranes (Fig. 2.9B). Indeed, most of T33 and T92 proteins did not co-
localize with MTS-CFP mitochondrial marker protein or with Rhodamine B 
mitochondrial dye (Fig. 2.9B). Altogether, these experiments established that the 
homologous combination of T33/T92 is mostly localized in the ER (in pex3∆ yeast) and a 
fraction in the mitochondria, while C36/C95 is located in the mitochondrial membrane as 
shown previously (32, 48, 107).   
 To test the membrane preference of the heterologous combinations of the 
tombusvirus replication proteins in pex3∆ yeast, first we performed co-localization 
studies. We found that the heterologous combinations of either T33/C95 or C36/T92 are 
co-localized in yeast cells (Fig. 2.9C). Second, we performed subcellular localization of 
YFP-C95 in pex3∆ yeast co-expressing T33, which showed partial co-localization with 
the CFP-Pho86 ER marker protein (Fig. 2.9D) and the mitochondrial dye (Fig. 2.9E). 
Similarly, YFP-T33 showed partial co-localization with the CFP-Pho86 ER marker 
protein (Fig. 2.9D) and the mitochondrial dye (Fig. 2.9E) in yeast co-expressing the 
heterologous C95. Thus, it seems that T33 and C95, albeit they are co-localized, they are 
present in both ER and mitochondria, with fractions of the T33 and C95 molecules 
divided between the two organelles.  
 Intriguingly, we observed similar split/divided distribution of C36 and T92 
between the ER and mitochondrial membranes (Fig. 2.9F-G) in heterologous co-
expression studies in pex3∆ yeast. Therefore, we suggest that the tombusviruses 
replication proteins can be localized to both ER and mitochondrial membranes in yeast 
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co-expressing the heterologous combinations (T33/C95 or C36/T92) of replication 
proteins. This distribution could be interesting during tombusvirus evolution by allowing 
less restricted use of subcellular membranes by putative interviral tombusvirus 
recombinants (see discussion). 
 
2.4 Discussion 
All known (+)RNA viruses of plants and animals depend on various subcellular 
membranes for their replication. Yet, we do not know why different (+)RNA viruses 
select different subcellular membranes/compartments for replication. Tombusviruses 
could be valuable for understanding the roles of various subcellular membranes in viral 
replication since they show different preferences. For example, TBSV, CNV and 
CymRSV preferably utilize the peroxisomal membranes, or in the absence of 
peroxisomes, the ER membranes (10, 18, 32, 107, 113). On the other hand, CIRV 
replicates in the mitochondrial membranes (19, 48). At a late stage of tombusvirus 
replication in plants, however, large multivesicular bodies form that frequently contain 
ER membranes and mitochondria as well (124). These observations suggest complex 
interactions between subcellular membranes and tombusvirus replication proteins.  
 In this paper, we have developed in vitro tombusvirus replication assays with 
isolated organelles (Fig. 2.3) or enriched organellar preparations (Fig. 2.4) to directly 
address the roles of the various subcellular membranes in tombusvirus replication. We 
have shown that (i) both (+) and (-)-strand RNA synthesis occurring in these assays; (ii) 
the process is asymmetrical leading to excess amount of (+) over (-)-strands; (iii) 
membrane-bound replicase complex forms; (iv) there is requirement of cellular factors; 
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(v) there is requirement of both p33 and p92 replication proteins for replication; (vi) the 
newly made (+) RNAs are released to the solution; (vii) while the (-) RNA is kept 
protected in the replicase bound to the membrane. All these pieces of evidence support 
that the tombusvirus replication in the isolated organelles is a complete cycle of authentic 
replication process, similar to that developed using the whole CFE (49, 102).  
 Interestingly, we find that TBSV replication proteins utilized the isolated ER 
membrane efficiently for repRNA replication, while the CIRV replication proteins did 
not (Fig. 2.3-2.4). These data are in agreement with the in vivo observations that TBSV 
uses the ER membranes (in the absence of the peroxisomes), while CIRV favors the 
mitochondria for replication in yeast and plant cells (10, 19, 32, 48, 107, 113). 
Surprisingly, however, TBSV was also able to utilize the isolated mitochondria for 
replication (Fig. 2.3-2.4), suggesting that this tombusvirus could be less restricted in its 
ability to utilize subcellular membranes. Indeed, we did see some co-localization of 
TBSV T33 and T92 replication proteins with mitochondrial markers (based on both 
MTS-CFP and a mitochondrial dye, Fig. 2.9B) in pex3∆ yeast, suggesting that 
mitochondria is likely used for TBSV replication at some extent, possibly at the late stage 
of replication when peroxisomal or ER membranes had already been fully exploited. 
Similarly, we observed some co-localization of CIRV C36 and C95 replication proteins 
with the ER marker protein (Fig. 2.9A), supporting that ER membranes might be targeted 
for CIRV replication. However, the activity of the CIRV replicases in the ER membranes 
is likely less robust than in the mitochondrial membranes, based on the in vitro 
experiments with the isolated microsomes (Fig. 2.3). Altogether, the in vitro and in vivo 
experiments suggest that TBSV show rather high flexibility in membrane utilization for 
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replication, while CIRV is somewhat more restricted, at least in vitro.  
 Unfortunately, we failed to obtain peroxisomal preparations supporting either 
TBSV or CIRV replication from yeast cultured in oleic acid media to induce peroxisome 
formation (Fig. 2.4). It is possible that peroxisomes are too fragile and damaged during 
the isolation procedure. It is also possible that the oleic-acid induced peroxisomes are not 
suitable to support TBSV replication. Indeed, addition of oleic acid to the culture media 
did not increase TBSV replication in yeast (Panavas and Nagy, unpublished). Therefore, 
it is highly likely that the CFEs obtained from yeast support TBSV replication occurring 
mainly in the ER-derived membranes (Fig. 2.1). Because ER is as suitable to support 
TBSV replication as the peroxisomes in yeast (32, 107), the obtained in vitro data are 
likely valuable in dissecting TBSV replication in vitro. We also propose that the CFE 
likely supports weak CIRV replication (when compared with TBSV) due to the limiting 
amount of mitochondria present in the CFE prepared from yeast cultured under the 
standard conditions. Indeed, comparison of CFE (Fig. 2.1) and microsomal and 
mitochondrial preps (Figs. 2.3-2.4) revealed similarity between CFE and microsomal 
preparations, suggesting that most of the in vitro repRNA replication in the CFE is likely 
supported by the ER membrane. This could be due to the growth conditions for yeast, 
which favors the presence of low number of mitochondria and peroxisomes, but abundant 
ER membranes (125). The isolated mitochondrial preparation, however, supported CIRV-
based repRNA replication efficiently, making this approach suitable for future 
mechanistic studies. 
Combinations of heterologous replication proteins reveal remarkable flexibility of 
membrane usage by tombusviruses. One of the surprising discoveries from the in vitro 
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tombusvirus replication assays with the combinations of heterologous replication proteins 
is the extended ability of tombusviruses to utilize subcellular membranes more efficiently 
than some homologous combinations. For example, CIRV C36 and C95 co-localized 
more efficiently with the ER membranes when present in heterologous than in 
homologous combinations (Fig. 2.9). Moreover, the CIRV C36 protein became part of a 
more efficient replicase in the ER membranes when associated with T92 RdRp protein 
than in homologous combination with C95 (Fig. 2.6A) without becoming less efficient in 
the mitochondrial membrane (Fig. 2.6B). Also, the TBSV T92 RdRp showed increased 
activity in the mitochondrial membrane when combined with C36 cofactor than in 
combination with TBSV T33 (Fig. 2.6B).  This suggests that tombusviruses might be able 
to utilize various subcellular membranes more efficiently during some co-infections with 
other tombusviruses when compared with single infections. 
 Even more interesting is the possibility of generation of chimeric tombusviruses 
due to RNA recombination between tombusviruses. RNA recombination is well 
documented for tombusviruses in vitro, in yeast, and in planta (16, 17, 93, 94, 126-130). 
The formation of chimeric tombusviruses could expand the efficiency of using various 
subcellular compartments by the tombusvirus replicase, based on the chimeric constructs 
tested in Figs. 2.7-2.8. Indeed, particular chimeric constructs replicated efficiently in both 
ER and mitochondrial preps (e.g., T33c/T92c, Fig. 2.8). We propose that the extra 
flexibility in membrane-usage by these chimeric tombusviruses could be useful for 
tombusviruses when infecting some plant species, thus expanding the wide range of 
plants supporting tombusvirus replication. Accordingly, recombinant CIRV strains were 
recently isolated that had similar N-terminal sequences to the TBSV p33 replication 
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protein and targeted the peroxisome for replication (131, 132). Thus, recombination 
involving the p33/p36 ORF can occur in nature creating new variants or strains. 
 
Adaptation to subcellular membranes for robust tombusvirus replication depends on 
multiple domains within the replication proteins. The heterologous combinations of 
tombusvirus replication proteins revealed that T92 and C95 are major determinants of 
repRNA replication in particular subcellular membranes. For example, the C95 RdRp 
was mostly functional in the mitochondrial preps, while the T92 RdRp was active in both 
microsomal and mitochondrial preps (Fig. 2.6C-D). Furthermore, the results with 
chimeric proteins suggest that the RdRp domain in T92 is very active in both microsomal 
and mitochondrial preps (Fig. 2.7C-D), while the origin of the N-terminal, overlapping 
domain in the tombusvirus RdRp was also important for the activity of VRC during 
replication. Therefore, we suggest that multiple domains within the replication proteins 
affect the ability and efficiency of the tombusvirus VRCs to support repRNA replication 
in particular subcellular membranes. It is also possible that C36 forms a single 'domain' 
that favors mitochondrial targeting as a whole, and swapping its C-terminal and/or trans-
membrane regions with corresponding regions of T33 disrupts the structure necessary for 
specific targeting to mitochondria.  
 Altogether, the developed in vitro tombusvirus replication assays based on CFE, 
isolated microsomes and mitochondrial preparations will be powerful to gain mechanistic 
insights into the roles of membranes in (+)RNA virus replication, virus-host interactions 
and possibly viral evolution. 
Copyright © American Society for Microbiology  
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Fig. 2.1 In vitro reconstitution of the CIRV replicase in yeast cell extract.  
(A) Purified recombinant p33 (named T33) and p92pol (named T92) replication proteins 
of TBSV or purified recombinant p36 (named C36) and p95pol (named C95) replication 
proteins of CIRV in combination with the TBSV-derived DI-72 (+)repRNA were added 
to the cell extract (lanes 1 and 7), to the membrane plus soluble fractions (lanes 3 and 9), 
to the soluble fraction (lanes 4 and 10), to the 1% Triton-treated membrane plus soluble 
fractions (lanes 5 and 11), and to the membrane fraction (lanes 6 and 12) of the yeast cell 
extract. The CFE-based replication assay mixture lacked T92 (lane 2) or C95 (lane 8) as a 
negative control. Denaturing PAGE analysis of the 32P-labeled repRNA products 
obtained is shown. The full-length repRNA is indicated by an arrowhead. The result of 
the CFE-based replication assay with T33 and T92 was chosen as 100% (lane 1). (B) The 
heterologous combinations of TBSV and CIRV replication proteins are functional in the 
CFE-based replication assay. The activity of the reconstituted tombusvirus replicases is 
estimated as for panel A. Denaturing PAGE analysis of the replicase products is as shown 
in panel A. (C) Detection of plus- and minus-stranded RNA products produced by the 
reconstituted TBSV and CIRV replicases in the CFE-based replication assay. The blot 
contains the same amounts of cold plus- and minus-strand DI-72 RNA, while the 32P-
labeled repRNA probes were generated in the CFE-based replication assay. Note that we 
used 5 times more CIRV replication products than TBSV to increase the signal. The ratio 
of plus- and minus-strand RNA products was estimated. (D) The heterologous 
combinations of TBSV and CIRV replication proteins with the CIRV-derived DI-1 
repRNA are functional in the CFE-based replication assay. See further details described 
for panel B. Each experiment was repeated. 
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Fig. 2.2 The heterologous combinations of TBSV and CIRV replication proteins are 
functional in N. benthamiana.  
The accumulation of DI-72 repRNA was measured by Northern blotting in N. 
benthamiana leaves. The expression of TBSV and CIRV replication proteins and the 
repRNA was launched from the 35S promoter in an Agrobacterium plasmid (introduced 
into the leaves via agroinfiltration). Samples were taken from the infiltrated leaves at 3.5 
days after infiltration. Note that coagroinfiltration of single protein-expressing constructs 
with the repRNA-expressing construct did not result in repRNA accumulation (lanes 17 
to 24). Each experiment was repeated. (B) Affinity binding (pulldown) assay to detect 
interaction between GST-His6-p33C (representing the C-terminal half of T33, involved 
in protein interaction) or GST-His6-p36C (representing the C-terminal half of C36) and 
the MBP-tagged TBSV and CIRV replication proteins. The MBP-tagged TBSV and 
CIRV replication proteins and the MBP produced in E. coli were immobilized on 
amylose-affinity columns. GST-His6-tagged p33C or GST-His6-p36C expressed in E. 
coli was then passed through the amylose affinity columns with immobilized MBP-
tagged proteins. The affinity-bound proteins were specifically eluted with maltose from 
the columns. The eluted proteins were analyzed by Western blotting with anti-6×His or 
anti-GST antibody to detect the amount of GST-His6, GST-His6-p33C, or GST-His6-
p36C specifically bound to MBP-tagged viral proteins. A similarly produced GST-His6 
protein preparation was used as a negative control. 
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Fig. 2.3 In vitro reconstitution of the TBSV and CIRV replicases in yeast microsome 
and mitochondrial preparations.  
 
(A) Scheme of the replication assays. The purified recombinant T33 and T92 as well as 
C36 and C95 replication proteins and the TBSV-derived (+)repRNA were used as 
described for Fig. 2.1. (B) Top panel, denaturing PAGE analysis of the 32P-labeled 
repRNA products obtained in the replication assays with the isolated yeast microsome 
preparation. The synthesized full-length repRNA is indicated by an arrowhead. The result 
from the replication assay with T33 and T92 was chosen as 100% (lane 1). Each 
experiment was repeated. Bottom panels, Western blot analysis of various marker 
proteins in the microsome preparation with the help of specific antibodies. The left lane 
represents the standard yeast proteins present in CFE as positive controls. (C) Detection 
of plus- and minus-strand RNA products produced by the reconstituted TBSV and CIRV 
replicases in the microsome-based replication assay. See further details described for Fig. 
2.1C. (D) The TBSV and CIRV replication proteins are functional in the mitochondrion-
based replication assay. Top panel, the activity of the reconstituted tombusvirus 
replicases is estimated as for panel B. Denaturing PAGE analysis of the replicase 
products is as shown for panel B. Note that we used the 2× purified mitochondria 
preparations for this assay. Bottom panels, Western blot analysis of various marker 
proteins in the microsome preparations with the help of specific antibodies. The left lane 
represents the standard yeast proteins from yeast induced with oleic acid as positive 
controls. The crude mitochondrial sample was prepared without sucrose density gradient 
centrifugation, while 1× and 2× indicate single and double sucrose density gradient-
purified mitochondrial preparations, respectively. (E) Detection of plus- and minus-strand 
RNA products produced by the reconstituted TBSV and CIRV replicases in the 
mitochondrion-based replication assay. See further details described for Fig. 2.1C. 
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Fig. 2.4 In vitro reconstitution of the TBSV and CIRV replicases in yeast membrane 
fractions.  
 
(A) Yeast was grown on oleate-rich medium to increase peroxisome numbers prior to 
isolation. The crude peroxisome sample was subjected to 10 to 70% sucrose density 
gradient centrifugation, and the fractions of the sucrose gradient were tested for the 
ability to support RNA replication by the CIRV or TBSV replicases assembled in vitro. 
The purified recombinant T33 and T92 as well as C36 and C95 replication proteins and 
the TBSV-derived (+)repRNA were used as described for Fig. 2.1. Top two panels, 
denaturing PAGE analysis of the 32P-labeled repRNA products obtained in the 
replication assays with various membrane fractions. The synthesized full-length repRNA 
is indicated by an arrow. The most active fraction in the replication assay was chosen as 
100%. The fractions most enriched for peroxisome are boxed with dotted lines. The 
samples on the left represent the top of the gradient (10%), while the samples on the right 
are from the bottom of the gradient (70%). Bottom panels, Western blot analysis of 
various marker proteins in the membrane fractions with the help of specific antibodies. (B) 
The crude mitochondrial sample was subjected to 10 to 70% sucrose density gradient 
centrifugation, and the fractions of the sucrose gradient were tested for the ability to 
support RNA replication by the CIRV or TBSV replicases assembled in vitro. The most 
active fraction in the replication assay was chosen as 100%. The fractions most enriched 
for mitochondria are boxed with dotted lines. See further details described for panel A. 
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Fig. 2.5 The in vitro-assembled TBSV or CIRV replicases form an RNase-resistant 
structure in microsomal or mitochondrial preparations.  
 
(A) Scheme of the in vitro assay. The in vitro reconstitution of the TBSV or CIRV 
replicases is started by the addition of purified recombinant T33 and T92 as well as C36 
and C95 replication proteins and the TBSV-derived (+)repRNA (zero time point) as 
described for Fig. 2.1. Note that we applied a 15-min treatment with micrococcal 
nuclease (which was inactivated by addition of EGTA at the end of the treatment) at 
various time points, followed by RNA synthesis up to 4 h (total length of incubation). (B 
and C) Denaturing PAGE analysis of the 32P-labeled repRNA products obtained. Note 
that only the VRC-bound (membrane-associated) repRNA is resistant to nuclease 
treatment and not the (+)repRNA released to the buffer from the VRCs. (B) Results with 
microsomal preparations; (C) results with mitochondrial preparations. (D) Intact 
organellar membranes are required for tombusvirus replication in vitro. Various amounts 
of sorbitol in the assay buffer were used to test TBSV and CIRV replication. 
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Fig. 2.6 In vitro reconstitution of heterologous combinations of tombusvirus replicases 
in yeast microsome and mitochondrial preparations.  
 
(A) Denaturing PAGE analysis of the 32P-labeled repRNA products obtained in 
replication assays with the isolated yeast microsome preparation. The synthesized full-
length repRNA is indicated by an arrow. The result from the replication assay with T33 
and T92 was chosen as 100% (lanes 1 and 2). (B) Denaturing PAGE analysis of the 32P-
labeled repRNA products obtained in the replication assays with the isolated yeast 
mitochondrial preparation. (C) SDS-PAGE analysis of microsome membrane association 
assay using [35S]methionine-labeled recombinant T33 or C36 and a microsome 
preparation in the presence of the soluble extract from yeast. The bottom panel (encircled) 
represents samples incubated in the absence of the microsome preparation. (D) 
Mitochondrial membrane association assay. [35S]methionine-labeled recombinant T33 or 
C36 was used with the mitochondrial preparation in the presence of the soluble extract 
from yeast. Asterisks represent 35S-labeled proteins. See further details described for 
panel C. 
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Fig. 2.7 In vitro reconstitution of chimeric tombusvirus replicases in yeast microsome 
and mitochondrial preparations.  
 
(A) The known functional domains in the TBSV p33 RNA chaperone and the p92pol 
RdRp protein. The N-terminal segment in p92pol contains the same sequence as in p33 
due to the strategy for overlapping expression of the TBSV genome, while the C-terminal 
region of p92pol carries the RdRp domain. mPTS, peroxisomal membrane targeting 
sequences; ub, monoubiquitinated region; TMD, transmembrane domains; late domain, 
sequence recognized by the ESCRT factors; P, phosphorylation sites; RPR, arginine-
proline-rich RNA binding domain; S1 and S2, subdomains of the p33:p33/p92 interaction 
domain. (B) Schematic representation of the chimeric RdRp proteins made between the 
corresponding TBSV and CIRV replication proteins as shown. (C) Denaturing PAGE 
analysis of the 32P-labeled repRNA products obtained in replication assays using the 
chimeric RdRp proteins based on the isolated yeast microsome preparation. The 
synthesized full-length repRNA is indicated by an arrow. The result from the replication 
assay with T33 and T92 was chosen as 100% (lanes 1 and 2). (D) Denaturing PAGE 
analysis of the 32P-labeled repRNA products obtained in the replication assays with the 
chimeric RdRp proteins using the isolated yeast mitochondrial preparation. See further 
details described for panel C. 
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Fig. 2.8 
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Fig. 2.8 In vitro reconstitution of additional chimeric tombusvirus replicases in yeast 
microsome and mitochondrial preparations.  
 
(A) Schematic representation of the chimeric replication proteins made between the 
corresponding TBSV and CIRV replication proteins as shown. The T33 and C36 
sequences were divided into three segments based on the known functions/roles (see Fig. 
2.7A). (B) Denaturing PAGE analysis of the 32P-labeled repRNA products obtained in 
replication assays using the chimeric tombusvirus replication proteins based on the 
isolated yeast microsome preparation. The synthesized full-length repRNA is indicated 
by an arrow. The result from the replication assay with T33 and T92 was chosen as 100% 
(lanes 1 and 2). (C) Denaturing PAGE analysis of the 32P-labeled repRNA products 
obtained in the replication assays with the chimeric tombusvirus replication proteins 
using the isolated yeast mitochondrial preparation. See further details described for panel 
B. (D) Coomassie blue-stained SDS-PAGE of the affinity-purified replication proteins 
expressed in E. coli as MBP fusion proteins. 
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Fig. 2.9 
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 Fig. 2.9 Distribution of TBSV and CIRV replication proteins when expressed in 
heterologous combinations.  
 
(A) Confocal laser microscopy images show the colocalization of Pho86p-CFP (ER 
marker protein) with YFP-T92, YFP-T33, YFP-C95, or YFP-C36 expressed from the 
GAL1 promoter in a pex3Δ yeast strain. The description on the left shows the 
combination of replication proteins expressed in yeast. The merged images show the 
colocalization of Pho86p-CFP with YFP-tagged replication proteins. Differential 
interference contrast (DIC) images are shown on the right. (B) Localization of YFP-T92 
or GFP-T92, YFP-T33 or GTP-T33, GFP-C95, or GFP-C36 expressed from the GAL1 
promoter to the mitochondria in a pex3Δ yeast strain. We used rhodamine B (RhodB, red) 
fluorescent dye to visualize the mitochondria. See further details described for panel A. 
(C) Colocalization of YFP- or CFP-tagged TBSV and CIRV replication proteins in a 
pex3Δ yeast strain. See further details described for panel A. (D) ER localization of YFP-
C95 or YFP-T33 in a pex3Δ yeast strain expressing heterologous combinations of 
tombusvirus replication proteins. See further details described for panel A. (E) 
Mitochondrial localization of GFP-C95 or GFP-T33 in a pex3Δ yeast strain expressing 
heterologous combinations of tombusvirus replication proteins. See further details 
described for panel A. (F) ER localization of YFP-T92 or YFP-C36 in a pex3Δ yeast 
strain expressing heterologous combinations of tombusvirus replication proteins. See 
further details described for panel A. (G) Mitochondrial localization of GFP-T92 or GFP-
C36 in a pex3Δ yeast strain expressing heterologous combinations of tombusvirus 
replication proteins. See further details described for panel A. Yeast was grown under 
similar conditions and images were taken as described for panel A. Each experiment was 
repeated. 
  
 56 
 
Chapter 3 
THE HOP-LIKE STRESS INDUCED PROTEIN 1 CO-CHAPERONE IS A 
NOVEL RESTRICTION FACTOR FOR MITOCHONDRIAL TOMBUSVIRUS 
REPLICATION 
(This chapter was published on Journal of Virology ahead of print at 11 June 2014, 
doi:10.1128/JVI.00561-14, Copyright © American Society for Microbiology) 
3.1 Introduction 
 
Cells produce a yet unknown number of host restriction factors that limit replication of 
plus-stranded (+)RNA viruses. The cellular restriction factors could be virus-specific or 
components of the cell-intrinsic innate systems of the host through targeting diverse 
pathogens (133-139). Cellular factors are also recruited by (+)RNA viruses to aid viral 
replication, which takes place in membrane-bound viral replicase complexes (VRCs) in 
the cytoplasm of infected cells (13, 39, 40, 73-76, 78, 79). The diverse, often opposite 
roles of host factors, is reflected by the identification of stimulatory as well as inhibitory 
host proteins in genome-wide screens with various hosts and viruses, such as tomato 
bushy stunt virus (TBSV), West Nile virus, brome mosaic virus (BMV), hepatitis C virus 
(HCV), dengue virus and Drosophila virus C (12, 95, 140-146). However, the detailed 
functions of the majority of the identified host proteins in (+)RNA virus replication have 
not been fully revealed. 
  TBSV is a plant-infecting (+)RNA virus used extensively to study virus 
replication, recombination, and virus - host interactions based on yeast (Saccharomyces 
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cerevisiae) model (1, 5, 91, 92). We have performed several genome-wide screens of 
yeast genes and different global proteomics approaches that have led to the identification 
of over 500 host genes/proteins putatively involved in TBSV replication or 
recombination (12, 93-99, 110, 126, 147-149). The above systematic screens have also 
identified host stimulatory and restriction factors of TBSV replication. For example, the 
Cyp40-like Cpr7p cyclophilin and the Ttc4 oncogene-like Cns1p co-chaperone are strong 
inhibitors of TBSV replication in yeast and in vitro (109, 150). Additional cellular 
cyclophilins, such as the CypA, and the related Ess1p parvulin also decrease TBSV RNA 
accumulation in yeast and plants (109, 110, 151). Moreover, the cellular nucleolin, an 
RNA binding protein, inhibits TBSV replication by blocking the recruitment of the viral 
RNA into replication (112). Another group of cellular restriction factors is the WW-motif 
containing host proteins, such as Rsp5p Nedd4-like E3 ubiquitin ligase, which regulate 
the degradation of tombusviral p92pol in yeast cells and inhibit the activity of VRC in 
vitro (108, 111). Cellular kinases, such as Pkc1p, could also restrict TBSV replication in 
yeast (96). Altogether, studies on cellular restriction factors could help unraveling the full 
arsenal of the native cell-intrinsic innate immune system in the host cell. 
  Similar to other (+)RNA viruses, tombusviruses, such as TBSV, uses intracellular 
membranes for replication. Interestingly, TBSV utilizes the peroxisomal membrane, 
while the closely related Carnation Italian ringspot virus (CIRV) takes advantage of the 
outer mitochondrial membranes to build VRCs in infected plants and yeast (18, 19, 48). 
The two viral replication proteins (i.e., p33 and p92pol for TBSV and p36 and p95pol in 
case of CIRV) co-opt 8-10 host proteins to assemble the tombusvirus VRC (97-99, 152). 
The highly homologous p33 of TBSV and p36 of CIRV replication proteins are master 
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regulators of replication, playing multifunctional role in recruitment of the tombusviral 
(+)RNA to the site of replication, the assembly of the VRC and viral RNA synthesis by 
acting as RNA chaperones  (3, 7, 9, 10, 32, 152). The RdRp protein p92pol of TBSV and 
p95pol of CIRV are also components of the functional VRCs (2, 9, 10, 49, 92). The 
subverted host proteins have been shown to bind to the viral RNA and the viral 
replication proteins (13, 37, 98). Detailed studies showed that heat shock protein 70 
(Hsp70), eukaryotic elongation factor 1A (eEF1A) and several members of the ESCRT 
(endosomal sorting complexes required for transport) family of host proteins are required 
for the assembly of VRCs (81, 100, 101, 103). Additional subverted host proteins include 
the DDX3-like Ded1p and the human p68-like Dbp2 DEAD-box RNA helicases, 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), eEF1Bγ and eEF1A, all of which 
have been shown to affect viral RNA synthesis (37, 103, 104, 106, 153, 154). 
  Previous works with TBSV revealed the unexpected inhibitory function for 
several TPR domain (tetratricopeptide repeats)-containing proteins, such as the Cyp40-
like Cpr7p cyclophilin and Ttc4-like Cns1p co-chaperone in yeast and in vitro (109, 150). 
Mechanistic studies showed that the inhibitory effect of Cpr7p was due to its interaction 
with the RNA-binding domain of the tombusviral p33 replication protein that leads to 
inhibition of p33/p92pol -based recruitment of the TBSV (+)RNA for replication and 
decrease of the efficiency of the VRC assembly. Importantly, the key element in Cpr7p 
was not the cyclophilin domain, but its TPR domain consisting of three TPR modules in 
Cpr7p (109). Similarly, via its TPR-domain, Cns1p bound to the tombusviral p33 and 
p92pol replication proteins and inhibited VRC assembly and reduced TBSV replication in 
yeast and in vitro based on a yeast cell-free (CFE) assay (150). However, in case of 
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Cns1p, the interaction targeted the p33:p33/p92 interaction domain, suggesting that TPR-
containing cellular proteins might restrict TBSV replication via different mechanisms. 
  The TPR domains consists of repeats of 34 amino acid sequence adopting a right-
handed helical helix-loop-helix structure with an amphipathic channel, which are 
involved in many protein-protein interactions (155, 156). Although the TPR-domains are 
highly variable, which likely affect substrate specificity, the canonical TPR-domain 
contains a pattern of small and large hydrophobic amino acids. The TPR-domain proteins 
are abundant in all kingdoms of life, including 200 proteins in mammals, 80 in C. elegans 
and 29 in yeast (157). TPR-domain proteins function in protein trafficking, protein import 
to organelles, transposon silencing, apoptosis and synaptic vesicle fusion (158, 159). 
Various TPR-domain proteins are involved in numerous human diseases, such as cancer, 
amyloidosis, cystic fibrosis, prion protein propagation, and bacterial pathogenesis (160-
165). Several TPR-domain proteins have been shown to affect infections by viruses, such 
as Chikungunya virus, West Nile virus, Vesicular stomatitis virus, herpes simplex virus, 
poxvirus, and baculovirus (166-171). TPR-domain proteins are also important in 
interferon-induced antiviral responses, including the IFIT protein family (137, 171-174). 
  Our previous discoveries invited our attention to TPR-like sequences, including 
the well-studied stress-induced protein 1 (Sti1p in yeast, Hop protein in mammals and 
plants) co-chaperone. Sti1p, which is a conserved highly abundant protein lacking 
chaperone activity on its own, is a co-chaperone of Hsp70 and Hsp90 chaperones (175, 
176). Sti1p contains three TPR domains, which are involved in binding to Hsp90s and 
Hsp70s. Sti1p plays a role in client protein transfer from the Hsp70 complex to the Hsp90 
complex. Interestingly, Sti1p can simultaneously bind to Hsp70 and Hsp90 and by 
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inhibiting the ATPase activity of Hsp90, Sti1p stabilizes the ternary Hsp70 : Hsp90 : 
client protein intermediate complex (177, 178). 
  In this paper, we show that the yeast Sti1p co-chaperone has a strong inhibitory 
function during the mitochondrial CIRV replication but not in the peroxisomal 
tombusvirus replication. Detailed analysis of Sti1p revealed that it interacted with the 
RNA-binding domain of CIRV p36 replication protein and ultimately restricted VRC 
assembly in vitro and CIRV RNA accumulation in yeast and the orthologous Hop 
inhibited CIRV accumulation in plants. Thus, TPR-containing cellular co-chaperone 
proteins emerge as new cell-intrinsic restriction factors of a mitochondrial (+)RNA virus. 
 
3.2 Materials And Methods 
 
Yeast strains and expression plasmids. Yeast strains BY4741 (MAT a his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0) and sti1Δ (single-gene deletion strain) were obtained from Open 
Biosystems (Huntsville, AL, USA). For tombusviral replication in yeast, pESC-
HisCNVp33-DI72, pYES-CNVp92, pESC-C36/DI72, pYES-C95 were described 
previously (9). To generate pESC-C36/DI1, CIRV DI-1 (14) (constructed by D. Barajas 
and Nagy, unpublished) was PCR-amplified using primers #4124 
(CCGGAATTCAGAAATATCTCAGGATTTGACCGTCC)/#1069(CCGGTCGAGCTC
TACCAGGTAATATACCACAACGTGTGT) and digested with EcoRI/SacI, then 
inserted into EcoRI/SacI-digested pESC-HisCNVp33-DI72, generating pESC-
HisCNVp33-DI1. Then, CNV p33 sequence was removed by BamHI/XhoI digestion, and 
replaced with BamHI/XhoI-digested CIRV p36 sequence, which was PCR-amplified from 
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pESC-C36/DI72 using primers #900 
(CGACGGATCCGAGGGTTTGAAGGCTGAGTCTACCA)/#3230 
(CCGCTCGAGCTATTT-GACACCGAGGGATT), generating pESC-C36/DI1. To 
generate Twin-Strep-tagged CIRV and CNV replication proteins, the following primer 
pairs: #5351 (CATCCACAATTCGAAAAATCTGCTGGTGGAGGTGG-
ATCCATGGATACCATCAAGAGGATG)/#952 (CCCGCTCGAGTCATGCTACGG-
CGGAGTCAAGGA), #5350 
(GTGGTTCTGGTGGTGGTTCTGGTGGTTCTGCTTGG-
TCTCATCCACAATTCGAAAAATCTG)/#952, #5349 (GGAAGATCTAAAAA-
TGTCTGCTTGGTCTCATCCACAATTCGAAAAAGGTGGTGGTTCTGGTGGTGGT
TCTGGTGG)/#952, were sequentially used for PCR using template pYES-CNVp92 to 
introduce Twin-Strep tag on CNV p92, generating Twin-Strep-tagged CNVp92  
sequence. The DNA was then digested with BglII/XhoI and inserted into pESC-DI72, 
generating pESC-StrepCNVp92/DI72. CIRV p36 sequence was PCR-amplified using 
primers #900/#3230 and digested with BamHI/XhoI, and then inserted into BamHI/XhoI-
digested pESC-StrepCNVp92/DI72, generating pESC-StrepC36/DI72. To generate 
pYES-StrepC95, pYES2-NTA (Invitrogen) was digested with HindIII/KpnI and then 
treated with T4 DNA polymerase, and subsequently self-ligated to remove 6xHis tag. The 
modified pYES2-NTA vector without 6xHis tag was digested with BamHI/XhoI and used 
with BglII/XhoI-digested PCR product of Twin-strep-tagged CNVp92 for ligation, 
generating pYES-StrepC92. CIRV p95 sequence was PCR-amplified using primers 
#900/#970 (CCCGCTCGAGTCAAGCTACGGCGGAGTCGAGGA) from pYES-C95 
and digested with BamHI/XhoI, and then inserted into BamHI/XhoI-digested pYES-
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StrepC92, generating pYES-StrepC95. To generate yeast vector expressing STI1 gene, 
pTEF1 promoter and tCYC1 terminator was PCR-amplified from yeast genomic DNA 
and pESC-C36/DI72 (9), respectively, using primer pair #2764 
(CCGCGAGCTCATAGCTTCAAAATGTTTCTAC)/#3726 
(CCGCGCGGCCGCGTAATTAAAACTTAGATTAGATTGC), or #3728 
(CCGCGTCGACGAGGGCCGCATCATGTAA) /#3730 
(CCGCGGGCCCAGCTTGCAAATTAAAGCCTTC), and digested with SacI/NotI or 
ApaI/SalI. Digested pTEF1 and tCYC1 were sequentially inserted into SacI/NotI or 
ApaI/SalI-digested pRS315 vector, generating pRS315-pTEF1 (Zhenghe Li and PD 
Nagy, unpublished data). pRS315-pTEF1 was digested with NotI/SalI and ligated with 
annealed primers of #5157 
GGCCGAAAATGAGATCTGGCACTAGTGACTACAAGGACGACGATGACAAGG
GTGGCGGTC /#5158 
CTAGGACCGCCACCCTTGTCATCGTCGTCCTTGTAGTCACTAGTGCCAGATCT
CATTTTC to introduce Flag-tag, generating pRS315-NFlag.  
 Plasmids expressing wt Sti1p or derivatives (C49Y, G325D; ∆TPR2; or ∆TPR1) 
were generated by using available STI1 mutants (179, 180) in PCR-amplifications using 
primer pairs #2863 CGCGGGATCCATGTCATTGACAGCCGATG /#2864 
CGCGCTCGAGTTAGCGGCCAGTCCGGATG or #5156 
CGCGGGATCCAACCCAAAAACTAGCGAAATGATG /#2864, and the obtained PCR 
products were treated with BamHI/SalI and then were inserted into BamHI/SalI-digested 
pRS315-NFlag. To visualize Sti1p in yeast, mRFP1 was PCR-amplified from pGAD-
PEX13-RFP (81) using primers #2630 
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CGCGGGATCCATGGCCTCCTCCGAGGACGTC /#5159 GGACTAGTGGCGCC-
GGTGGAGTGG, and the PCR product was digested with BamHI/PstI, and inserted into 
BglII/PstI-digested pRS315-Sti1 to generate pRS315-mRFP1-Sti1. 
 E. coli-based expression plasmids, pGEX-2T-Sti1 and mutated derivatives (C49Y, 
G325D, ∆TPR1, ∆TPR2) were generated by PCR using primers  #2863 
(CGCGGGATCCATGTCATTGACAGCCGATG) and #4860 
(CGCCGAATTCTTAGCGGCCAGTCCGGATGAT), followed by digestion with 
BamHI/EcoRI and then ligation into BamHI/EcoRI-digested pGEX-2T. 
 Arabidopsis thaliana STI1 ortholog AtHOP-1 (181) and the TPR1 deletion 
version (AtHOP1∆TPR1) were PCR -amplified from Arabidopsis cDNA using primers 
#5659 CGCTGATCAATGGCGGAAGAAGCAAAATCCAAAGG /#5661 
CCGCTCGAGTTACCGGACCT-GAACAATTCCGGCACTAACC and  #5660 
CGCTGATCAATGGATCCGGGGACTAGGGTTTATTTGGAG /#5661, respectively, 
followed by digestion with BclI/XhoI, and the PCR products were inserted into 
BamHI/SalI digested pRS315-NFlag, generating pRS315-AtHOP1 and pRS315-
AtHOP1∆TPR1, respectively. 
 
Analysis of CIRV repRNA replication in yeast. For measuring CIRV repRNA 
accumulation, yeast strains BY4741 and sti1∆ were transformed with plasmids pESC-
C36/DI72 and pYES-C95. For complementation and overexpression studies, we 
transformed yeast strains BY4741 and sti1∆ with pRS315-Sti1 (FLAG-Sti1 plasmid). 
Tombusvirus repRNA replication was induced by culturing in sc-ULH- with 2% 
galactose medium after overnight culture and then yeast was cultivated for 2 days at 
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23°C. Total RNA was isolated from yeast and used for detection of repRNA levels by 
Northern blot analysis as described previously (182). Replication was calculated by 
measuring the accumulation of CIRV DI1 repRNA or the TBSV DI-72(+) repRNA 
relative to the accumulation of 18S ribosomal RNA. The tombusvirus replication protein 
analysis was performed as described previously using an anti-His6 antibody as the 
primary antibody for the detection of His6-p36 and His6-p95. Detection of Flag-Sti1p and 
Sti1p was carried out using primary anti-Flag and anti-Sti1 antibody, respectively. The 
secondary antibody for both primary was alkaline phosphatase-conjugated anti-mouse 
immunoglobulin G (Sigma) (109). 
 
Analysis of protein-protein interaction by split-ubiquitin assay. The bait constructs, 
pGAD-BT2-N-His36 and pGAD-BT2-N-His33, expressing CIRV replication protein p36 
and p33 tombusvirus replication protein have been published before (99, 110). The PCR 
products of STI1 and its various truncation versions were digested with BamHI/XhoI and 
ligated into the pPRN-N-RE vector digested with BamHI/SalI enzymes. Yeast strain 
sti1∆/NMY51 was co-transformed with pGAD-BT2-N-His36 or pGAD-BT2-N-His33 
and pPR-N-RE (NubG) or one of the prey-constructs carrying STI1 and plated onto Trp-
/Leu- (TL-) synthetic minimal medium plates for plasmid selection (99, 110). Yeast 
colonies were re-suspended in 50 µl water and spotted onto Trp-/Leu-/His-/Ade-  (TLHA-
) plates for 2-4 days to detect bait–prey interactions.  Plasmid containing the yeast SSA1 
Hsp70 gene served as the positive control and empty vector (pPR-N-RE) as negative 
control in this assay (99, 110). 
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Protein purification from E. coli. pMAL-p33 (TBSV p33), pMAL-p92 (TBSV p92),  
pMAL-p36 (CIRV p36),  and pMAL-p95 (CIRV p35) (149) were transformed separately 
into E. coli strain BL21DE3CodonPlus. Protein expression was induced using isopropyl 
β-D-thiogalactopyranoside (IPTG) for 8 h at 16°C, and the cells were harvested by 
centrifugation at 5,000 rpm at 4°C for 5 min to remove the medium prior to -80°C 
storage.  Affinity columns containing amylose resin (NEB) were used to purify MBP-
tagged recombinant proteins. The frozen pellets were suspended and sonicated in MBP 
column buffer containing 20 mM Tris-Cl pH 8.0, 150 mM NaCl, 1 mM EDTA, 10 mM 
β-mercaptoethanol and 1 mM phenylmethylsulfonyl fluoride (PMSF).  The sonicated 
extract was centrifuged at 15,000 rpm for 5 min, and the supernatant was added to the 
pre-equilibrated amylose resin for 1 h rotating incubation at 4°C.  After washing the resin 
3 times with column buffer and once with a low salt column buffer (25 mM NaCl), the 
proteins were eluted with a low salt column buffer containing 0.18% (V/W) maltose and 
stored at -80°C in 6% (V/V) glycerol.  Protein fractions used for the replication assays 
were 95% pure, as determined by 12% SDS-PAGE and staining with Coomassie-Blue. 
  Expression of GST-tagged proteins Cpr7p, Cpr7-TPRp, Cns1p, Sti1p and its 
mutated versions (C49Y, G325D, ∆TPR1, and ∆TPR2) were induced using isopropyl β-D-
thiogalactopyranoside (IPTG) for 6 h at 23°C, and the cells were harvested by 
centrifugation at 5,000 rpm at 4°C for 5 min to remove the medium and stored at -80°C. 
Purification of GST-tagged proteins was carried out using glutathione resin and eluted 
with 10 mM glutathione, 10 mM ß-mercaptoethanol in the column buffer following the 
same protocol as MBP-proteins.   
 
 66 
 
In vitro tombusvirus replication assay using yeast mitochondrial preparations. Yeast 
intact mitochondria were purified as described previously (149). The purified 
mitochondrial fraction (1 µl) and different dilutions of GST, Sti1p, Cpr7p, or Cns1p 
proteins (8, 16, 32 µM each) were incubated at 25°C for 1 hr in 8 µl buffer A (containing 
30 mM HEPES-KOH [pH 7.4], 150 mM potassium acetate, 5 mM magnesium acetate, 
and 0.6 M sorbitol) with 15 mM creatine phosphate, 1 mM ATP, and GTP, 0.1 mg/ml 
creatine kinase, 0.1 μl of RNase inhibitor, 10 mM dithiothreitol, 0.5 μg DI-72 RNA 
transcript, and affinity-purified 0.5 μg MBP-36 (CIRV p36) and MBP-p95 (CIRV p95). 
The volume of the reaction mixture was then adjusted by adding 16 μl buffer B 
(containing 30 mM HEPES-KOH [pH 7.4], 150 mM potassium acetate, and 5 mM 
magnesium acetate) with 15 mM creatine phosphate, 1 mM ATP, CTP, and GTP, 0.025 
mM UTP, 0.2 μl of [32P]UTP, 0.1 mg/ml creatine kinase, 0.2 μl of RNase inhibitor, 10 
mM dithiothreitol, and 0.05 mg/ml actinomycin D. The reaction mixture was incubated at 
25°C for 3 h and terminated by adding 100 µl stop buffer (1% sodium dodecyl sulfate 
and 0.05 M EDTA, pH 8.0) followed by 100 µl phenol-chloroform extraction, 
isopropanol-ammonium acetate precipitation overnight at -20°C and washing by 70% 
ethanol.  The newly synthesized 32P-labeled RNA products were incubated at 85°C for 5 
min and separated by electrophoresis in a 5% polyacrylamide gel containing 0.5× Tris-
borate-EDTA buffer with 8 M urea. Signals were detected using a Typhoon 9400 
imaging scanner (GE/Amersham) and quantified by imageQuant software. 
 
Co-purification of host proteins with Twin-Strep-tagged CIRV replication proteins 
from yeast. To purify the protein of interest, 200 mg BY4741 yeast cells transformed 
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with plasmids pESC-StrepC36/DI72 pYES-StrepC95 and pFLAG-Sti. Cultured yeasts 
were re-suspended and homogenized in Buffer B (50 mM Tris-HCl, pH 7.5; 15 mM 
MgCl2, 10 mM KCl, 10 mM β-mercaptoethanol, 1% [V/V] yeast protease inhibitor 
cocktail) by glass beads [modified from (92)]. Membrane fractions from cell 
homogenates were collected and solubilized with column buffer (50 mM Tris-HCl pH 
7.5, 15 mM MgCl2, 500 mM KCl, 1% Triton X-100, 5% SB3–10 [caprylyl sulfobetaine] 
(Sigma), 10 mM β-mercaptoethanol, 1% [V/V] yeast protease inhibitor cocktail), and 
incubated with 40 µl StrepTactin Superflow hi-capacity 50% resin (IBA Life Sciences) 
for 1 hour at 4°C in a column. StrepTactin resin was then washed two times with column 
buffer, two times with wash buffer (50m M Tris-HCl pH 7.5, 15 mM MgCl2, 10 mM 
KCl, 0.1% Triton X-100, 10 mM β-mercaptoethanol, 1% [V/V] yeast protease inhibitor 
cocktail), and eluted with SDS-PAGE loading buffer, then subjected to SDS-PAGE and 
Western blotting analysis with Strep-Tactin AP Conjugate (IBA Life Sciences), anti-Flag 
and anti-Hsp70 antibodies (Abcam). 
 
Confocal laser microscopy. Wild type BY4741 or sti1∆ yeast strains were transformed 
with the following expression plasmids: pESC-GFP-C36/DI72, pYES-C95, or pESC-
GFP-C33/DI72, pYES-C92 (9), as well as pRS315-RFP-Sti1p.  The yeast cultures were 
incubated in galactose medium overnight, sampled and imaged with Olympus FV1000 
confocal laser scanning microscope (Olympus America Inc., Melville, NY). The 
microscope settings were the following: excitation and emission for GFP and RFP were 
488nm laser/500-530nm filter and 543nm laser/560-660nm filter, respectively. 
 
 68 
 
Virus induced gene silencing of Sti1/HOP ortholog gene. Virus induced gene silencing 
(VIGS) in Nicotiana benthamiana was performed as described in (183). The C-terminal 
fragment of N. benthamiana HOP gene (yeast STI1 ortholog, based on Arabidopsis 
AtHOP-1 gene) was PCR-amplified from total N. benthamiana cDNA using primers 
#5786 (CGCGGATCCAGGGCATACAGCAACAGGGC) /#5787 
(CCGCTCGAGTTATTTGACTTGAATAATTCCTGCACTAACCAAC). The obtained 
PCR product was digested with BamHI/XhoI and inserted into pTRV2 digested with 
BamHI/XhoI, generating pTRV2-NbHop. As a control for the VIGS experiments, the C-
terminal-half of GFP sequence was PCR-amplified by primers #5353 
CGCGGATCCGAAGGTGATACCCTTGTTAATAGAATCGAG /#3712 
CGGCCTCGAGTTACGCATAGTCAGGAACATCGTATGGGTAGAGTCCGGACTT
GTATAGTT from pESC-GFP-C36/DI72, digested with BamHI/XhoI and inserted into 
pTRV2 generating pTRV2-1/2GFP. VIGS-treated N. benthamiana plants were sap 
inoculated with CIRV or CNV inocula on the 14th day post silencing. Samples from the 
inoculated leaves were harvested and subjected to total RNA extraction and Northern blot 
analysis for viral RNA (81, 183). Efficiency of NbHOP silencing was evaluated by semi-
quantitative reverse transcription PCR using NbHOP and Actin gene-specific primer 
pairs: #5785 (CGCGGATCCAGAGCAGCAAGAGTATTTCGATCCAC) /#5787 and 
#3993 (GGAAGTAGCATAAGATGGCAGATGGAGAGG) /#3994 
(CCAGATCTTCTCCATATCATCCCAGTTGCTGAC), respectively. 
 
3.3 Results 
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Yeast-based studies reveal that Sti1p co-chaperone selectively inhibits mitochondrial 
CIRV replication, but not the peroxisomal TBSV replication. Based on our previous 
findings that two abundant cytosolic TPR-containing cellular proteins, namely Cpr7p 
cyclophilin and Cns1p co-chaperone, showed robust restriction activity against TBSV 
(109, 150), we also tested the abundant TPR-containing protein Sti1p co-chaperone for 
possible effect on the accumulation of TBSV and CIRV replicon (rep)RNAs in sti1∆ 
yeast versus wt yeast cells. Interestingly, sti1∆ yeast supported CIRV repRNA 
accumulation at a ~3-fold higher level than in wt yeast (Fig. 3.1A, lanes 5-6 versus 1-2). 
However, replication of the TBSV repRNA was comparable in sti1∆ and wt yeast (Fig. 
3.1B, lanes 4-6 versus 1-3), suggesting that Sti1p has a CIRV-specific inhibitory effect. 
To test if Sti1p-based inhibition targets the CIRV RNA, we also tested TBSV repRNA 
accumulation in the presence of CIRV p36 and p95pol replication proteins, which are 
capable of supporting the replication of the heterologous TBSV repRNA (9), in sti1∆ 
yeast versus wt yeast cells. The obtained data showed ~2-fold increased level of TBSV 
repRNA accumulation (Fig. 3.1C, lanes 4-6 versus 1-3), demonstrating that the inhibitory 
effect of Sti1p is targeted against the CIRV p36 and p95pol and not the viral RNA. 
Comparison of the accumulation of CIRV p36 and p95pol in sti1∆ yeast versus wt yeast 
cells revealed similar replication protein levels (Fig. 3.1C), arguing that Sti1p is unlikely 
to affect translation or stability of CIRV p36 and p95pol in yeast cells.  
To further test if Sti1p can inhibit CIRV replication in vivo, we over-expressed N-
terminally FLAG-tagged Sti1p in yeast supporting CIRV or TBSV accumulation. We 
found that over-expression of Sti1p reduced CIRV accumulation by ~3-fold in wt yeast 
(Fig. 3.2A, lanes 4-6 versus 1-3) and by ~5-fold in sti1∆ yeast (Fig. 3.2A, lanes 10-12 
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versus 7-9). The level of CIRV p36 and p95pol replication proteins was comparable in 
sti1∆ or wt yeasts over-expressing FLAG-Sti1p (Fig. 3.2A), suggesting that Sti1p is 
unlikely to affect the stability of these viral proteins in yeast. In contrast, replication of 
the TBSV repRNA was not affected by the over-expression of Sti1p in wt (Fig. 3.2B, 
lanes 13-16) or in sti1∆ or wt yeasts (lanes 17-24). Altogether, these data support that 
Sti1p is a strong inhibitor of the CIRV p36 and p95pol replication proteins, while Sti1p 
seems to be ineffective against the tombusviral p33 and p92pol replication proteins in 
yeast. 
 
The binding of Sti1p involves different regions in CIRV p36 and the TBSV p33 
replication proteins. Sti1p contains three TPR domains (Fig. 3.3A) that are predicted to 
interact with the tombusviral replication proteins. To test if Sti1p can interact with the 
CIRV p36 versus the TBSV p33 replication proteins, we first used the split-ubiquitin 
based two-hybrid assay in sti1∆ yeast (184, 185). We observed strong interaction 
between Sti1p and p36 (Fig. 3.3B) and Sti1p and p33 (Fig. 3.3C). We confirmed the 
interaction between Sti1p and p36 replication protein in sti1∆ yeast (Fig. 3.3D, lane 2) 
using a co-purification assay with recombinant Sti1p. The reciprocal co-purification 
assay with Strep-tagged p36 also resulted in co-purification of Flag-Sti1p from sti1∆ 
yeast (Fig. 3.3E, lane 1).   
To test what region(s) of Sti1p interacts with p36, we used well-characterized 
Sti1p mutants lacking particular functional domains (179, 180) as shown in Fig. 3.3A. 
The split-ubiquitin assay showed that the interaction with p36 was not eliminated by 
deletion (∆TPR1) or mutation (C49Y, and K73E) in the TPR1 region (Fig. 3.3B), which 
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binds to Hsp70 (175, 186). Similarly, deletion (∆TPR2) or mutations (G325D or T526I) in 
the TPR2 region (Fig. 3.3B), which binds to Hsp90, did not debilitate interaction with 
p36 replication protein. These findings were confirmed in the reciprocal co-purification 
experiments (Fig. 3.3D-E), demonstrating that Sti1p could use both the TPR1 and TPR2 
sequences to bind to the p36 replication protein. Interestingly, binding of Sti1p to the 
TBSV p33 replication protein showed similar features with p36 binding (Fig. 3.3C versus 
Fig. 3.3B). Thus, the binding characteristics of Sti1p to CIRV p36 versus TBSV p33 do 
not explain why Stip1 can selectively inhibit CIRV replication, but not TBSV replication 
in yeast cells.  
 To map the Sti1p binding site in CIRV p36 replication protein, we have used 
pull-down experiments with immobilized MBP-p36 truncation derivatives (Fig. 3.4A) 
and Sti1p present in either E. coli lysate (Fig. 3.4B) or yeast extract containing Flag-Sti1p 
(Fig. 3.4C). These experiments revealed that Sti1p binds to a region that includes the 
RPR motif of p36, which is involved in RNA binding (Fig. 3.4B-C, lane 6, construct 
p36C4 in Fig. 3.4A). The RPR-motif in replication proteins is required for specific viral 
(+)RNA recruitment and replicase assembly, and it also binds to Cpr7p Cyp40-like 
cyclophilin (4, 102, 109, 187). Interestingly, the same RPR-containing region in p36 
replication protein could bind to both the TPR1 and TPR2 sequences in Sti1p (Fig. 3.4D-
E, lane 6).  
To map the Sti1p binding site in the TBSV p33 replication protein, we have used 
similar pull-down experiments with immobilized MBP-p33 truncation derivatives (Fig. 
3.4F) in combination with yeast extract containing Flag-Sti1p or its truncation derivatives 
(Fig. 3.4G). We found that Sti1p binds to the C-terminal region of TBSV p33 containing 
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the p33:p33/p92 interaction sequences (Fig. 3.4F). Deletion of the RPR motif, involved in 
RNA binding, did not inhibit p33 binding to Sti1p (Fig. 3.4G, lane 13).  Thus, there is a 
major difference in Sti1p binding to CIRV (the RPR-containing sequence) and TBSV 
replication proteins (the C-terminal region in TBSV p33), suggesting that the mechanism 
of inhibition of CIRV replication by Sti1p could be based on blocking the RNA-binding 
function of CIRV p36 replication protein.  
 
Sti1p is co-localized with CIRV p36 in yeast cells. To study if the mostly cytosolic Sti1p 
is recruited to the mitochondrial membranes, where CIRV replication takes place (9, 48), 
by the CIRV p36 in yeast cells, we co-expressed GFP-p36 with RFP-Sti1p in wt or sti1∆ 
yeast cells. Confocal laser microscopy revealed the robust recruitment of RFP-Sti1p by 
CIRV p36 to punctate structures, likely representing the mitochondrial membranes as 
shown before (9, 18, 48) in both wt and sti1∆ yeast cells (Fig. 3.5A). In contrast, the 
GFP-tagged p33 did not efficiently recruit RFP-Sti1p to p33-containing punctate 
structures (Fig. 3.5B), which likely represent peroxisomal membranes (10, 107). RFP-
Sti1p showed diffused, mostly cytosolic distribution in yeast expressing p33 replication 
protein. Based on these data, we suggest that unlike p33, the CIRV p36 replication 
protein efficiently recruits Sti1p to the site of replication, leading to robust inhibition of 
CIRV replication. 
 
The TPR1 domain in Sti1p is required to inhibit CIRV replication in isolated 
mitochondria-based assay and in yeast cells. To test what domain of Sti1p is required to 
block CIRV replication, we expressed mutated versions of Sti1p in wt yeast. We 
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observed ~2-fold inhibition of CIRV repRNA accumulation by ∆TPR2 and G325D 
mutants, comparable to that obtained with the full-length Sti1p (Fig. 3.6A), while 
expression of ∆TPR1 or C49Y mutants had no detectable and lesser inhibitory effects, 
respectively (lanes 9-12 and 21-24 in Fig. 3.6A). All these mutated versions of Sti1p 
were expressed at comparable levels in wt yeast without substantially affecting CIRV p36 
or p95 levels (Fig. 3.6B-C). Altogether, based on these data, we suggest that the TPR1 
domain of Sti1p is required to inhibit CIRV replication in yeast. 
To further test the roles of the TPR sequences of Sti1p in CIRV replication, we 
applied an isolated mitochondria-based replication assay, which take advantage of 
purified recombinant CIRV p36, p95pol replication proteins and repRNA transcripts to 
support full CIRV replication in vitro (Fig. 3.7A) (9, 49, 102). Addition of the affinity-
purified full-length recombinant GST-Sti1p (Fig. 3.7B) decreased the production of 
repRNA by up to 3-fold (Fig. 3.7C, lanes 5-7 versus 2-4), confirming that Sti1p has an 
inhibitory effect on CIRV replication in vitro. Pre-incubation of Sti1p either with Ssa1p 
Hsp70 chaperone or p36 replication protein to facilitate protein complex formation did 
not alter the inhibitory effect of Sti1p (Fig. 3.7D), suggesting that Sti1p has robust effect 
on CIRV replication in vitro. The presence of recombinant Sti1p lacking functional TPR2 
domain (e.g., ∆TPR2 or mutant G325D) was also inhibitory, reducing CIRV replication by 
up to ~5-fold in the isolated mitochondria-based assay (Fig. 3.7C, lanes 11-16 and 7D, 
lanes 15-22). In contrast, inactivation of TPR1 (∆TPR1 or mutant C49Y) resulted in the 
loss of the inhibitory function of Sti1p (Fig. 3.7C, lanes 8-10, 17-19 and 7D, lanes 11-14) 
in the isolated mitochondria-based replication assay, thus emphasizing the critical role of 
the TPR1 sequence in Sti1p.  
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Comparison of the inhibitory effects of host proteins carrying TPR domains on CIRV 
replication in isolated mitochondria-based replication assay. Two other cellular proteins 
with TPR domains, namely Cpr7p cyclophilin and Cns1p co-chaperone, have been shown 
to inhibit TBSV replication (109, 150). Test if these host proteins have comparable 
activities to Sti1p in inhibition of CIRV replication, we used the isolated mitochondria-
based in vitro replication assay and purified recombinant cellular proteins and CIRV 
replication proteins (Fig. 3.8A-B). Interestingly, all these TPR-containing proteins 
inhibited CIRV replication in vitro with Sti1p and the TPR region of Cpr7p showing up 
to ~10-fold reduction in repRNA production in the isolated mitochondria-based 
replication assay (Fig. 3.8A, lanes 6-8 and 12-14 versus 3-5). Cns1p was the least 
effective in this assay (Fig. 3.8A, lanes 15-17), but this could be due to the lower amount 
of recombinant GST-Cns1p obtained from E. coli (Fig. 3.8B). However, the purified 
recombinant GST-Cns1p was the most effective inhibitor of TBSV replication by 
reducing TBSV replication by up to ~20-fold in total cell-free extract (CFE)-based 
replication assay (Fig. 3.8C) (150). Altogether, the TPR-containing Cpr7p seems to have 
strong inhibitory effect against both TBSV and CIRV replication, while Sti1p efficiently 
inhibits CIRV, but its effect is only moderate on TBSV replication in vitro.   
 
The plant Hop ortholog of the yeast Sti1p inhibits CIRV replication in yeast and plants. 
Arabidopsis thaliana has three orthologs of Sti1p co-chaperone, namely AtHop1-3, that 
carry TPR1 and TPR2 domains (181, 188). To test if AtHop-1 could inhibit CIRV 
replication, we expressed it in yeast. Similar to the yeast Sti1p, AtHop-1 inhibited CIRV 
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accumulation by ~5-fold in yeast (Fig. 3.9, lanes 4-6). Deletion of the TPR1 sequence 
made AtHop-1 less effective inhibitor of CIRV replication (Fig. 3.9, lanes 7-9), 
suggesting that the TPR1 sequence is important for the inhibitory function of AtHop-1. 
 To test the relevance of the plant Hop protein in tombusvirus replication, we 
tested the accumulation level of Hop mRNA in Nicotiana benthamiana host. The semi-
quantitative RT-PCR analysis revealed the induction of NbHop mRNA upon infection 
with CIRV (Fig. 3.10A). In addition, knockdown of NbHop level via VIGS in N. 
benthamiana led to ~3-fold increased CIRV genomic RNA accumulation (Fig. 3.10B). 
As expected, due to the high level CIRV accumulation, the Hop-knockdown in N. 
benthamiana plants died even more rapidly than control plants when infected with CIRV 
(Fig. 3.10C). In contrast, the accumulation of the genomic RNA of the related CNV (a 
peroxisomal replicating tombusvirus, closely related to TBSV) was not significantly 
affected by Hop-knockdown N. benthamiana plants (Fig. 3.10D). Also, the symptom 
severity of CNV-infected knockdown or control plants was comparable (Fig. 3.10E). 
Based on these in planta experiments, we suggest that the plant Hop ortholog plays a 
potent inhibitory role, similar to the yeast Sti1p, in the mitochondrial CIRV replication, 
but not in the peroxisomal CNV replication. 
 
3.4 Discussion 
 
Identification of the Hop-like Sti1p co-chaperone as a novel cell-intrinsic restriction 
factor against CIRV replication in mitochondria. Cellular protein chaperones are 
important for virus replication and during other steps of the infectious process (74, 189-
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195). For example, Hsp70 has been shown to affect the intracellular localization and 
membrane insertion of TBSV replication proteins and the assembly of the tombusviral 
VRCs (100-102). Although Hsp70 interacts directly with the tombusviral replication 
proteins, it is possible that other cellular factors could affect the subversion of Hsp70s by 
TBSV. Since co-chaperones facilitate selection and delivery of client proteins to the 
major Hsp70 and Hsp90 chaperones (196-198), some co-chaperones might also be 
involved in viral infections as demonstrated in this paper and earlier (74, 189-195).  
 Our finding that the conserved cellular Hop-like Sti1p co-chaperone is a restriction 
factor for CIRV replication in the mitochondria contributes to the emerging complex 
roles of cellular chaperones in virus replication (74). While deletion of Sti1p led to a 2-to-
4-fold increase in CIRV replication in yeast model host or knockdown of the orthologous 
Hop in N. benthamiana increased CIRV accumulation by ~3-fold, over-expression of 
Sti1p or AtHop-1 in yeast was inhibitory. In vitro CIRV replication experiments based on 
isolated mitochondria also confirmed the robust inhibitory effect of Sti1p on CIRV. 
Moreover, the expression of the Sti1 ortholog Hop is increased during CIRV replication 
in plant leaves. Thus, Sti1p is a new member of the growing family of cell-intrinsic 
restriction factors. 
 However, Sti1p did not have robust effect on replication of the closely related TBSV 
in yeast or on the replication of CNV in plants, both of which utilize the peroxisomal 
membranes for replication (10, 107). This contrasting finding with Sti1/Hop for different 
tombusviruses exploiting different subcellular locations could be due to the difference in 
accessibility of Sti1/Hop to replication proteins of tombusviruses in their respective 
cellular environments. For example, it has been shown in plants that Hop/Sti1 is involved 
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in transportation of freshly synthesized mitochondrial and chloroplast proteins from the 
cytosol into these organelles (199). Moreover, the delivery/import of mitochondrial 
preproteins from the cytosol to the mitochondria often depends on Hsp70/Hsp90 
chaperones and includes Hop/Sti1 and the TPR domain in Tom70 mitochondrial receptor 
(200, 201). Also, the CIRV p36 replication protein was shown to interact with various 
Tom receptor proteins, which might have roles in mitochondrial membrane insertion of 
p36 (19). Based on these studies, we propose that Sti1/Hop might be easily accessible and 
bind efficiently to the mitochondria-targeted CIRV replication proteins in cells, while the 
cellular Sti1/Hop co-chaperone has a lesser chance to bind to the peroxisome-targeted 
TBSV and CNV replication proteins. Accordingly, live cell imaging showed the re-
localization of Sti1p to the mitochondria in the presence of CIRV p36, while Sti1p 
showed mostly cytosolic localization in yeast cells expressing the CNV p33 replication 
protein (Fig. 3.5). Thus, the difference in accessibility of Sti1/Hop could be the major 
mechanism restricting CIRV but not TBSV or CNV replication.     
 
 Mechanisms of Sti1p co-chaperone-driven restriction of CIRV replication. 
Recruitment of the tombusvirus (+)RNA into replication requires selective binding by the 
tombusvirus replication proteins via recognition of a RNA recruitment element (named 
p33RE) within the polymerase gene sequence (3, 202). The same p33RE element is also 
required for the VRC assembly and activation of the polymerase function of the 
replication protein (4, 203). The specific recognition of p33RE is performed by arginines 
within the RPR motif in p33/p92pol (123, 204). Therefore, binding of cellular factors to 
the RPR motif containing region could block the ability of p33/p92pol to bind the viral 
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(+)RNA, thus inhibiting the essential viral processes of (+)RNA recruitment, VRC 
assembly and replicase activation (203, 205). Indeed, the TPR domain of Cpr7p binds to 
the RPR region in the tombusvirus replication proteins and blocks the above viral 
processes, thus acting as a restriction factor (109). We find that Sti1p also binds to the 
RPR region in the CIRV p36/p95pol replication proteins (Fig. 3.4) and this could explain 
the strong in vitro inhibitory effect of recombinant Sti1p on CIRV replication based on 
mitochondrial preparations (Fig. 3.7). The CIRV p36 interaction with Sti1p also leads to 
the recruitment of Sti1p to punctate structures (mitochondrial membranes) in yeast cells, 
suggesting robust p36:Sti1p interaction in cells. Thus, direct interaction between the 
Sti1p and CIRV p36 might block viral RNA recruitment (see Model 1, Fig. 3.11). 
 However, the picture on the mechanism of CIRV inhibition is likely more complex. 
This is because both the TPR1 and TPR2 regions of Sti1p bind to the RPR domain of 
CIRV p36, yet the expression of TPR1 is inhibitory, while TPR2 is less effective in 
reducing CIRV accumulation in yeast or CIRV replication in vitro with mitochondrial 
preparations (Figs. 3.6-3.7). Thus, the binding to the RPR domain in p36 is unlikely 
enough for Sti1p to effectively inhibit p36 functions. 
 Interestingly, Sti1p does not bind to the RPR region of the TBSV p33 replication 
protein. The binding between p33 and Sti1p involves the C-terminal region of p33 
containing the p33:p33/p92 interaction sequence (Fig. 3.4F-G). It is possible that this 
interaction is not robust/stable enough to interfere with p33 functions in cells. It is likely 
that p33 could readily interact with additional p33 molecules, while binding to Sti1p 
molecules by p33 might be less favored in cells. Indeed, Sti1p is not efficiently 
relocalized to punctate structures containing the p33 molecules in yeast cells (Fig. 3.5B). 
 79 
 
A similar situation was observed with Cpr6p Cyp40-like cyclophilin, which also binds to 
p33 within the C-terminal domain and does not inhibit p33 functions (109). Yet, this rule 
is not general, since Cns1p co-chaperone binds to the p33:p33/p92 interaction sequence 
in TBSV p33 replication protein and effectively inhibits TBSV replication in yeast (150) 
and in vitro (Fig. 3.8C). It seems that the intracellular accessibility of these TPR-
containing host proteins might be a major factor in their ability to inhibit replication of 
different tombusviruses. 
 Although direct interaction between the RPR region of CIRV p36 and the TPR1 
sequence in Sti1p might explain the inhibitory effect on CIRV replication (Fig. 3.11, 
model 1), it is also possible that Sti1p limits the functions of subverted cellular factors, 
such as Hsp70, for its ontiviral activity. Cytosolic Hsp70s are co-opted by tombusviruses 
and they are permanent residents in the tombusviral VRCs (98). This model is supported 
by the observation that, in spite of the binding of both TPR1 and TPR2 sequences to the 
RPR region of CIRV p36 (Fig. 3.3), only the expression of the Hsp70-interacting TPR1 
region (175, 177) was able to robustly inhibit CIRV replication in yeast and in vitro 
(Figs. 3.6-3.7). Moreover, mutation within the TPR1 sequence (i.e., mutant C49Y) that 
debilitates the interaction with Hsp70, but not with p36 (Fig. 3.3) had lesser inhibitory 
effects on CIRV replication when expressed in yeast (Fig. 3.6). In contrast, a mutation 
(i.e., mutant G325D) that affects interaction with Hsp90 did not interfere with the 
inhibitory function of Sti1p in vivo or in vitro.  Based on these findings, we propose that 
the recruited Sti1p co-chaperone inhibits the proviral function of the co-opted cellular 
Hsp70 molecules during CIRV replication. For example, the predicted Sti1p:Hsp70 
interaction during the formation of VRC or within the assembled VRC might inhibit the 
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Hsp70-driven activation of the polymerase function of p95 or other steps/functions (Fig. 
3.11, model 2). 
 The major role of Sti1p co-chaperone in eukaryotic cells is to bring Hsp70:client 
protein complex together with Hsp90 chaperone to facilitate robust refolding/activation 
of client proteins by the powerful Hsp90 system (177, 206, 207). This is facilitated by the 
ability of Sti1p to bind simultaneously to Hsp70 (via the TPR1 sequence) and Hsp90 (via 
the TPR2A region). However, based on our data, it is unlikely that this function of Sti1p 
is critical to inhibit CIRV replication. This is because deletion of the entire TPR2 domain 
from Sti1p did not eliminate the inhibitory function of Sti1p in vitro or in yeast (Fig. 3.6-
3.7). Also, blocking the function of Hsp90 by applying geldanamycin inhibitor in yeast 
had no effect on tombusvirus replication (data not shown), arguing against the functional 
role of Hsp90 in tombusvirus replication. Therefore, the direct effect of Sti1p on CIRV 
p36/p95 and the co-opted Hsp70 is the best suited to explain the current experimental 
data (Fig. 3.11). 
 Sti1/Hop is the first cellular restriction factor specifically affecting one tombusvirus 
(i.e., the mitochondria replicating CIRV), but not other tombusviruses (TBSV and CNV, 
both replicating in peroxisomal membranes). The previously identified TPR domain-
containing cellular proteins, namely Cpr7p and Cns1p, could inhibit the replication of all 
these tombusviruses [this work and (109, 150)]. Interestingly, all three cellular factors are 
part of the Hsp70/Hsp90 chaperone system, suggesting that they, at least in part, inhibit 
tombusvirus replication via regulating chaperone functions. Because the Hsp70/Hsp90 
chaperone system is known to affect many viruses [reviewed in (74, 208)], it is possible 
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that the identified restriction factor activities of these TPR-containing cellular proteins 
might be functional against other viruses and pathogens.  
 Another use of Hop/Sti1 in host innate defense against pathogens is its role in 
maturation and transport of rice chitin receptor OsCERK1, which is a pattern recognition 
receptor (PRRs), against rice blast fungus (209). This function of Hop/Sti1 might link the 
functions of PRRs, small Rho-type GTPases and resistance against pathogens. Sti1p is 
also known to affect prion propagation in yeast (210) and its expression is increased in 
SV40-transformed MRC-5 fibroblasts and some tumor tissues (165, 211). Thus, Hop/Sti1 
is emerging as a possibly key component in propagations of several infectious agents and 
innate defense responses of host cells. 
 
Summary: The current and recent works (109) with tombusviruses indicate that some 
members of the large family of TPR-containing proteins might act as cell-intrinsic 
restriction factors of tombusviruses. The list includes the Hop-like Sti1p and Ttc4 
oncogene-like Cns1p co-chaperones and Cyp40-like Cpr7p cyclophilin. Yet, based on the 
yeast Cyp40-like Cpr6p cyclophilin (109), we already know that not all TPR-containing 
proteins are viral restriction factors in spite of their abilities to interact with tombusvirus 
replication proteins. Since many TPR-containing proteins are expressed in all eukaryotes, 
it will be important to identify all the members of these cellular protein family that act as 
restriction factors during tombusvirus and other (+)RNA virus replication. 
Copyright © American Society for Microbiology 
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Fig. 3.1 Increased CIRV replication in sti1∆ yeast.  
 
(A) Northern blot analysis of accumulation of CIRV DI-1 repRNA in sti1∆ or wt yeast 
strains at 23ºC. We launched CIRV repRNA replication by expressing CIRV His6-p36 
and His6-p95 from the galactose-inducible GAL1 promoter and DI-1 (+)repRNA from the 
galactose-inducible GAL10 promoter in sti1∆ and the parental (wt, BY4741) yeast 
strains. Note that the data were normalized based on 18S rRNA. Each experiment was 
repeated three times. (B) Northern blot analysis of accumulation of TBSV DI-72 repRNA 
in sti1∆ or wt yeast strains. TBSV repRNA replication was launched by expressing CNV 
His6-p33 and CNV His6-p92 from the GAL1 promoter and DI-72 (+)repRNA from the 
GAL10 promoter in sti1∆ and the parental (wt BY4741) yeast strains. See further details 
in panel A. Bottom images: Western blot analysis of CNV His6-p33, CNV His6-p92 
accumulation by anti-His antibody and Sti1p accumulation by anti-Sti1 antibody. (C) Top 
images: Northern blot analysis of the CIRV p36/p95-driven TBSV DI-72 RNA 
accumulation in sti1∆ or wt yeast strains. Same as panel A except DI-72 was used as a 
repRNA with CIRV His6-p36 and His6-p95, which support viral RNA replication on 
mitochondrial membrane surfaces. Bottom images: Western blot analysis of CIRV His6-
p36, CIRV His6-p95 accumulation by anti-His antibody and Sti1p accumulation by anti-
Sti1 antibody. 
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Fig 3.2 
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Fig. 3.2 Over-expression of Sti1p inhibits CIRV accumulation in yeast. 
 
(A) Top panel: Northern blot analysis of CIRV RNA accumulation in wt or sti1∆ yeasts 
overproducing the FLAG-tagged Sti1p. Second panel: Northern blot analysis to 
demonstrate the comparable level of ribosomal RNA loading in the yeast samples. 
Bottom panels: Western blot analysis of CIRV His6-p95 and CIRV His6-p36 
accumulation by anti-His antibody and Sti1p accumulation by anti-Sti1 antibody. (B) 
Northern blot analysis of TBSV DI-72 repRNA accumulation in wt or sti1∆ yeasts 
overproducing the FLAG-tagged Sti1p in the presence of peroxisomal CNV p33/p92 
replication proteins. See further details in panel A 
 
.  
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Fig 3.3 
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Fig. 3.3 Interaction between Sti1p and CIRV p36 replication protein in yeast and in 
vitro.  
 
(A) Domain structure of the yeast Sti1p. TPR1 (tetratricopeptide repeat) sequence 
interacts with Hsp70, while DP1 (dipeptide repeat of aspartic acid and proline) might 
stabilize the bound client protein. TPR2A and TPR2B bind to Hsp90 and together inhibit 
the ATPase activity of Hsp90. TPR2B also binds to Hsp70, but only in concert with 
Hsp90 binding to TPR2A. The debilitating mutations are marked with an asterisk and 
deletion constructs are shown schematically at the bottom of the panel. (B) Split ubiquitin 
MYTH assay was used to test intracellular interaction between CIRV p36 and the wt or 
mutated yeast Sti1p. The bait p36 was co-expressed with the prey Sti1p protein in sti1∆ 
yeast. SSA1 (HSP70 chaperone), and the empty prey vector (NubG) were used as positive 
and negative controls, respectively. (C) The same split ubiquitin MYTH assay as in panel 
B, except TBSV p33 was used as a bait protein. (D) Co-purification of CIRV p36 
replication protein with the yeast Sti1p from yeast cells. The membrane fraction of yeast 
co-expressing the wt or mutated FLAG-Sti1p and His6-p36 was solubilized and the Sti1p 
variants were purified using a FLAG-column. The eluted proteins were tested using 
Western blotting with anti-FLAG antibody (top image) and anti-His6 antibody (bottom 
image). (E) Reciprocal co-purification of the yeast Sti1p with CIRV p36 and p95 
replication proteins from yeast cells. The same as in panel D, except yeast co-expressed 
the twin-strep-tagged CIRV p36 and p95 and Flag-Sti1p. The purification was based on 
streptactin columns. The eluted proteins were tested using Western blotting with anti-
Strep-Tactin-AP conjugate (top image), anti-Flag antibody (middle image) and anti-
Hsp70 antibody (bottom image). 
 
 
Note: Experiments in Fig. 3.3B, C&D were in collaboration with Dr. Jing-Yi Lin. 
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Fig 3.4 
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Fig. 3.4 Defining the sequence within the tombusvirus replication proteins needed for 
binding to Sti1p in vitro.  
 
(A) Schematic representation of the CIRV p36 and its truncated derivatives used in the 
binding assay.  The various domains include: TMD, transmembrane domain; RPR, 
arginine-proline-rich RNA binding domain; P; phosphorylated serine and threonine; S1 
and S2 subdomains involved in p36:p36/p95 interaction. (B-E) Affinity binding (pull-
down) assay to detect interaction between Flag- or His6-Sti1p, ∆TPR1, ∆TPR2 and the 
MBP-tagged CIRV p36 protein derivatives. The MBP-tagged viral proteins produced in 
E. coli were immobilized on amylose-affinity columns. Then, the recombinant Sti1p and 
derivatives expressed in E. coli (panels B, D, E) or in yeast (panel C) was passed through 
the amylose-affinity columns with immobilized MBP-tagged p36 protein (its truncated 
versions). The affinity-bound proteins were eluted with maltose from the columns (shown 
in the bottom image). Top images in each panel: The eluted proteins were analyzed by 
Western blotting with anti-Flag or anti-His antibodies to detect the amount of Flag- or 
His6-Sti1p specifically bound to MBP-tagged viral proteins. Bottom image: SDS-PAGE 
analysis of the viral protein and its truncated derivatives after elution from the amylose-
affinity columns. Note that the MBP has a C-terminal extra tail sequence (not present in 
the fusion protein constructs) due to the sequence in the original cloning vector.  (F) 
Schematic representation of the TBSV p33 and its truncated derivatives used in the 
binding assay. (G) Affinity binding (pull-down) assay to detect interaction between 
FLAG-Sti1p and the MBP-tagged viral p33 protein (the soluble C-terminal portion). The 
MBP-tagged viral protein or MBP control produced in E. coli was immobilized on 
amylose-affinity columns. See further details in panel B above. The eluted proteins were 
analyzed by Western blotting with anti-FLAG antibody to detect the amount of FLAG-
Sti1p specifically bound to MBP-tagged viral protein. 
 
 
Note: Experiments in Fig. 3.4G were in collaboration with Dr. Jing-Yi Lin. 
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Fig 3.5 
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Fig. 3.5 Relocalization of yeast Sti1p co-chaperone when co-expressed with CIRV p36 
replication protein in yeast.  
 
(A) Confocal laser microscopy images show the partial co-localization of RFP-Sti1 with 
CIRV GFP-p36 in wt (top images), or in sti1∆ yeast strains. The merged images show the 
co-localization within punctate structures, likely representing mitochondria, which are the 
sites of CIRV replication. DIC (differential interference contrast) images are shown on 
the right. (B) Absence of co-localization of RFP-Sti1 and GFP-p33 in yeast. Note the 
cytosolic distribution of RFP-Sti1, while GFP-p33 is present in punctate structures 
representing the peroxisomes. Each experiment was repeated. 
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Fig. 3.6 Functional TPR1 domain of Sti1p is required for inhibition of CIRV 
replication in yeast. 
 
(A) Northern blot analysis of CIRV accumulation in wt yeast overproducing the FLAG-
tagged Sti1p or derivatives. Bottom panel: Northern blot analysis to demonstrate the 
comparable level of ribosomal RNA loading in the yeast samples. (B) Western blot 
analysis of CIRV His6-p36, and CIRV His6-p95 accumulation by anti-His antibody from 
yeast overproducing Sti1p or derivatives. (C) Detection of the overproduced FLAG-Sti1p 
or its derivatives in yeast by Western blot analysis using anti-FLAG antibody. 
 
Note: Experiments in Fig. 3.6 were in collaboration with Dr. Jing-Yi Lin. 
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Fig. 3.7 Functional TPR1 domain of Sti1p blocks CIRV replication in vitro.  
 
(A) Scheme of in vitro reconstitution of the CIRV replicase in yeast mitochondrial 
preparation. The purified GST-tagged Sti1p or derivatives, the purified recombinant 
CIRV MBP-p36 and MBP-p95 proteins and the TBSV-derived (+)repRNA were used in 
isolated mitochondrial preparations. (B) Coomassie Blue stained SDS-PAGE was used 
for analysis of affinity-purified GST-tagged Sti1 or derivatives. (C) Denaturing PAGE 
analysis of the 32P-labeled repRNA products obtained in the replication assays with the 
isolated yeast mitochondrial preparation and the soluble fraction of yeast CFE that 
provided soluble host factors. The synthesized full-length repRNA is pointed at by an 
arrow. The replication assay with CIRV p36 and p95 (without added Sti1) was chosen as 
100% (lane 1). The recombinant proteins were added in 8, 16 and 32 μM amounts. Each 
experiment was repeated. (D) CIRV mitochondrial replication assays were performed 
(see panel A) to test the effect of pre-incubation of various components. Lanes “a” show 
samples when the purified Ssa1p Hsp70 (from sti1∆ yeast strain) was pre-incubated for 
10 min with comparable amount of GST, GST-Sti1p or mutants (from E. coli), while in 
lanes “b”, the MBP-p36/MBP-p95 of CIRV (from E. coli) was pre-incubated with Ssa1p. 
In lanes “c”, the MBP-p36/MBP-p95 of CIRV was pre-incubated with GST, GST-Sti1p 
or mutants, while in lanes “-“ no pre-incubation was performed. In each experiment, we 
used comparable amounts of each component for pre-incubation that lasted for 10 min in 
the reaction buffer. After the pre-incubation step, we added the missing components and 
performed the CIRV replication assay (see panel A). Each experiment was repeated at 
least twice. 
 
 
Note: Experiments in Fig. 3.7 were in collaboration with Dr. Jing-Yi Lin. 
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Fig. 3.8 Comparison of the inhibitory effects of TPR-containing cellular proteins on 
CIRV replication in isolated mitochondria in vitro. 
 
(A) Denaturing PAGE analysis of the 32P-labeled repRNA products obtained in the 
replication assays with the isolated yeast mitochondrial preparations. The purified GST-
tagged Sti1p, the yeast Cpr7p Cyp40-like cyclophilin, the TPR domain of Cpr7p or 
Cns1p co-chaperone (8, 16 and 32 μM) was added in combination with purified 
recombinant CIRV MBP-p36 and MBP-p95 proteins and the TBSV-derived (+)repRNA 
to the isolated mitochondrial preparations to perform the in vitro replication assay. The 
synthesized full-length repRNA is marked by an arrow. See further details in Fig. 3.7. (B) 
Coomassie Blue stained SDS-PAGE was used for analysis of affinity-purified GST-
tagged Sti1p, Cpr7p and Cns1p. (C) The level of in vitro TBSV repRNA replication in 
total yeast cell-free extracts in the presence of purified TBSV p33 and p92 replication 
proteins and purified GST-tagged Sti1p, Cpr7p, the TPR domain of Cpr7p or Cns1p (16 
and 32 μM). 
 
 
 
Note: Experiments in Fig. 3.8 were in collaboration with Dr. Jing-Yi Lin. 
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Fig. 3.9 Inhibition of CIRV replication by expression of the orthologous AtHop-1 in 
yeast.  
 
(A) Northern blot analysis of CIRV RNA accumulation in wt yeast overproducing the 
FLAG-tagged AtHop-1 or its TPR1-deletion derivative. Second panel: Northern blot 
analysis to demonstrate the comparable level of ribosomal RNA loading in the yeast 
samples. Third and fourth panels: Western blot analysis of CIRV His6-p36, and CIRV 
His6-p95 accumulation by anti-His antibody. Bottom panels: Detection of the 
overproduced FLAG-AtHop-1 in yeast by Western blot analysis using anti-FLAG 
antibody and the Coomassie-stained SDS-PAGE as a loading control. 
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Fig 3.10 
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Fig. 3.10 Knockdown of Hop gene by VIGS increases CIRV accumulation in whole 
plants.  
 
(A) Semi-quantitative RT-PCR analysis of the accumulation of NbHOP mRNAs in 
CIRV-infected N. benthamiana plants (3 dpi, days post-inoculation) and in the control 
mock-inoculated plants. Semi-quantitative RT-PCR analysis of NbActin mRNA level 
served as a control. (B) Top image: Accumulation of CIRV genomic and subgenomic 
RNAs in the inoculated leaves of HOP knockdown N. benthamiana plants 2 dpi, based 
on Northern blot analysis. VIGS was performed via agroinfiltration of TRV vectors 
carrying NbHOP sequence or the TRV vector carrying the C-terminal half of GFP insert 
(as a control). Inoculation with CIRV gRNA was done 14 days after VIGS. Second 
image: Ribosomal RNA level in the samples used as loading control. Bottom images: 
Semi-quantitative RT-PCR analysis of the accumulation of NbHOP mRNA in the 
knockdown N. benthamiana plants and in the control plants 2 days after inoculation with 
CIRV. Semi-quantitative RT-PCR analysis of the NbActin mRNA from the same 
samples served as a control. (C) Accelerated CIRV-induced symptom development in the 
NbHOP knockdown plant (shown on the right) at 7 dpi when compared to the control 
plant infiltrated with the control TRV vector. Note the minor phenotypic effect in the 
uninfected NbHOP knockdown N. benthamiana plants when compared to the control 
plants, which were agroinfiltrated with the pTRV1/2GFP vector (the plants on the left 
side of the images).  (D) Accumulation of CNV gRNA in the inoculated leaves of HOP 
knockdown N. benthamiana plants 2 days post-inoculation, based on Northern blot 
analysis. See further details in Panel B. (E) Comparable CNV-induced symptom 
development in the HOP knockdown and control plants. See further details in Panel C. 
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Fig 3.11 
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Fig. 3.11 Models on the inhibitory role of Sti1p co-chaperone in CIRV replication. 
 
Model 1 predicts that direct interaction between Sti1p and the RPR region of CIRV p36 
replication protein blocks the viral (+)RNA recruitment function of p36, and thus blocks 
replication of CIRV. Model 2 emphasizes the additional role of Sti1p through the co-
opted Hsp70 chaperone. Binding of the TPR1 domain of Sti1p to Hsp70 within the CIRV 
replicase might inhibit the function of the subverted Hsp70 in VRC assembly, by possibly 
stabilizing the Hsp70-p95 complex. Note that both mechanisms might operate inside the 
cell. 
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Chapter 4 
RNA VIRUS REPLICATION DEPENDS ON ENRICHMENT OF 
PHOSPHATIDYLETHANOLAMINE AT REPLICATION SITES IN 
SUBCELLULAR MEMBRANES 
 
 
4.1 Introduction 
 
Many steps in the infection cycles of positive-strand RNA viruses, including entry into the 
cell, replication, virion assembly and egress, are associated with subcellular 
membranes(20). Therefore, viruses have to interact with different lipids, such as 
phospholipids and sterols, which affect the biophysical features of membranes, including 
the fluidity and curvature (57, 64, 70, 144). The subverted cellular membranes could 
protect the viral RNA from recognition by the host nucleic acid sensors or from destruction 
by the cellular innate system. In addition, membranes facilitate the sequestration of viral 
and co-opted host proteins to increase their local concentrations and promote 
macromolecular assembly, including formation of the replicase complex or virion 
assembly. To optimize viral processes, RNA viruses frequently manipulate lipid 
composition of various intracellular membranes. Overall, the interaction between cellular 
lipids and viral components is emerging as one of the possible targets for antiviral methods 
against a great number of viruses. 
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 Among the various lipids, the highly abundant phospholipids are especially 
targeted by RNA viruses (57). In general, phospholipids likely affect the replication of 
most RNA viruses, which takes place within membranous structures(31). Accordingly, 
lipidomics analyses of cells infected with Dengue virus and Hepatitis C virus (66, 67) 
revealed enhanced virus-induced lipids biosynthesis, resulting in changes in the global 
lipid profile of host cells. Phosphatidylinositol-4-phosphate (PI4P) was shown to be 
enriched at sites of enterovirus replication, and RNA polymerase of Poliovirus selectively 
binds to PI4P (33), suggesting that micro-environment enriched for PI4P facilitates 
enterovirus replication. However, our knowledge on the roles of various phospholipids in 
RNA virus replication is currently incomplete. By using tombusviruses, small model RNA 
viruses of plants that can replicate in yeast surrogate host (13), a major role for 
phospholipid and sterol biosynthesis has been revealed (89, 90). In this paper, development 
of artificial vesicle-based replication of tomato bushy stunt virus (TBSV) identified the 
essential role of phosphatidylethanolamine (PE) in RNA virus replication. It is also shown 
that TBSV could recruit and enrich PE to the sites of viral replication in yeast and plant 
cells. Moreover, genetic changes that increase PE levels in yeast greatly stimulated TBSV 
replication, confirming the key role of PE in the formation of TBSV replicase.  
 
4.2 Materials and Methods 
 
Yeast Strains and expression plasmids. Parental yeast strain BY4741 (MAT a his3Δ1 
leu2Δ0 met15Δ0 ura3Δ0) and single-gene deletion yeast strains (cho2∆, pex3∆) were from 
Open Biosystems.  E. coli protein expression plasmids for recombinant TBSV p33 and 
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p92, pMAL-p33 and pMAL-p92, were previously described (102). pESC-T33/DI72 and 
pYES-T92 used for yeast expression of viral components were described (9).  
 
Preparation of CFE, membrane fraction (P40) and soluble fraction (S40). The yeast 
cell-free extracts (CFE) from train BY4741 were prepared according to (49). CFE 
preparations were centrifuged at 40,000 x g for 1hr to separate the membrane fraction 
(P40) and the soluble fraction (S40). Collected P40 and S40 were immediately stored at -
80 °C until use. 
 
Artificial phospholipid vesicles preparation. Phospholipids were obtained from Avanti 
Polar lipids, Inc. Phospholipids (269 nmol/preparation) were dissolved in chloroform and 
transferred into glass vials, mixed, and subsequently dried under a small stream of nitrogen 
for 1 hour under fume hood. The phospholipids were further dried in a speed-vacuum for 
additional 2-3 hours to completely remove chloroform. To each glass vial, 400 µl HEPES 
buffer (30 mM, pH 7.4) was added, followed by sonication in a bath sonicator (Avanti 
Polar lipids, Inc.) filled with ice for 20 minutes. The mixtures became visually 
homogeneous. The concentrations of the obtained phospholipid vesicle preparations were 
672 µM. Phospholipids vesicles were prepared in the same day of in vitro replication 
assay. 
 
In vitro TBSV replication assay using artificial phospholipid vesicles. The procedure 
for in vitro replication assay using phospholipid vesicles was adapted from the previously 
published procedure using purified yeast organelles (9), except that 100,000 xg supernatant 
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(S100) was replaced with S40 fraction of CFE. Briefly, 2 µl of phospholipid vesicles and 1 
µl of S40 fraction were incubated at 25 °C for 1 hour in 8 µl buffer containing 30 mM 
HEPES-KOH (pH7.4), 150 mM potassium acetate, 5 mM magnesium acetate, 0.6 M 
sorbitol, 15 mM creatine phosphate, 1 mM ATP, CTP and GTP and 0.025 mM UTP, 0.1 µl 
of [32P]UTP, 0.1 mg/ml creatine kinase, 0.1 µl of RNase inhibitor (Thermo Scientific), 10 
mM dithiothreitol, 0.5 µg DI-72 RNA transcript, and 0.5  µg MBP-tagged recombinant 
TBSV p33 and p92 replication proteins. Then, the reaction mix was incubated for 3 hours 
in  16 µl cell-free replication buffer B (30 mM HEPES-KOH pH7.4, 150 mM potassium 
acetate, 5 mM magnesium acetate) with 15 mM creatine phosphate 1 mM ATP, CTP and 
GTP 0.025 mM UTP, 0.2 µl of [32P]UTP, 0.1 mg/ml creatine kinase, 0.2 µl of RNase 
inhibitor, 10 mM dithiothreitol and 0.05 mg/ml actinomycin D. After reaction, total RNA 
was extracted and analyzed in a denaturing gel. Determination of viral (+)RNA/(-)RNA 
ratio, as well as micrococcal nuclease treatment were described previously (9). 
 
Membrane flotation assay. [35S]methionine-labeled TBSV p33 (101) was incubated with 
different phospholipid vesicles as previously described using purified yeast organelles (9). 
The membrane flotation assay was performed as previous described (212) with minor 
modifications. Briefly, the reaction mixture (24 µl) were mixed with 126 µl 85% sucrose 
in HEPES buffer in a final concentration of 71.25%, then overlaid with 900 µl 65% 
sucrose and 150 µl 10% sucrose in HEPES  buffer (30 mM, pH 7.4). The gradient was 
centrifuged at 134,000 x g for 16 hours at 4 °C in a swing bucket rotor (Beckman TLS-55).  
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TBSV RNA recruitment assay. For the viral RNA recruitment assay, phospholipids 
vesicles were mixed with MBP-tagged recombinant TBSV p33 and p92 replication 
proteins (0.5µg each) as in vitro replication assay, except that UTP was omitted from the 
reaction mixture, and 1 µg/µl yeast tRNA was added as non-specific competitor and 1 µl 
radioactive [32P]UTP labeled DI-72 RNA transcripts were added. After incubation for 1 
hour at 25 °C, the reaction mixtures were subjected to membrane flotation assay in sucrose 
gradients as described above. Total RNA from the top fraction of each gradient was 
extracted and analyzed in a denaturing RNA gel (5% polyacrylamide gel containing 8M 
urea).  
 
Lipid extraction and mass-spectrometry for lipidomics analysis. For yeast 
phospholipid analysis, yeast carrying the TBSV expression plasmids were pre-cultured in 
glucose-containing media overnight, washed and diluted to 0.3 OD600 units/ml in 
galactose-containing media and cultured for approximately 24 h at 23 ºC until reaching ~2 
OD600 units/ml. Yeast cells (0.4 g) were placed into a 15 ml glass tube, containing 1.2 ml 
water, 2 ml chloroform, 4 ml methanol, 0.8 g glass beads, followed by mixing and 
vigorous vortexing. Then, 2 ml chloroform and 2 ml water were added into the tube and 
centrifuged at low speed. Then, the lower organic phase was collected. 2 ml chloroform 
was mixed with the remaining inorganic phase; lower organic phase was withdraw. The 
chloroform extraction step was repeated. All the organic phases from previous steps were 
combined and washed with 0.5 ml 1M KCl and then with water.  
To determine the phospholipids profile of TBSV-infected plants, 3 weeks old 
Nicotiana benthamiana plants were inoculated with TBSV genomic RNA transcripts or 
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mock-inoculated with buffer. Then, at 6 days post infection, the upper leaves showing the 
characteristic TBSV symptoms were harvested. Lipid extraction was as described 
previously (213). Briefly, about 0.15-0.2 grams of leaves from one plant were collected 
and incubated with 3 ml isopropanol containg 0.01% butylated hydroxytoluene (BHT) at 
75 °C for 15 min. Extraction of lipids with chloroform/methanol (2:1) incubated at room 
temperature was performed for 1 hour, in total five times. Organic phases from each 
extraction were combined and washed with 0.5 ml 1 M KCl and water, respectively.  
Washed organic phase was analyzed on a triple quadrupole MS/MS equipped for 
electrospray ionization (ESI). Di 10:0 PE/PC/PG (Avanti Polar Lipids, Inc) were mixed 
with yeast or plant samples before extraction as spiked lipids standards for PE/PC/anionic 
phospholipids during the extraction step. In addition, two internal lipid standards of each 
phospholipid class were mixed with each sample before ESI-MS/MS analysis for 
quantification of each lipid class (213). Data were obtained from 3 repeats.  
 
Purifiation of biotinylated duramycin. Biotinylation of duramycin (Sigma Cat. #: 
D3168), followed by purification, was performed as described for cinnamycin (214, 215). 
Briefly, 500 µM duramycin in 0.1 M NaHCO3 was mixed with equal volume of 8.7 mg/ml 
EZ-link NHS-LC-biotin dissolved in sterile water (Thermo Scientific, Product #: 21336) 
for 4 hours at room temperature and quenched by adding one-fifth volume of 0.1 M lysine. 
Biotinylated duramycin were purified by reverse-phase high-performance liquid 
chromatography using Waters Nova-Pak C18 Column (Model: WAT086344). The 
biotinylated duramycin was eluted with a linear gradient of 10 mM sodium acetate (pH 
4.2) starting from 5% to 60% for 50 min, at a flow rate of 0.5 ml/min. Biotinylated 
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duramycin was collected at 28 to 30 min after starting of elution. No peak was detected at 
the “32 min” time-point, when elution of nonbiotinylated duramycin was expected, 
suggesting that all duramycin molecules became biotinylated. 
 
Imaging of PE distribution and viral protein localization in yeasts and plant 
protoplasts. Yeast cultures were grown in glucose containing media overnight and 
switched to galactose containing media with initial 0.3 OD600. To prepare spheroplasts, 
overnight cultures were harvested and the yeast cells were fixed with 3.7% formaldehyde 
for 40 min at room temperature in dark, washed twice with 0.1 M potassium phosphate 
(pH 7.5), and then re-suspended in SPP (0.1 M potassium phosphate pH 7.5, 1.2 M 
sorbitol) with zymolase 20T (1 mg/ml). Cells were incubated at 30 °C for 1 hour, and then 
incubated with SPP with 50 mM NH4Cl for 15 min to quench free aldehyde groups. 
Spheroplasts were collected after washing twice with SPP, and then applied to poly-L-
lysine coated slides. Slides were immersed in methanol for 6 min and acetone for 30s, 
respectively, at -20 °C. Biotinylated-duramycin was added into phosphate-buffered saline 
(PBS, pH 7.4) containing 0.05% Nonidet P-40 and 1% BSA (15 µg/ml), and incubated 
overnight with the fixed cells at -4 °C. Slides were washed and incubated with Streptavidin 
conjugated with Alexa Fluor® 405 (Life Technologies, Cat. #: S-32351) for 1 hour before 
imaging. 
The distribution of PE was also monitored using fatty acid-labeled NBD-PE and 
NBD-PC internalization. M-C6-NBD-PE (1-myristoyl-2-(6-[(7-nitro-2-1,3-benzoxadiazol-
4-yl)amino]hexanoyl)-sn-glycero-3-phosphoethanolamine) and M-C6-NBD-PC (1-
myristoyl-2-(6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl)-sn-glycero-3-
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phosphocholine) (Avanti Polar lipids, Inc.) were dissolved in DMSO in 8 mM 
concentration (216) and stored at -20 °C. Wild type yeast transformed with pESC-mRFP-
T33 and pRS315-Pex13p-BFP was pre-grown in SC medium, then cultured in SC medium 
containing 2% galactose with 80 µM NBD-PE or NBD-PC at 0.5 OD600, and incubated at 
23 °C for 16 hours. Cells were washed with SCNaN3 medium (216) (SC medium with 2% 
sorbitol and 20 mM sodium azide) and subjected to confocal laser microscope analysis. 
N. benthamiana protoplasts were prepared and eletroporated with in vitro 
transcribed TBSV full length genomic RNA as described previously (204). Protoplasts 
were fixed with 3.7% formaldehyde in protoplast culture medium (204), applied to poly-L-
lysine coated slides, and processed using the above procedure for PE staining. For dual 
staining of p33 and PE, anti-p33 primary antibody (a gift from Dr. Herman B. Scholthof) 
was diluted (1:400) and incubated with fixed protoplasts in PBS containing 1% 
BSA/0.05% Nonidet P-40 overnight. After washing three times with PBS/1% BSA/0.05% 
Nonidet P-40, cells were incubated with anti-mouse secondary antibody conjugated to 
Alexa Fluor® 488 (Life Technologies, Cat. #: A-11001) for 1 hour before imaging. 
Confocal images were obtained with an Olympus FV1000 microscope (Olympus 
America, Melvie, NY). Alexa 405, GFP/Alexa 488, and RFP were excited using 405 nm, 
488 nm or 543 nm lasers, respectively. Images were obtained sequentially, and merged 
using Olympus FLUOVIEW 1.5 software. 
 
4.3 Results 
 
Efficient replication of TBSV RNA in artificial PE vesicles. To test what type of 
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phospholipids are required for tombusvirus replication, we developed an artificial 
vesicle- (liposome-) based replication assay involving purified recombinant tombusvirus 
p33 and p92pol replication proteins, TBSV (+) replicon (rep)RNA and cellular cytosolic 
proteins present in yeast cell-free extract (CFE, Fig. 1A). Interestingly, artificial vesicles 
prepared only from phosphatidylethanolamine (PE) supported TBSV repRNA 
replication, reaching about half of the level that takes place in the standard CFE obtained 
from wt yeast (Fig. 1A, lanes 3-4 versus 1-2). On the contrary, vesicles consisting of only 
phosphatidylcholine (PC, Fig. 1A, lanes 5-6), or lysoPE showed 5% viral RNA 
replication activity when compared with PE vesicles (Fig. 2A, lanes 3-4 and 13-14), 
while PG, PS, PI, CA, and lysoPC vesicles did not support TBSV RNA replication (Fig. 
2A). These data support a model that PE is the only phospholipid required for TBSV 
replication in vitro, while the other phospholipids are not sufficient by themselves. 
To examine the nature of TBSV replication in PE vesicles, we measured (-) 
versus (+)-strand RNA synthesis. These experiments revealed that TBSV replication led 
to the production of ~10-fold more (+)- than (-)-stranded RNAs, similar to the ratio seen 
in yeast CFE preparation containing yeast membranes (Fig. 1B) (102). Thus, the in vitro 
assembled TBSV replicase in PE vesicles can support a complete cycle of replication and 
asymmetrical RNA synthesis, which is hallmark of (+)-strand RNA viruses. We also 
tested if the PE vesicles are required for RNA synthesis by adding various concentrations 
of Triton X-100, which could disrupt lipid bilayer. Viral RNA synthesis was inhibited up 
to 90% in the presence of 0.01%, while it was completely blocked by the presence of 0.1 
or 1.0% Triton X-100 (Fig. 1C), suggesting that the membranous environment is needed 
for TBSV replication in vitro. To test if TBSV replicase could form a nuclease-resistant 
 113 
 
compartment, as the case in cells and in the yeast CFE (49, 102), we performed the in 
vitro assays in the presence of micrococcal nuclease, which can destroy the unprotected 
viral RNAs. These studies revealed that TBSV replicase formed in the presence of PE 
vesicles was much less protective of the viral RNA against the nuclease than the replicase 
assembled in yeast CFE (Fig. 2B). This finding suggests that not only PE, but additional 
phospholipids, other types of lipids or membrane proteins in the yeast CFE also 
contribute to the assembly of the authentic TBSV replicase. 
To estimate optimal PE level for TBSV replication, we made artificial vesicles 
containing PE and increasing amounts of a mixture of other phospholipids (PC, PI, PS, 
PG, lysoPE and lysoPC, mixed as their molar ratio from TBSV infected N. benthamiana 
leaves as shown in Fig. 7) (Fig. 1D). The highest level of TBSV replication was observed 
with the vesicle containing 82-90% PE (Fig. 1D). On the other hand, vesicles containing 
less than 70% PE did not support efficient TBSV replication in vitro. We also tested PE 
and other phospholipids in pair-wise combinations. These in vitro assays revealed that the 
presence of only 10% of PC or lysoPE in PE vesicles enhanced TBSV replication by 
more than 50%, while these phospholipids were inhibitory when applied in higher than 
20% concentrations (Fig. 3A-B). In contrast, the presence of other phospholipids (PS, PI, 
CA, lysoPC) were inhibitory to TBV replication, except for 10% of PG (Fig. 3B). Thus, 
various phospholipids (other than PE) have inhibitory effects on TBSV replication when 
present in higher than 20% amounts. These results indicate that TBSV replication is 
greatly affected by different kind of phospholipids. 
To test whether phospholipids affect the membrane association of the viral 
replication proteins, we performed membrane flotation experiments with artificial 
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vesicles and 35S-labeled p33 replication protein. As expected, in the absence of 
membranes/vesicles, p33 stays at the bottom of the sucrose gradient (Fig. 4B), while 
~30% of p33 are present in the top fraction in the presence of either PE or PC vesicles 
(Fig. 7C-D). In addition, p33 can strongly associate with PG, PS and CA vesicles, while 
binding to PI vesicles is poor (Fig. 4). These data suggest that, except for PI, most of 
phospholipids does not inhibit p33 targeting to membrane. Similar studies with the viral 
(+)repRNA, which has to be recruited to the sites of replication in the membranes by 
replication proteins (3, 102, 202), revealed that the (+)repRNA bound to membrane 
associated p33/p92pol replication proteins with the highest efficiency in the presence of 
PE, PC and lysoPE vesicles, while PG, PS, PI, CA and lysoPC vesicles does not 
stimulate (+)repRNA recruitment (Fig. 5). Therefore, we suggest that binding of 
p33/p92pol replication proteins to PE, PC and lysoPE phospholipids facilitate the 
recruitment of the viral (+)repRNA to replicase complexes.  
 
PE is enriched at the sites of TBSV replication. Since TBSV requires membranes with 
high PE content to assemble the functional VRCs in vitro, we wondered if PE, which is 
among the most abundant phospholipids in yeast, is enriched at the sites of replication. We 
used Alexa405-labeled duromycin, which specifically binds to PE (217), to monitor the 
distribution of PE during TBSV replication. Interestingly, PE was highly enriched in the 
subcellular locations in yeast cells containing GFP-p33 expressed alone or with p92pol 
replicating the TBSV repRNA (Fig. 6A). These sites co-localized with both Pex13p-
mRFP/GFP peroxisomal marker and GFP/RFP-p33 (Fig. 6B), indicating that PE is 
enriched at the sites of TBSV replication in the peroxisomal membrane. On the contrary, 
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the peroxisomal membrane was not enriched with PE in the absence of TBSV replication 
proteins and PE was dispersed in many parts of the yeast cell (Fig. 6B, -TBSV treatment). 
We confirmed the above findings using fatty acid fluorescently-labeled PE (NBD-PE) 
added to the culture media. Accordingly, NBD-PE was enriched in the subcellular location 
also containing RFP-p33 and Pex13p-GFP (Fig. 6C). On the contrary, NBD-PE was not 
enriched in the peroxisomal membranes in the absence of TBSV p33 (Fig. 6C). Unlike 
NBD-PE, NBD-PC was not highly enriched at the sites of TBSV replication (Fig. 6C). 
Based on these data, we propose that PE molecules are efficiently re-localized to and 
enriched at the sites of viral replication in the peroxisomal membranes. To test if similar 
phenomena also occur in plant cells during TBSV replication, we stained TBSV infected 
plant cells (N. benthamiana protoplasts) with Alexa405-labeled duromycin and anti-
p33/p92 antibody. Importantly, confocal imaging showed high enrichment of PE in 
subcellular locations containing the p33/p92 replication proteins (Fig. 6D). The subcellular 
distribution of PE was dramatically different in uninfected plant cells. Based on all these 
data, the emerging picture is that PE, unlike PC, is efficiently redistributed to the 
peroxisomal membranes to facilitate TBSV replication. 
 
Increased PE level in yeast and plant cells supporting TBSV replication. To test if TBSV 
replication alters phospholipid metabolism to facilitate its replication, we performed 
lipidomics of yeast cells replicating TBSV repRNA or lacking all TBSV components. 
These experiments revealed that the relative PE percentage within 5 major phospholipids 
increased from 17.6% to 29.3% (~1.7 fold increase) in yeast replicating TBSV (Fig. 7A). 
On the contrary, PC and PI levels, which are two of the most abundant phospholipids, are 
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decreased by ~6% and 8.4%, respectively, when yeast supported TBSV replication (Fig. 
7A). These data suggest that TBSV selectively increases PE level in yeast. The overall 
phospholipid content of yeast cells after normalized by cell weight before lipid extraction 
increased by 38.4% (Fig. 8A), suggesting that yeast cells are induced by TBSV to produce 
new phospholipids. Considering overall phospholipids also increased in TBSV replicating 
cells, the PE content of yeast cells replicating TBSV increased by ~2.3-fold. This increased 
level of PE in yeast cells likely serves the virus’ need to build new membrane-bound 
replicase complexes (see below). Lipidomics analysis revealed no significant changes in 
the fatty acid length or saturation status of the PE in yeast replicating TBSV versus the 
control yeast (Fig. 8C&D). 
 The PE level was also increased in TBSV-infected plant leaves from 21.2% to 28.8%  
within 7 major phospholipids analyzed (Fig. 7B). In contrast to yeast, the PC level also 
increased in plants, which could be the results of overall elevated phospholipid synthesis 
(Fig. 8B). Nevertheless, the lipidomics data support the increased synthesis of PE in 
TBSV-infected plant cells, similar to the yeast counterpart.   
 
Increased PE level in cho2∆ yeast promotes TBSV replication. To examine if PE level 
can directly affect TBSV replication in cells, we deleted CHO2, which codes for 
phosphatidylethanolamine methyltransferase (PEMT), in yeast. Cho2p catalyzes the first 
step in the conversion of PE to PC, and in its absence, PE level is increased and PC level is 
decreased (218). We find that TBSV replication is increased by ~10-fold in cho2∆ yeast in 
comparison with wt yeast (Fig. 9A, lanes 5-8 versus 1-4). In addition, the amounts of p33 
and p92pol replication proteins were also increased (Fig. 9A). Lipidomics analysis of cho2∆ 
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yeast supporting TBSV replication showed that PE becomes the most abundant within 5 
major phospholipids by reaching up to ~42% level (Fig. 9B, upper panel). And within 
same amount of cell weight, PE increased ~2.5-fold comparing with wild type yeast 
replicating TBSV extraction (Fig. 9B, lower panel). 
We have also performed in vitro TBSV replicase assembly assay in isolated 
membrane fractions from wt or cho2∆ yeasts. The viral replicase assembled with 
membrane fractions from cho2∆ yeast showed ~3-fold higher activity in vitro than from wt 
yeast (Fig. 9C). Since we used the same amount of the recombinant viral proteins in the 
CFE preparations, the increased TBSV replicase activity from cho2∆ yeast suggests that 
the high accumulation level of TBSV repRNA in cho2∆ yeast is due to enhanced replicase 
activity in cho2∆ yeast (Fig. 9A). Confocal microscopy analysis of cho2∆ yeast showed 
robust re-distribution of PE to the sites of TBSV replication, containing the viral 
replication proteins and peroxisome membranes (Fig. 9D).  
To test if the high accumulation of PE in the peroxisome membranes is critical for 
TBSV replication, we deleted PEX3 peroxisome biogenesis gene in cho2∆ yeast. In the 
absence of PEX3 there is no peroxisome or peroxisome membrane remnants in yeast (ref) 
and TBSV switches to the ER for replication (32). ER can support as robust TBSV 
replication as the peroxisomes in yeast (32, 107). We find that TBSV replication is 
increased by ~13-fold in cho2∆pex3∆ yeast (Fig. 10), suggesting that TBSV can take 
advantage of increased PE level in the ER membrane in the absence of peroxisomes.  
To test if the pro-viral role of PE also extends to other viruses, we analyzed 
replication of the closely-related cucumber necrosis tombusvirus (CNV), which also 
replicates on peroxisomal membranes. Similar to TBSV, CNV replication was increased in 
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cho2∆ yeast (Fig. 11A-B) and the CNV p33 protein induced the re-localization of PE in 
yeast cells (Fig. 11C). To study if viruses replicating in other subcellular compartments 
could take advantage of the increased PE level in cho2∆ yeast, we used Carnation Italian 
ringspot virus (CIRV, a tombusvirus), which replicates in the outer mitochondrial 
membranes  (9, 19). CIRV accumulation is increased by ~5-fold in cho2∆ yeast (Fig. 
12A). Moreover, the p36 replication protein of CIRV induced the efficient enrichment of 
PE in the same subcellular locations that harbor p36 (Fig. 12B). Replication of another 
mitochondrial RNA virus, the unrelated Nodamura virus (NoV) insect RNA virus, also 
benefitted from the increased PE level in cho2∆ yeast (Fig. 12C). Interestingly, protein A 
replication protein of NoV is also localized at highly PE-enriched subcellular locations 
(Fig. 12C). Therefore, we conclude that tombusviruses and NoV could take advantage of 
the increased PE level in various subcompartments in cho2∆ yeast. Similar to TBSV, the 
replication proteins of these viruses can induce the efficient enrichment of PE at the sites 
of virus replication, suggesting that different (+)RNA viruses build PE enriched 
environment for replication. 
 
4.4 Discussion 
 
It is universally accepted that plant and animal RNA viruses require cellular 
membranes for their propagation in infected cells (20). These viruses replicate in various 
subcellular compartments that contain unique composition of lipids. However, it is 
currently poorly understood how different lipids could affect the viral replication process. 
By using the highly tractable tombusviruses, we show that PE plays an essential role in 
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viral replication. The supporting evidence includes: (i) in vitro data with artificial vesicles 
that facilitated TBSV replication only when PE was present above 70%, (ii) the relative 
increase of PE in yeast and plant cells replicating tombusvirus; (iii) PE enrichment in the 
replication sites of tombusviruses and Nov; and (iv) cell-based results showed increased 
tombusviruses and Nov replication in cho2∆ yeast that contain high level of PE at the 
expense of PC level.  
Essential role of PE in TBSV VRC assembly. Based on in vitro approaches, the 
major function of PE is during the assembly of the VRCs. We show that VRCs are only 
functional in the presence of artificial PE vesicles, while other phospholipids are 
insufficient to support efficient VRC assembly and they are inhibitory when present in 
20% or more in comparison with PE level in artificial vesicles. In addition, membrane 
fractions from cho2∆ yeast support enhanced TBSV replication in vitro, suggesting more 
efficient VRCs assembly when PE is abundant in membranes.  
 Interestingly, PE does not seem to be essential at the very early steps of replication 
(prior to the VRC assembly), because PE is not favored to bind to the TBSV p33 
replication protein when compared to other phospholipids. Also, PC is even more efficient 
than PE for facilitating the p33/p92-driven recruitment of the viral (+)repRNA in vitro. 
However, efficient viral replication requires high level of PE at the replication sites. It is 
likely that p33 induce PE enrichment at sites of replication after p33 associated with 
subcellular membrane at the very initial step of replication. Meanwhile, binding to PE 
might stabilize p33/p92, because we observed elevated levels of p33/p92 in cho2∆ yeast in 
comparison with wt yeast. We have previously shown that total phospholipids are 
important for p33/p92 stability in yeast (89).   
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Based on TBSV replication studies with artificial vesicles, TBSV requires high 
local concentration of PE at the sites of replication (above 70%, Fig. 1). However, PE is 
below that level in subcellular membranes (51), such as peroxisomes(219), 
mitochondria(220, 221) and ER(221). TBSV changes cell lipidome upon infection with 
increased PE level, as shown by lipidomics data from yeast and plant cells. Meanwhile, 
confocal microscopy images show the robust accumulation of PE at peroxisomal sites 
where TBSV p33 replication protein accumulates (to form VRCs). Interestingly, PEs 
(NBD-PE) provided in the yeast culture media found its way to the TBSV replication sites, 
suggesting that existing PE is efficiently re-distributed to the sites of TBSV replication. 
Overall, TBSV utilizes different pathways to increase the local concentrations of PE to 
serve the virus’ need during VRC assembly. 
The development of artificial vesicle-based TBSV replication clearly demonstrates 
that TBSV requires PE for VRC assembly. TBSV replicase assembled on the PE vesicles 
could support complete cycle of RNA replication, including (-)- and (+)-RNA synthesis in 
an asymmetrical manner, producing ~10-times more (+)-strands than (-)-strands. 
Asymmetrical replication of the RNA genome is one of the hallmarks of (+)-strand RNA 
viruses (222). However, optimal TBSV replication also requires additional phospholipids, 
because the highest TBSV RNA synthesis was observed with vesicles containing ~15% 
additional phospholipids and ~85% PE. PE possess a conical molecular structure and 
introduce negative curvature into lipid bilayer. Such negative curvature likely contribute to 
membrane invagination occurs upon formation of spherule structures build by TBSV at the 
sites of replication (81).  
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A wide-spread role of PE in (+)RNA virus replication? Many other (+)RNA viruses also 
induce membrane invagination during replication (79), including CNV (223), CIRV (114) 
and NoV (224). Indeed, PE enrichment at replication sites seems to be a common feature 
among these (+)RNA viruses. Using cho2Δ yeast lacking PEMT to convert PE to PC, we 
demonstrate that the TBSV-related CNV (peroxisomal replication) and CIRV 
(mitochondria) and the unrelated NoV (mitochondria) all supported enhanced replication 
when PE is abundant in membranes. Also “forcing” TBSV to switch to ER membranes in 
the absence of peroxisomes in cho2Δ yeast (due to pex3Δ background), still resulted in 
efficient TBSV replication, suggesting that these (+)RNA viruses could take advantage of 
abundant PE in various subcellular membranes. In summary, the emerging picture from 
our work is that various (+)RNA viruses might subvert PE in order to build VRCs and 
replicate efficiently in infected cells. 
 
(Copyright © Kai Xu 2014) 
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Fig. 4.1. In vitro reconstitution of the TBSV replicase in artificial PE vesicles.  
(A) Scheme of the assay. Purified recombinant p33 and p92pol replication proteins of 
TBSV in combination with the TBSV-derived (+)repRNA were added to PE or PC 
vesicles or the P40 membrane-fraction of yeast CFE. The S40 fraction of CFE was also 
added to each sample to provide soluble host factors required for TBSV VRC assembly. 
The denaturing PAGE analysis of the 32P-labeled repRNA products obtained is shown. 
The full-length repRNA is pointed at by an arrow. The CFE-based replication assay with 
CFE was chosen as 100% (lanes 1-2). (B) Asymmetrical RNA synthesis by TBSV VRCs 
assembled in PE vesicles. The amounts of TBSV (+) and (-)-stranded RNA products 
produced by the reconstituted TBSV VRCs are measured by using the 32P-labeled 
repRNA probes generated in the in vitro assays. The blot contains the same amount of 
cold (+) and (-)-stranded DI-72 RNA. (C) TBSV RNA synthesis by the reconstituted 
VRCs in PE vesicles requires vesicles/membranes. The PE vesicles were disturbed by 
Triton-X100 treatment as shown. The denaturing PAGE analysis of the replicase products 
is as shown in Panel A. (D) Increased VRC activity in PE vesicles containing a fraction 
of other phospholipids. The PE vesicles contained the shown % of PE plus a mixture of 
other phospholipids (the ratio was: 54.5 of PC,  6.1 of PI, 1.2 of PS, 8.3 of PG, 0.9 of 
LPE, and 0.6 of LPC). The denaturing PAGE analysis of the replicase products is as 
shown in Panel A. 
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Fig. 4.2. In vitro reconstitution of the TBSV replicase in artificial phospholipid vesicles.  
(A) Artificial vesicles were prepared from the shown phospholipids, followed by in vitro 
TBSV replication assay in the presence of purified recombinant TBSV p33 and p92pol 
replication proteins, TBSV repRNA in combination with the S40 fraction of yeast CFE to 
provide soluble host factors required for TBSV VRC assembly. The denaturing PAGE 
analysis of the 32P-labeled repRNA products obtained is shown. The full-length repRNA is 
pointed at by an arrow. The PE vesicle-based replication assay was chosen as 100% (lanes 
1-2). (B) High level nuclease-sensitivity of the tombusvirus replicase assembled in 
artificial vesicles. Scheme of the vesicle-based TBSV replication assay shows that 
micrococcal nuclease was added to the assay for 15 minutes at various time points as 
shown (after which it was inactivated by EGTA). The total length of the in vitro replication 
assay was 3 h. Denaturing PAGE analysis of in vitro replicase activity in comparison with 
the untreated preparation (that was chosen as 100%). Note that the repRNA is protected 
from micrococcal nuclease degradation by the proper formation of the membrane-bound 
viral replicase complex. 
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Fig. 4.3. Effects of various phospholipids on the TBSV replicase activity in artificial PE 
vesicles.  
(A) Scheme of the assay. (B) Artificial vesicles were prepared from PE only (lane 1), or 
PE (always the same amount as in lane 1) + 10% (lane 2, ratio of PE versus other 
phospholipid is 10:1), 20% (lane 3, 5:1 ratio), 40% (lane 4, 5:2 ratio), 60% (lane 5, 5:3 
ratio) or 80% (lane 6, 5:4 ratio) of the shown phospholipids, followed by in vitro TBSV 
replication assay in the presence of purified recombinant TBSV p33 and p92pol replication 
proteins, TBSV repRNA in combination with the S40 fraction of yeast CFE. The 
denaturing PAGE analysis of the 32P-labeled repRNA products obtained is shown. The 
full-length repRNA is pointed at by an arrow. The PE vesicle-based replication assay was 
chosen as 100% (lane 1). Each experiment was done three times. 
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Fig. 4.4. Binding of TBSV p33 to artificial vesicles containing different phospholipids. 
 
 (A) Scheme of the in vitro binding assay and membrane-flotation experiments. The 35S-
labeled p33 was incubated with artificial vesicles (in the presence of the in vitro 
translation system to provide soluble cellular factors, such as heat shock protein 70), 
followed by centrifugation in 10-to-70% sucrose density gradient. Eight fractions of the 
sucrose gradient were tested for the presence of 35S-p33. (B-J) SDS-PAGE analysis of the 
presence of 35S-p33 in the eight fractions with the 1st fraction representing the bottom 
fraction with the free (not membrane-bound) 35S-p33. The total amount of 35S-p33 
applied to the gradient was chosen as 100%. The graph shows the amount of 35S-p33 
present in the top fraction, representing the vesicle-bound 35S-p33. 
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Fig. 4.5. TBSV p33/p92-mediated binding of TBSV RNA to artificial vesicles containing 
different phospholipids.  
(A) Scheme of the in vitro binding assay and membrane-flotation experiments. The 32P-
labeled TBSV (+)repRNA (DI-72) was incubated with artificial vesicles in the presence of 
purified recombinant TBSV p33 and p92 (in the presence of S40 fraction of yeast CFE to 
provide soluble cellular factors, such as heat shock protein 70), followed by centrifugation 
in 10-to-70% sucrose density gradient. The top fraction of the sucrose gradient was tested 
for the presence of 32P-labeled TBSV (+)repRNA. (B) Denaturing RNA gel analysis of the 
presence of 32P-labeled TBSV (+)repRNA in the top fraction. The amount of 32P-labeled 
TBSV (+)repRNA with the PE vesicles was chosen as 100%.  
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Fig. 4.6. Enrichment of PE at TBSV replication sites in yeast and plant cells.  
 
(A) Confocal laser microscopy images show the enrichment of PE and its co-localization 
with the GFP-tagged TBSV p33 expressed from GAL1 promoter in the presence of TBSV 
repRNA replication (top two images) or only GFP-p33. DIC (differential interference 
contrast) images are shown on the right. Localization of PE is detected by using 
biotinylated duramycin peptide and streptavidin conjugated with Alexa Fluor 405. The 
bottom image shows the more even distribution of PE in the absence of viral components. 
(B) Peroxisomal enrichment of PE in the presence of TBSV replication proteins. 
Peroxisomal membranes are visualized with the help of mRFP-tagged (top images) or 
GFP-tagged (middle images) yeast Pex13 protein. The bottom image shows the lack of 
PE enrichment in peroxisomes in the absence of viral components. See further details in 
panel A. (C) Enrichment of exogenous PE in subcellular compartment containing the p33 
replication protein. NBD-PE was added to yeast cultures (D) Enrichment of PE in N. 
benthamiana protoplasts with viral proteins replicating TBSV genomic RNA. The TBSV 
p33/p92 replication proteins were detected with p33/p92-specific primary antibody and 
secondary antibody conjugated with Alexa Fluor488. The bottom images show the more 
even distribution of PE in the absence of viral components. See further details in panel A. 
  
 134 
 
 
 
 
 
Fig. 4.7 
  
 135 
 
Fig. 4.7. Increased level of PE in yeast and plant cells replicating TBSV.  
Relative levels of phospholipids in yeast (~24 h after induction of replication, panel A) and 
plants (from systemic leaves showing symptoms, 6 days after infection, panel B) 
replicating TBSV RNA or the TBSV-free control were determined using mass-spec 
analysis.  
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Fig. 4.8 Lipidomics analyses of phospholipids in yeast and plant cells replicating 
TBSV.  
(A) The amounts of phospholipids in yeast (~24 hours after induction of replication) 
replicating TBSV (red columns) or TBSV-free control (blue columns) were determined 
using mass-spec analysis. Each experiment was repeated three times. (B) The amounts of 
phospholipids in N. benthamiana systemic leaves (6 days after infection) infected with 
TBSV (red columns) or TBSV-free control (blue columns) were determined using mass-
spec analysis. Each experiment was repeated three times. (C) Lack of changes in fatty-
acid composition of PE in yeast (~24 hours after induction of replication) replicating 
TBSV (red columns) or TBSV-free control (blue columns) based on mass-spec analysis. 
(D) Comparable analysis of fatty-acid composition of PE in N. benthamiana leaves (6 
day after inoculation) replicating TBSV (red columns) or TBSV-free control (blue 
columns). 
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Fig. 4.9. Deletion of the CHO2 PEMT gene enhances TBSV repRNA accumulation in 
yeast.  
(A) Top panel: Replication of the TBSV repRNA in wt and cho2∆ yeast was measured 
by Northern blotting 24 h after initiation of TBSV replication. Yeast co-expressed the 
TBSV p33 and p92 replication proteins. The accumulation level of repRNA was 
normalized based on the ribosomal (r)RNA. Each sample is obtained from different yeast 
colonies. Middle and bottom panels: The accumulation levels of His6-p92 and His6-p33 
were tested by Western blotting. Note that in the absence of Cho2p, which catalyzes the 
first step in the conversion of PE to PC, the PE level is increased. Each experiment was 
repeated. (B) Relative and absolute levels of phospholipids in cho2∆ versus wt yeasts 
(~24 h after induction of replication) replicating TBSV RNA were determined using 
mass-spec analysis. (C) Enhanced TBSV repRNA replication in CFE prepared from 
cho2∆ yeast. The scheme of the CFE-based TBSV replication assay. Purified 
recombinant TBSV p33 (0.5 µg) and p92pol (0.5 µg) replication proteins, DI-72 
(+)repRNA (0.5 µg) in combination with the soluble fraction (S40 fraction from WT 
yeast) were added to the membranous fraction (P40) of cho2∆ or wt CFEs. Denaturing 
PAGE analysis of the 32P-labeled repRNA products obtained is shown. The full-length 
single-stranded repRNA is pointed at by an arrow. (D) Confocal laser microscopy images 
show the enrichment of PE at peroxisomal sites of TBSV p33 accumulation in cho2∆ 
yeast. See further details in Fig. 4.6. 
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Fig. 4.10. Increased PE level facilitates TBSV RNA replication in the ER in 
pex3∆cho2∆ yeast.  
Top panel: Replication of TBSV repRNA in pex3∆cho2∆ versus pex3∆ yeast was 
measured by Northern blotting 24 h after initiation of TBSV replication. Yeast co-
expressed the TBSV p33 and p92 replication proteins. Middle and bottom panels: The 
accumulation levels of His6-p92 and His6-p33 were tested by Western blotting. Each 
experiment was repeated. Note that peroxisomal membranes are absent in pex3∆ or 
pex3cho2∆ yeast, “forcing” TBSV to switch to the ER membranes for replication.   
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Fig. 4.11. Increased PE level facilitates CNV RNA accumulation in cho2∆ yeast.  
(A-B) Top panels: Replication of CNV in wt and cho2∆ yeast was measured by Northern 
blotting 24 h after initiation of CNV replication at 23 ºC (panel A) or at 29 ºC (panel B). 
Yeast co-expressed the CNV p33 and p92 replication proteins. Middle and bottom panels: 
The accumulation levels of CNV His6-p92 and His6-p33 were tested by Western blotting. 
Each experiment was repeated. (C) Confocal laser microscopy images show the 
enrichment of PE at peroxisomal sites of CNV p33 accumulation in cho2∆ yeast. See 
further details in Fig. 4.6.  
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Fig. 4.12. Increased PE level facilitates CIRV and NoV RNA accumulation in cho2∆ 
yeast. 
 (A) Top panel: Replication of CIRV repRNA in wt and cho2∆ yeast was measured by 
Northern blotting 24 h after initiation of CIRV replication. Yeast co-expressed the CIRV 
p36 and p95 replication proteins. Middle and bottom panels: The accumulation levels of 
His6-p95 and His6-p36 were tested by Western blotting. Each experiment was repeated. (B) 
Confocal laser microscopy images show the enrichment of PE at mitochondrial sites of 
CIRV p36 accumulation in cho2∆ yeast. See further details in Fig. 4.6. (C) Replication of 
NoV RNA1 and RNA3 in wt and cho2∆ yeast was measured by Northern blotting 24 h 
after initiation of NoV replication. (D) Confocal laser microscopy images show the 
enrichment of PE at mitochondrial sites of NoV Flag-tagged protA replication protein 
accumulation in cho2∆ yeast. See further details in Fig. 4.6. 
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Chapter 5 
VACUOLE TARGETING PATHWAY IS REQUIRED FOR EFFICIENT TBSV 
REPLICATION AND MAYBE RELATED TO PE ENRICHMENT IN THE 
PEROXISOMAL MEMBRANES 
 
 
 
5.1 Introduction 
 
Recent studies revealed an emerging picture on involvement of cellular early secretory 
pathway in positive strand RNA viruses replication, including those viruses infecting 
human (33, 225), animals (226) or plant hosts (227, 228). 
 Poliovirus (PV) infected cells develop special organelle-like structures specialized 
for virus replication (229). This viral replication organelle is derived from rearrangement 
of cellular early secretory membrane systems into clusters of vesicles, which harbor viral 
replication proteins and viral RNAs (230). Formation of Poliovirus replication organelles 
were identified to be associated with COPII-dependent anterograde transportation 
pathway between ER and Golgi (230), as well as host factors involved in retrograde 
transportation pathway (33, 231), like small RAS-family GTPase ADP-ribosylation 
factor 1 (ARF1), GBF1 [a guanine nucleotide exchange factor (GEF) for ARF1] and 
phosphatidylinositol 4-kinase-β (PI4KIIIβ; also known as PI4Kβ) (33). It was proposed 
that initial PV replication happens in Golgi-TGN compartment. This initiated by 
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interaction between PV viral protein  3A (232) and GBF1 which recruits Arf1 to the site 
of replication (33). These events then bring various of effectors, including PI4Kβ, to 
build ERGIC (Endoplasmic reticulum–Golgi intermediate compartment) as site for 
replication (33). Recently, Dorobantu CM et al. (233) found that enterovirus recruitment 
of PI4Kβ to ERGIC is independent of GBF1 and Arf1, suggesting GBF1/Arf1 may have 
other roles in enterovirus replication. 
 Foot-and-mouth disease virus (FMDV) belongs to Aphthovirus genus, 
picornaviridae, induce replication complexes on membranes that are formed from 
endoplasmic reticulum (ER) exit sites (ERES) (226). RNAi mediated down-regulation of 
Sar1 GTPase or over-expression of  dominant negative Sar1a-GDP mutant inhibited 
FMDV replication. However over-expression of dominant active Sar1a-GTP mutant or 
dominant negative Arf1 mutant either have no effects or increased FMDV replication 
(226). Brefeldin A (BFA), a Arf GEF inhibitor, also increased FMDV replication. These 
data suggesting early secretory pathway is linked to FMDV replication. 
 A plant virus red clover necrotic mosaic virus (RCNMV), Dianthovirus genus, 
tombusviridae, was shown to replicate on ER membranes (234). RCNMV replication 
auxiliary protein p27 interacts with Arf1 directly (228). Arf1 was shown to be recruited 
from Golgi apparatus to ER by p27. RNAi-mediated down-regulation of Arf1 or 
expression of both dominant negative Arf1-GDP or dominant positive Arf1-GTP mutants 
inhibited RCNMV replication. Expression of dominant active Sar1-GTP mutant inhibited 
RCNMV replication. BFA treatment inhibited RCNMV replication and canceled ER 
localization of p27 replication protein. BFA treated cell expressing ER-GFP and p27-
mCherry showed dispersed pattern of both proteins, however interestingly BFA did not 
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change localization pattern of ER-GFP when it was expressed alone. Altogether, 
disruption of anterograde or retrograde transportation pathway could inhibit RCNMV 
replication, although the importance of these events for RCNMV is currently obscure. 
 A major question left unanswered from those studies on different (+)RNA 
viruses: does early secretory pathway play a common role for (+)RNA viruses? Studies 
showed different involvement of anterograde or retrograde transportation in different 
(+)RNA viruses, however the actual functions of secretory pathway in (+)RNA viruses 
replication remain far from understood. 
 In spite of variable involvement of anterograde or retrograde transportation 
pathways, and different replication sites, replication proteins of many (+)RNA viruses 
contain transmembrane domains (TMDs) which determine membrane association of viral 
replication complexes. Properties of TMDs have emerged as major determinants of 
protein fate in secretory pathways and endocytic pathways (235, 236). Bioinformatics 
analyses of eukaryotic-encoded integral membrane proteins revealed that TMDs from ER 
is different from post-ER organelles. TMDs of ER proteins is shorter than those in post-
ER organelles, and do not possess the asymmetric amino acid distribution along the 
membrane (236). Proteins with short TMDs are proposed to be secreted from ER to cis-
Golgi via COP-II-dependent secretion, and then bound by Rer1, a transmembrane protein 
that cycles between the Golgi apparatus and the ER (237), at cis-Golgi (238, 239), thus 
cycled back to ER via COP-I mediated retrograde transportation (235). In contrast, 
proteins with long TMDs could interact with Erv14 (240) at ERES and be transported 
along the secretory pathway to TGN and beyond (241). 
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 The physical properties of TMDs also determine localization of the given proteins 
within lipid micro-domains (235). Alternatively, due to different properties, TMDs were 
believed to attract and  sort specific lipids around them (235, 236). 
 Since PE is an obligate phospholipid for TBSV replication (Chapter 4) and could 
be enriched in peroxisomal membranes by TBSV p33 replication protein alone, it could 
be interesting to understand which cellular pathway leads to PE enrichment at the sites of 
TBSV replication. 
 Various cellular pathways affecting PE distribution are emerging. The source of 
PE in autophagy has been extensively studied, and might shed lights on our 
understanding of PE in TBSV replication. PE is a key molecule for phagophore 
membrane formation in early stage of macroautophagy, where PE conjugates with Atg8p 
(LC3-I) to form Atg8-PE (LC3-II), which usually used as a molecular marker of 
macroautophagy occurrence. Different sub-cellular sources of PE has been proposed by 
different groups, which includes ER (242), mitochondria (243) or ER-mitochondria 
contact site(244). Clathrin-coated vesicles from plasma membrane also were shown to 
contribute to early Atg16L1-positive autophagosome precursor formation via fusion with 
VAMP7/SNARE complex (245, 246). In addition, trans-golgi network (247-251), early 
endosomes (252), vesicles from early secretory pathway (253, 254) were demonstrated to 
contribute to the membrane source of autophagosomes. Despite of many microscope 
based experiments, an cell-free LC3 lipidation assay using fractionated sub-cellular 
membranes from mouse embryonic fibroblast (255) showed that ERGIC is the only 
membrane source to trigger LC3 lipidation, which requires conjugation of LC3 with PE, 
suggesting ERGIC provides the initial PE source for autophagosomes formation. 
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 In this chapter, I used varies of approaches to identify factors affecting PE 
enrichment at peroxisomal membranes by TBSV p33, and I will discuss possible sub-
cellular route that PE was redistributed by the virus.  
 In yeast or plants, there are two pathways of PE synthesis, CDP-DAG pathway 
and de-novo synthesis pathway (Fig. 5.1A). In CDP-DAG pathway, phosphatidylserine 
(PS) decarboxylases directly convert PS into PE. In yeast there are two PS decarboxylase 
genes, PSD1 (256) and PSD2 (257). Psd1 is localized in mitochondria (256, 258), while 
Psd2 is localized to TGN (259, 260), endosomes(260) and vacuole membrane (259) 
compartments (components of post-golgi organelles). In Arabidopsis, there are three PSD 
genes, namely PSD1, PSD2 and PSD3 (261). AtPSD1 is localized in mitochondria, 
AtPSD2 localized to vacuole membrane (Tonoplast), while AtPSD3 localized to ER 
(261). 
 In de-novo synthesis pathway, ethanolamine is converted to phosphoethanolamine 
by ethanolamine kinase (EKI), then converted to CDP-ethanolamine by 
CTP:phosphoethanolamine cytidylyltransferase (ECT), and converted to PE by 
aminoalcoholphosphotransferase (AAPT). AAPT has substrate specificity among 
ethanolamine and choline. In yeast, there are two AAPTs, EPT1 and CPT1. EPT1 has 
major activity using ethanolamine, while minor activity using choline. While CPT1 have 
predominant substrate activity using choline for PC synthesis (262). In plants (263-266), 
AAPTs were also been identified which show both ethanolamine or choline substrate 
activity. TaAAPT1 and TaAAPT2 from wheat were shown to be localized to ER and 
Golgi apparatus (264). A human CPT1 is localized to Golgi apparatus, while human 
CEPT1 (major substrate activity to choline, minor to ethanolamine) localized to ER and 
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nuclear membrane (267). However, the localization of EPT1 is not characterized yet in 
yeast. 
 In plants, the CDP-DAG pathway is not essential since psd1/psd2/psd3 mutant 
arabidopsis plants are viable and display no obvious growth or morphological defects 
(261). The total phospholipid composition was unchanged, while PE level in isolated 
mitochondria from mutant plant was decresed  (261). In yeast, deletion of any one of the 
three or two of the three PE synthesis genes, PSD1, PSD2 or EPT1, is not lethal. While 
deletion of all three of them is lethal in yeast (268). 
 
 
5.2 Materials and Methods 
 
Yeast strains and expression plasmids. Yeast strains BY4741 (MAT a his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0) and pep4∆, tlg2∆, pep12∆, vam3∆ or vam7∆ (single-gene deletion 
strain) were obtained from Open Biosystems (Huntsville, AL, USA). For TBSV 
replication in yeast, pESC-T33/DI72 and pYES-T92 were described previously. Yeast 
double deletion strains of tlg2∆tlg1∆ or vam3∆vam7∆ were generated from tlg2∆ or 
vam7∆ using homologous recombination of a PCR fragment harboring a selection marker 
hygromycin B phosphotransferase amplified fragment from Euroscarf collection plasmid 
pFA6a-hphNT1(269) . 
 For yeast plasmid pRS315-CFlag, primer pairs #5100 
(AGCTTGGTGGTGACTACAAGGACGACGATGACAAGGGTGGTAGATCTGGCG
TCGACTAA)/#5101 
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(TCGATTAGTCGACGCCAGATCTACCACCCTTGTCATCGTCGTCCTTGTAGTCA
CCACCA) were annealed and inserted into pRS315-pTef1 (described in Chapter 3). To 
generate pCUP1 driven C-terminal Flag-tagged SAR1 or ARF1, pRS315-CFlag were 
digested with SacI/NotI and inserted with SacI/NotI digested PCR fragment of pCUP1 
promoter amplified from pEsc-His/Cup-FLAG/ssa1 with primer pair #3039 
(CGCGGAGCTCGACATTTGGGCGCTATACGTGCATATGT)/#5861 
(GCGGCGGCCGCTACAGTTTGTTTTTCTTAATATCTATTTCGA), resulting 
plasmid pRS315-pCUP1p-CFlag. SAR1 and ARF1 mutants were generated via site 
directed mutagenesis and amplified with primer pair #5865 
(CGCGGATCCATGGCTGGTTGGGATATTTTTGG)/#5866 
(GCCCTGCAGAATATATTGAGATAACCATTGGAACGCCTC), or #3132 
(gccggatccatgggtttgtttgcctctaagttgttc)/#5742 
(GCCCTGCAGAGTTGAGTTTTTCAAACTGTTACTTAACCATTC), digested with 
BamHI/PstI, and inserted into pRS315-pCUP1-CFlag.  
 To generate N-Terminal Flag-tagged Tlg2p, TLG2 was amplified from yeast 
genome using primer pair #5717 
(CGCGGATCCATGTTTAGAGATAGAACTAATTTATTTTTATCATACCGTAGG) 
and #5718 (GCGCTCGAGTCAAAGTAGGTCATCCAAAGCATCATTC), digested 
with BamHI/XhoI, and inserted into BamHI/SalI digested pRS315-NFlag (described in 
Chapter 3), generating pRS315-NFlag-Tlg2. 
 To generate pTef1 promoter driven no tagged COP1 expressing vector, PCR 
fragment of COP1 were amplified from yeast genome using primer pair #1858 
(GGCGGGATCCATGAAGATGTTAACTAAATTTG)/ #1859 
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(GGCGCTCGAGTTATACACGTATTCTTAATCCGGA), digested with BamHI/XhoI 
and inserted into BamHI/SalI digested pRS315-pTef1, generating pRS315-COP1. 
 
Confocal laser microscopy. Wild type BY4741 or sti1∆ yeast strains were transformed 
with the following expression plasmids: pESC-GFP-T33/DI72, pYES-T92 (9), as well as 
pRS315-Pex13-mRFP1 (described in Chapter 4). The yeast cultures were incubated in galactose 
medium overnight, sampled and imaged with Olympus FV1000 confocal laser scanning 
microscope (Olympus America Inc., Melville, NY). The microscope settings were the following: 
excitation and emission for GFP and RFP were 488nm laser/500-530nm filter and 543nm 
laser/560-660nm filter, respectively. PE staining with biotinylated duramycin and streptavidin 
conjugated with Alexa-405 was described in Chapter 4. 
 
Free GFP detection assay. pESC-GFP-T33 (described in Chapter 4) and pYES-GFP-T92 
(9) together with an empty plasmid or SAR1 mutants were transformed into wild type or 
mutant yeast strains. GFP-p33/p92 were induced for expression in SC media containing 
2% galactose for 24 hours. Total protein was extracted and subjected to western blot 
analysis using an anti-GFP antibody. 
 
5.3 Results 
 
TBSV replication in yeast mutants defective in PE synthesis pathways. Since PE is 
essential for TBSV replication in vitro, we then ask: could any specific pathway of PE 
synthesis be hijacked by TBSV to favor virus replication? Genes of PE synthesis were 
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systemically deleted from wild type yeast, generating: psd1∆, psd2∆, ept1∆cpt1∆, 
psd1∆ept1∆cpt1∆, psd2∆ept1∆cpt1∆ and psd1∆psd2∆. We tested TBSV replication in 
yeast grown in SD media without ethanolamine (Fig. 5.1 B) or with ethanolamine (Fig. 
5.1C). Since ethanolamine is the precursor of de-novo PE synthesis pathway, 
psd1∆psd2∆ of which PE synthesis is inhibited will not grow without ethanolamine. In 
SD media without ethanolamine, major PE synthesis come from PSD1 or PSD2 pathway. 
TBSV repRNA accumulation level increased ~2 fold in those mutants, psd1∆ or 
psd1∆ept1∆cpt1∆,  which lacked the PSD1 mediated PE synthesis pathway. In those 
mutants in which PSD2 pathway was deleted, TBSV repRNA accumulated to similar 
level as wild type (Fig. 5.1B, upper panel). While viral protein accumulated to a similar 
level among all the mutant strains (Fig. 5.1B lower level).  
 In a growth condition where ethanolamine was provided (Fig. 5.1C), all three PE 
synthesis pathways could contribute to the overall PE pool in the cell. In such condition, 
TBSV repRNA accumulation also increased by ~80% in psd1∆ept1∆cpt1∆ yeast, in 
which PSD2 mediated PE synthesis pathway is the only PE source. While when PSD2 
and de-novo PE synthesis pathways were deleted in psd2∆ept1∆cpt1∆ yeast, TBSV 
repRNA accumulation decreased to ~60% (Fig. 5.1C upper panel). p33 replication 
protein accumulation in psd2∆ept1∆cpt1∆ yeast also decreased comparing to wild type 
(Fig. 5.1C lower panel). In other mutant yeasts, TBSV replication and viral protein level 
are comparable to those in wild type yeast (Fig. 5.1C). 
 
TBSV p33 replication protein is partially localized within TGN. In addition to the 
characteristic punctuate structures, we also observed diffused pattern of GFP-p33 in 
 155 
 
yeast, which did not co-localize with peroxisome marker protein (Fig. 5.2A). In Fig. 
5.2A, GFP-p33 was co-expressed with p92 and DI72 repRNA, as well as Pex13p-mRFP 
as a peroxisome marker for 10 hours after induction of protein expression. We observed 
some GFP- p33, which did not overlap with the peroxisome marker Pex13p-mRFP. Since 
we know that peroxisome in yeast under microscope is visible as round punctuate 
structure,  those diffused pattern with GFP-p33 suggested that TBSV p33 might be 
localized to other membrane structures during infection besides peroxisome. In chapter 4, 
we also observed that PE was also co-localized to these diffused structure with p33. It 
was interesting to identify which cellular compartment the diffused structures belong to. 
The answer may help us to understand PE enrichment at the site of TBSV replication. 
 Confocal microscopy was used to identify the localization of the diffused 
structure with many cellular marker proteins. Among those, TGN tSNARE protein Tlg2p 
(270) was identified to co-localize with the diffused structure of TBSV p33 (Fig. 5.2B).  
 
PE is enriched at both peroxisome and TGN locations in the presence of p33. To 
demonstrate that PE enriched at peroxisome and TGN locations of p33, we transformed 
yeast with plasmids expressing GFP-p33 together with peroxisome marker Pex13p-
mRFP (Fig. 5.3 A) or TGN marker mRFP-Tlg2p (Fig. 5.3 B). Viral proteins and repRNA 
were induced in galactose containing media for 10 hours, then the yeast cells were fixed 
and subsequently incubated with biotinylated duramycin, streptavidin-conjugated with 
Alexa Fluor 405 dye. Cells were observed under confocal microscope. In Fig. 5.3A, 
obvious punctuate structure was highlighted in all channels detecting PE, GFP-p33 and 
peroxisomes. However, PE and GFP-p33 were also co-localized and observed as diffused 
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pattern. To demonstrate that this diffused pattern indeed represented TGN, mRFP-Tlg2p 
were used to label TGN in addition to GFP-p33 and PE (Fig. 5.3B). In Fig. 5.3B, indeed, 
PE and GFP-p33 were co-localized and showed a diffused area outside the punctuate 
structure. This diffused area was labeled with TGN marker protein mRFP-Tlg2p. 
 
Deletion of TLG2 interfered with the enrichment of PE at site of TBSV replication. 
Since both the genetic study of PE synthesis pathway and confocal microscope study of 
PE localization site suggested the relevance of Trans-Golgi network in PE enrichment to 
TBSV site of replication. As well as in previously yeast single gene deletion library 
screen (12), deletion of TLG2 was shown to affect tombusvirus replication. We focused 
on the role of Trans-Golgi network in TBSV replication. 
 First, we confirmed that deletion of TLG2 could reduce TBSV replication to 
about 16% , by comparing repRNA accumulation with that of wild type yeast (Fig. 5.4A). 
Meanwhile, overexpression of a N-terminus Flag-tagged Tlg2 could compliment TBSV 
replication caused by the deletion of TLG2 in the mutant strain. 
 Secondly, in tlg2∆ yeast, plasmids expressing GFP-p33, p92, repRNA and 
pex13p-mRFP were co-transformed. Cells were induced for viral protein expression and 
labeled with biotinylated duramycin to detect PE localization. Importantly, in tlg2∆ yeast, 
PE was not co-localized with GFP-p33 (Fig. 5.4B).  
 
Deletion of genes coding for SNARE proteins in post-Golgi organelles reduces TBSV 
replication. Since genetic analysis showed that in mutant strains, in which only PSD2 
mediated PE synthesis, TBSV repRNA accumulation was ~2x fold more than wild type, 
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it suggested that PSD2 pathway might be the easiest for TBSV to hijack. PSD2 were 
shown to be localized at TGN or compartments of endocytic pathway in yeast or in plant 
(259-261). Furthermore, deletion of TLG2 in yeast also lead to dramatically decreased 
TBSV replication possibly due to lack of PE enrichment at TBSV replication sites. Tlg2p 
is a tSNARE on TGN (270). It would be interesting to see if gene deletion of other 
tSNAREs in endocytic pathway where Psd2p is localized could affect TBSV replication. 
 We tested deletion strains of TGN tSNAREs: tlg2∆ or tlg2∆tlg1∆, late endosome 
tSNARE: pep12∆ and vacuole tSNAREs: vam3∆, vam7∆ or vam3∆vam7∆. Surprisingly, 
all the SNARE protein deletions decreased TBSV repRNA accumulation to about 10% 
comparing to the wild type (Fig. 5.5A upper panel). Also p33 accumulation was 
decreased in all the mutant strain (Fig. 5.5A lower panel). 
 To test if p33 was targeted to the endocytic pathway, we utilized the vacuolar 
protease resistant feature of GFP when present as a fusion protein. TBSV p33 or p92 was 
tagged with GFP at the N-terminus (Fig. 5.5B). Free GFP detected by GFP-antibody 
would suggest presence of GFP-p33 or GFP-p92 in vacuole. We first checked GFP-
p33/p92 degradation pattern in wild type yeast, by western blot using anti-GFP antibody 
(Fig. 5.5C). In wild type yeast expressing GFP-p33/p92, anti-GFP antibody detected free 
GFP with size about 30kDa (Fig. 5.5C middle and right panel). While in wild type yeast 
expressing His-GFP, a expected ~33kDa band was detected (Fig. 5.5C left panel). 
 In addition, wild type yeast and SNARE gene mutants described above as well as 
a yeast strain with single gene deletion of PEP4, which aborts protein degradation in 
vacuole (271), were transformed with plasmids containing GFP-p33/p92 and induced for  
gene expression for 24 hours in 23°C. Total protein were analyzed by western blot using 
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anti-GFP antibody (Fig. 5.5D). In every strain, GFP-p33 and GFP-p92 were detected, 
however free GFP were only detected in wild type, tlg2∆, vam3∆, vam7∆ or 
vam3∆vam7∆, but not in pep4∆, tlg2∆tlg1∆ or pep12∆ (Fig. 5.5D upper panel and middle 
panel). Presence of free GFP in wild type strain and missing of free GFP in pep4∆ strain 
suggested a vacuole targeting of GFP-p33. And disruption of vesicle transport pathway 
by deletion of certain SNARE genes abolished the targeting of GFP-p33 to vacuole. 
 
Over-expression of SAR1 dominant mutant blocks vacuole targeting of p33 and 
reduces TBSV replication. Most of membrane proteins secreted to endocytic pathway 
through Golgi are dependent upon anterograde transportation pathway (235, 238). SAR1 
encode a GTPase which regulate anterograde transportation COP-II vesicle coat assembly 
and disassembly (272). Expression of GTP locked mutant SAR1-H77L could block cargo 
transportation to golgi (273, 274). Thus we tested its effects on p33 vacuole targeting as 
well as TBSV replication. 
 A C-terminal Flag-tagged SAR1-H77L was induced under controllable CUP1 
promoter at the same time point as the GFP-tagged viral proteins. After 24 hours protein 
expression, total proteins from different treatments were subjected to western blot 
analysis using anti-GFP antibody (Fig. 5.6A). As previously shown (Fig. 5.5 C &D), free 
GFP were detected in wild type yeast but not in pep4∆ strain (Fig. 5.6A). In wild type 
yeast co-expressing wild type SAR1 gene, free GFP was also detected in a similar 
amount as in wild type yeast. However in yeast co-expressing a SAR1 dominant mutant 
SAR1-H77L, free GFP was present in reduced amount in comparison with wild type 
yeast (Fig. 5.6A). 
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 To test effect of SAR1-H77L on TBSV replication, vectors expressing wild type 
SAR1 or SAR1-H77L, or an empty vector were transformed into yeasts together with 
TBSV p33, p92 and repRNA expressing plasmids. Viral components were induced 
together with SAR1 mutant for 24 hours. Total RNA and proteins were extracted from 
different treatments for RNA and protein blot analysis (Fig. 5.6B). Over-expression of 
wild type SAR1 did not affect TBSV repRNA accumulation, while over-expression of 
SAR1-H77L reduced TBSV repRNA accumulation to ~23%. 
 
Expression of ARF1 dominant-active mutant ARF1-Q71L, but not dominant-negative 
mutant ARF1-T31N, blocks TBSV replication. Since p33 is partially localized to TGN, 
and disruption of TLG2, tSNARE of TGN, aborted PE enrichment on peroxisome and 
reduced TBSV replication (Fig. 5.4), retrograde transportation from TGN could be a 
potential pathway that TBSV might hijack, and thus benefit to PE enrichment on 
peroxisome. To test this hypothesis, we utilized dominant mutants of ARF1, dominant-
negative mutant ARF1-T31N (275), or dominant-active mutant ARF1-Q71L (275, 276). 
Dominant negative mutant ARF1-T31N blocks the formation of COP-I vesicle, thus 
blocks COP-I-dependent retrograde transport. Dominant-active ARF1-Q71L stimulates 
formation of COP-I vesicles coats but blocks coatomer disassembly, thus also blocks 
retrograde transportation. 
 Empty vector, or vectors expressing controllable CUP1 promoter driven ARF1, 
ARF1-T31N and ARF1-Q71L ORFs were co-transformed with plasmids expressing 
TBSV viral proteins and repRNA. TBSV replication was induced in galactose containing 
media supplemented with copper to induce ARF1 and mutants expression. After 24 hours 
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induction of replicaiton, total RNA or proteins were extracted from samples and analyzed 
using RNA blot or western blot (Fig. 5.7A). RepRNA accumulation from samples over-
expressing ARF1 or ARF1-T31N did not show significant difference comparing to yeast 
samples transformed with an empty vector. While over-expression of dominant active 
ARF1-Q71L reduced replication to ~34%. Viral protein accumulation in ARF1-Q71L 
(lower panels in Fig. 5.7A) did not show significant difference comparing to those 
expressing an empty vector, ARF1 or ARF1-T31N.  
 
Alpha subunit of COP-I vesicle coatomer, Cop1p, inhibits TBSV replication. ARF1-
Q71L encodes a GTP locked form of ARF1, which stimulates the assembly of COP-I 
vesicle coatomer. To test if formation of COP-I vesicle benefits or inhibits TBSV 
replication in yeast, we tested TBSV replication while alpha subunit of COP-I vesicle 
was down-regulated. In yeast, COP1 encodes alpha subunit of COP-I vesicle coatomer 
and is essential to yeast growth (277). Replacing the COP1 promoter on the genome with 
a  tetracycline (tet)-regulatable promoter would allow control of the expression of COP1 
and study its function (278, 279). 
 We first obtained yeast strain of Tet-COP1 from Tet-promoters Hughes 
Collection (yTHC) (278). When 10 μg/ml doxycycline was added to media, Tet-COP1 
yeast growth was inhibited, suggesting genomic expression of COP1 was shut down. 
However expression of COP1 driven by a constitutive promoter from plasmid pRS315-
COP1 could rescue the inhibitory effect, thus allowed Tet-COP1 growth in doxycycline 
containing media (Fig. 5.7B). 
 161 
 
 Vectors expressing TBSV replication proteins and repRNA were transformed to 
Tet-COP1 strain with or without pRS315-COP1. Yeasts were cultured to induce TBSV 
replication with or without doxycycline. In the growth media with doxycycline where 
COP1 expression was inhibited, TBSV repRNA accumulation increased ~3 fold, 
comparing to that in yeast without doxycycline treatment. However, over-expression of 
COP1 under a constitutive promoter from plasmid inhibited TBSV repRNA accumulation 
to ~30% in the growth condition either with or without doxycycline, suggesting that 
COP1 or formation of COP-I complex inhibited TBSV replication.  
 
5.4 Discussion 
 
Can PE synthesis pathway be co-opted by TBSV? In chapter 4, TBSV p33 was 
demonstrated to induce PE accumulation in peroxisomal membranes, the site of TBSV 
replication. To better understand the virus-driven lipid sorting process, we tested yeast 
mutants with deletion of genes involved in PE synthesis pathways for TBSV replication. 
From previous studies (268, 280, 281) we know that PE is essential for yeast growth, 
three PE synthesis pathways could not be deleted in the same yeast, but single or double 
deletion of the three pathways are possible. This suggests that PE from any of the three 
pathways could be transported to other cellular components where PE is needed. 
However, this endogenous PE transportation process has not yet revealed, except that a 
study using purified yeast post-Golgi vesicles in an cell-free environment showed that 
yeast post-golgi secretory vesicles contains ~80% of PE in the cytosolic leaflet, and  P4 
ATPases Drs2p and Dnf3p are required to maintain the assymetry (282). 
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 We tested TBSV replication in yeast strains with single or double deletions of PE 
synthesis pathways genes (Fig. 5.1), and found none of these deletions caused TBSV 
replication to drop more than 50% comparing to that in the wild type yeast. 
 However, we noticed that in the presence of ethanolamine, in the yeast mutant 
psd2∆ept1∆cpt1∆ where the only PE source come from the PSD1 pathway, TBSV 
repRNA accumulation reduced to ~60% (Fig. 5.1C). These data suggesting that deletion 
of PE source from PSD2 and EPT1 would affect TBSV replication, although not totally 
required. Meanwhile, in yeast strain psd1∆ept1∆cpt1∆, TBSV repRNA accumulation 
increased to 180%, suggesting that in this yeast strain PE could be more accessible for 
TBSV. PSD2 pathway is the only PE source in psd1∆ept1∆cpt1∆, and thus TBSV may 
utilize PE from PSD2 pathway more easily. 
 We also tested growth condition without ethanolamine. In this growth condition, 
PSD1 or PSD2 pathway contribute to the major cellular PE sources, while double 
deletion mutant psd1∆ psd2∆ could not grow due to lack of ethanolamine which is PE 
precursor. TBSV repRNA accumulation increased to ~2-2.5 fold in the yeast strain psd1∆ 
or psd1∆ept1∆cpt1∆, comparing to that of the wild type. In these strains, PSD2 pathway 
is the dominant/only PE synthesis pathway. PSD2 localized at TGN (259, 260), 
endosomes(260) and vacuole membrane (259). This finding is in line with the hypothesis 
that PE from post-Golgi compartments could be accessed by TBSV easier than from 
other pathways. 
 
TGN tSNARE Tlg2 co-localizes with TBSV p33 and affects PE redistribution to 
peroxisome as well as TBSV replication. In addition to peroxisome localization of p33, 
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we also observe diffused pattern of GFP-p33 outside the peroxisome marker Pex13p-
mRFP (Fig. 5.2A), especially when cells were harvested at 10-12 hours after the 
induction of viral protein expression in yeast. A TGN tSNARE Tlg2p was shown to 
localize with the diffused GFP-p33 (Fig. 5.2B). This finding added new level of sub-
cellular dynamics of TBSV infection. Indeed in a study performed by another research 
group, similar pattern of TBSV p33 distribution outside of peroxisome was also detected 
in plant cells after 24 hours of plasmids bombardment (18). The observed reticular 
distribution of p33 was claimed to be peroxisomal-ER (pER) based on its co-localization 
with Chloramphenicol acetyltransferase tagged to 36 C-terminal residues of Peroxisomal 
ascorbate peroxidase (CAT-APX), which was believed to be sorted to peroxisome 
through a sub-domain of ER (pER). But they also found that the reticular p33 pattern did 
not co-localiz either with concanavalin A-stained ER or immunostained ER endogenous 
protein calreticulin (18). However, whether p33 interferes with the targeting of CAT-
APX to peroxisome remains unknown. In other words, CAT-APX localization may 
changed during p33 expression, thus its co-localization with reticular p33 pattern may not 
suggest their presence in a sub-domain of ER. 
 We later demonstrated that PE was not only enriched in peroxisomal membranes 
by p33, but also enriched at TGN (Fig. 5.3B). Based on this finding, we hypothesize that 
enrichment of PE driven by p33 may be connected to cellular functions of TGN. Indeed, 
when TLG2 was deleted, PE did not co-localized with p33 (Fig. 5.4B). Although p33 
localization to the peroxisome was not affected. Since tSNARE is essential for TGN's 
function, this finding supported previous hypothesis that cellular function of TGN is 
required for PE enrichment with p33. 
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Disruption of vesicle transport in endocytic pathway inhibited replication. We 
previously hypothesis PSD2 pathway of PE synthesis was more accessible for TBSV p33 
to hijack, and we also showed that cellular function of TGN is important for viral 
hijacking of PE. Psd2 localized with TGN (259, 260), endosome (260) and Vacuolar 
membrane(259), and tSNARE proteins from these sub-cellular compartments also 
important for TBSV replication similar to that of tlg2∆. It might be that disruption of 
vesicle transport in endocytic pathway would interfere transportation of PE from PSD2 
source. It is also surprising to see minor amount of GFP-p33 is targeted to vacuole, 
whether p33 is directly involved in PE re-distribution to peroxisomal membranes remains 
to be tested. 
 
Arf1 regulated retrograde transportation is not needed for, but could interfere with, 
TBSV replication. One question may raise due to complicated locations and functions of  
TBSV p33: how does the presence of p33 in endocytic pathway benefit assembly of 
TBSV replication complexes?  
 One possibility maybe that p33 was retro-transported from TGN to ER or 
peroxisome and PE was hijacked from the carrying vesicle. Although previous evidences 
suggested that asymmetrical distribution of PE on one side of membrane bilayers only 
happened on post golgi organelles and ER possess a symmetrical lipid distribution across 
the bilayer (282), we still tested the hypothesis. 
 By over-expression a dominant negative mutant of ARF1, ARF1-T31N, which 
inhibit COP-I dependent coatomer assembly, we showed that COP-I dependent 
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retrograde transportation is not required for TBSV replication. However over-expression 
of ARF1-Q71L, which stimulate COP-I coatomer assembly but not disassembly, 
inhibited TBSV replication to ~34%. The difference of these to mutants was probably 
due to stimulation of assembly of COP-I vesicles by ARF1-Q71L also led a consumption 
of phospholipids, including PE, from TGN, thus interfere with PE recruitment by TBSV.  
 
Summary: In this chapter, efforts were made for finding the PE source for TBSV 
replication. However, deletion of single or double PE synthesis genes did not lead to 
significantly reduced TBSV replication in yeast. However, PSD2 mediated PE synthesis 
pathway was favored among three PE synthesis pathways by TBSV. 
 TBSV p33 was demonstrated to localize to both TGN and peroxisome. PE was 
also enriched at both TGN and peroxisome together with p33. Moreover, a TGN 
tSNARE Tlg2p was shown to have major function in TBSV replication, possibly due to 
its ability to regulate PE enrichment in replication complexes. 
 By using GFP tagged TBSV replication proteins, a vacuole targeting pathway of 
p33 and p92 was identified. This p33/p92 targeting requires vesicle transportation 
pathway on the TGN and endocytic compartments. And disruption of vesicle transport in 
the endocytic pathway also have negative effect on TBSV replication.  
 This p33/p92 secretion was shown to be dependent on COP-II mediated 
anterograde transportation from ER to Golgi, and was essential for TBSV replication in 
yeast. However, a COP-I dependent retrograde transportation seems not to contribute to 
TBSV replication, but interfere with replication. 
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 Overall, we found evidences that p33 secretion from ER to vacuole through COP-
II dependent early secretory pathway contributed to TBSV replication. An TGN tSNARE 
Tlg2p was also shown to regulate PE enrichment at TBSV site of replication.  
 
(Copyright © Kai Xu 2014) 
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Fig. 5.1 Reduced TBSV replication in PE synthesis pathways deletion yeast strains.  
 
(A) Schematic of three PE synthesis pathways in yeast. (B) Replication of TBSV in yeast 
deletion strains grown in media without ethanolamine. Upper Panel: Northern blot of 
repRNA and 18S ribosomal RNA. Lower Panel: Western blot of total proteins extracted 
from different strains tested. TBSV p33 and p92 were tagged with HIS6 tag on their N-
terminals and detected with an anti-HIS antibody. Total proteins were stained with 
Ponceau S on PVDF membrane after transfer. (C) Replication of TBSV in yeast in 
deletion strains grown in media with ethanolamine. Note that psd1∆psd2∆ strain was able 
to grow under this condition. See further details described in panel B. Each experiment 
was repeated. 
 
  
 169 
 
 
Fig. 5.2 
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Fig. 5.2 p33 co-localization to peroxisomes and TGN. 
 
(A) GFP-tagged p33 localized in peroxisomal membrane. Wild type yeast was 
transformed with vectors expressing GFP-tagged p33, p92 and DI-72, as well as pex13p-
mRFP. Viral components were induced in yeast grown in SC media containing 2% 
galactose for 10 hours. Cells were collected  and subjected to confocal laser microscopy 
analysis. Results showed partial co-localization of TBSV GFP-p33 with peroxisomal 
marker Pex13p-mRFP. DIC (differential interference contrast) images are shown on the 
right. (B) Confocal laser microscopy images showed that TBSV GFP-p33 also partially 
co-localized with TGN marker Tlg2p-mRFP. 
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Fig. 5.3 
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Fig. 5.3 PE is enriched in both peroxisome and TGN where TBSV GFP-p33 is 
localized.  
 
(A) Confocal laser microscope image showed that PE was enriched at sites of GFP-p33 
accumulation and partially co-localized with peroxisomal marker Pex13p-mRFP as 
punctuate structures. PE was visualized using biotinylated duramycin and streptavidin 
conjugated with Alexa-405. (B) TGN localization of GFP-p33 where PE was also 
enriched showed diffused pattern, which is visually distinguishable from peroxisomal 
punctuate structures.  
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Fig. 5.4 
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Fig. 5.4 TGN tSNARE Tlg2 is required for efficient TBSV replication in yeast, 
affecting PE enrichment to sites of replication.  
 
(A) Deletion of TLG2 dramatically reduced TBSV replication, and expression of a N-
terminal Flag-tagged Tlg2 from a vector complemented the effect caused by deletion of 
TLG2 from genome. Upper panel: Northern blot repRNA and ribosomal 18S RNA. 
Lower panel: Western blot detecting viral proteins as well as Flag-Tlg2p by anti-HIS 
antibody or anti-FLAG antibody. Total protein was detected with Ponceau S on PVDF 
membrane after transfer. Experiments were repeated. (B) Confocal microscope images 
showed that unlike in wt yeast PE was not enriched at sites of replication in tlg2∆ yeast. 
See further description of yeast growth condition in Fig. 5.2, PE detection method in Fig. 
5.3. 
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Fig. 5.5  
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Fig. 5.5 Targeting of TBSV p33/p92 to vacuole through vesicle transport pathway. 
 
(A) Deletion of tSNARE genes of TGN or endocytic pathway dramatically reduced 
TBSV replication. (B) Cartoon representation of partial proteolysis of GFP tagged viral 
proteins in vacuole. (C) Free GFP was detected in wild type yeast expressing GFP tagged 
p33/p92 using anti-GFP antibody. Arrows on the left showed sizes of protein markers. 
Arrows on the right showed expected bands of Free GFP or GFP tagged viral proteins. 
Right panel is a digitally over-exposed (ex.) copy of His-GFP-p33/p92 sample. (D) Free 
GFP was not detected in pep4∆, tlg2tlg1∆ or pep12∆ yeast strains expressing GFP-tagged 
p33/p92. Upper panel: protein blot of total protein from different yeast strains expressing 
GFP-tagged p33/p92 using anti-GFP antibody. Middle panel: Small portion of digitally 
over-exposed image of boxed area from upper panel, showing the free GFP bands. 
Noting that Free GFP was not detected in pep4∆, tlg2tlg1∆ or pep12∆ yeast strains. 
Lower panel: coomassie blue staining of total protein loaded. 
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Fig. 5.6 
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Fig. 5.6 SAR1 dominant mutant SAR1-H77L inhibits vacuole targeting of GFP-
p33/p92 as well as TBSV replication.  
 
(A) SAR1-H77L inhibited GFP-p33/p92 targeting to vacuole, based on less amount of 
free GFP detected. See further details on Fig.5.5C and D. (B) Reduced TBSV replication 
in SAR1-H77L-Flag expressing yeast. Upper panel shows repRNA accumulation reduced 
upon expression of Sar1(H77L)-Flag. Lower panel shows protein expression level of 
TBSV p33, p92 and Sar1 or Sar1(H77L). Total protein was stained by ponceau S. 
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Fig. 5.7 
  
Vector Arf1-Flag
Arf1(T31N)
-Flag
Arf1(Q71L)
-Flag
repRNA
rRNA
His-p33
His-p92
Total protein
anti-Flag
A.  ARF1 dominant mutants
100±2.3 113.7±24.5 116.3±13.0   34.4±7.1       %repRNA
B. Tetracycline-controlled transcriptional inhibiton of COP1 from chromosome
- Doxycycline + Doxycycline
pRS315-empty
pRS315-COP1
C. Downregulation of COP1 leads to eleveated TBSV repRNA accumulation
pRS315
empty
pRS315
-COP1
pRS315
-COP1
- Doxycycline + Doxycycline
pRS315
empty
repRNA
rRNA
100      30.1      321.2     29.9        %repRNA
±16.5     ±2.1      ±11.1     ±5.6
 180 
 
Fig. 5.7 COP-I dependent retrograde transport from TGN to ER is not required for 
TBSV replication in yeast.  
 
(A) ARF1 dominant active mutant ARF1-Q71L inhibit TBSV replication, but not 
dominant negative mutant ARF1-T31N. See further detail about RNA and protein blot 
from Fig. 5.6B. (B) Doxycycline inhibited a yeast strain whose COP1 was under a 
tetracycline (tet)-regulatable promoter, while plasmid (pRS315-COP1) expression of 
COP1 rescued yeast growth caused by doxycycline. (C) Over-expression of COP1 from 
pRS315-COP1 inhibited TBSV replication, while down-regulation of COP1 from 
genome under tetracycline (tet)-regulatable promoter by adding doxycycline into growth 
media stimulated TBSV repRNA accumulation to ~3 fold comparing to that of without 
adding doxycycline. 
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Chapter 6 
CLASS III PHOSPHOINOSITIDE 3-KINASE VPS34 IS A KEY HOST FACTOR 
IN TOMBUSVIRUS REPLICATION 
 
 
6.1 Introduction 
 During the past decades, PI3K or its product Phosphatidylinositol 3-phosphate 
(PI3P) emerged as an important host factor regulating diseases caused by various of 
pathogens (284), including influenza viruses (285), hepatitis C virus (286), human 
pathogenic bacteria(287, 288), plasmodium (284) and pathogenic fungi (284, 289). 
 Phosphatidylinositide 3-kinases (PI3Ks) are a group of proteins  defined by their 
enzymatic activity to phosphorylate the 3 position hydroxyl group of the inositol ring of 
phosphatidylinositol (PtdIns), or 4 , 5 position phosphorylated PtdIns . There are three 
classes of PI3Ks based on their substrate specificity in vitro and protein size (290, 291). 
Class I PI3Ks, usually ~110 kDa in size,  could phosphorylate Phosphatidylinositol (PI), 
Phosphatidylinositol 4-phosphate (PI4P) or Phosphatidylinositol (4,5)-bisphosphate 
(PI(4,5)P2), but with substrate preference toward PI(4,5)P2. Class II PI3Ks , about ~170 
kDa, prefer PI over PI4P over PI(4,5)P2 for substrate (290, 291).  
 Although two classes of PI3Ks play important role in human and animal cells, 
they are not found in yeast and in plants (292, 293). Class III PI3Ks, or Vps34 (Vacuole 
protein sorting 34), is the only class of PI3Ks present in yeast and plants. It has substrate 
activity solely toward PI. VPS34's function was firstly known in regulating vacuole 
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protein sorting, as indicated by its name. Deletion of VPS34 from plants, at least in 
Arabidopsis thaliana, is lethal for plant development and growth (293). However deletion 
of VPS34 in yeast is viable for yeast growth . 
 Besides genetic approaches, chemical inhibitors were developed to inhibit the 
activity of the lipid kinase domain of PI3Ks. There are many PI3Ks inhibitors been 
developed and used in PI3K functional studies. These inhibitors showed varied inhibitory 
sensitivity towards different forms/classes of PI3Ks. For example, the famous PI3K 
inhibitor Wortamanin have significantly less half maximal inhibitory concentration (IC50) 
value with mammalian hVps34 than with yeast Vps34p (294). Specificity of different 
PI3K inhibitors restricted the study of different PI3Ks functions. However this issue is 
minor in yeast and plant in which Vps34p is the only PI3K. 
 Vps34p is involved in many cellular protein and membrane trafficking processes, 
including vacuole protein targeting, macroautophagy, endocytosis, Gpa1p signaling, et al 
(292). Different Vps34p complexes are responsible for different functions (292).  There 
are two major distinct Vps34p complexes in yeast proposed by Kihara, A. et al. (295), 
both contain Vps34p, Vps15p and Vps30p. Complex I contains one additional protein 
Atg14, and is required for autophagy (296). Complex II contains protein Vps38p, 
regulating vacuole sorting of the lysosomal hydrolase CPY (carboxypeptidase Y). 
Complex I is localized to vacuolar membrane and perivacuolar pre-autophagosomal 
structure (PAS), while complex II is localized to TGN, late endosome and vacuolar 
membrane (295-298). 
 However, deletion of VPS30 does not affect vacuole targeting and processing of 
newly synthesized protease A or protease B (292, 295). In additon, GTP-binding alpha 
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subunit of the heterotrimeric G protein (Gpa1p) forms complex with Vps34p and Vps15p 
and controls pheromone signalling (299). Thus, based on these information, Jonathan M. 
Backer proposed two additional Vps34p complexes in yeast (292) (Fig. 6.3A). 
 Single-copy AtVPS34 is the only PI3K in Arabidopsis thaliana. Although 
heterozygous T-DNA insertion mutant of AtVPS34 exist, homozygous vps34 mutation is 
not viable, since VPS34 is essential for plant growth, including pollen development 
(293). Blocking of the PI3P in plant cells by over-expression of a PI3P specific binding 
domain from human early endosome antigen 1 inhibited targeting of vacuolar protein 
sporamin (300). Treatment of tobacco cells with PI3K inhibitor Wortmannin also 
inhibited the vacuole targeting of COOH-terminal propeptide (CTPP) of the barley lectin 
precursor, but not the sporamin precursor (301). Plant Vps34 as well as Vps30, Atg3, 
Atg7 were shown to restrict spreading of hypersensitive reaction (HR) of tobacco mosaic 
virus (TMV) infected cells to adjacent cells in leaves (302). 
 In this Chapter, we show evidence supporting a novel and essential function of 
VPS34 for positive RNA virus replication in yeast and in plant. We will also discuss the 
molecular and cellular mechanism of VPS34 in TBSV replication. 
 
6.2 Materials and Methods 
 
Yeast strains and expression plasmids. Yeast strains BY4741 (MAT a his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0) and vps34∆, vps30∆, vps38∆ or atg14∆ (single-gene deletion strain) 
were obtained from Open Biosystems (Huntsville, AL, USA). 
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For yeast plasmid expressing Vps34p, VPS34 gene fragment was amplified from yeast 
genomic DNA using primer pair #5014 
(GGAAGATCTAAAATGTCACTGAACAACATAACATTCTGTG)/ #5015 
(GCCCTGCAGGGTCCGCCAGTATTGTGCC), digested with BglII/PstI and inserted into 
BamHI/PstI digested pRS315-CFlag (Chapter 5), generating pRS315-Vps34-CFlag. PCR 
fragment of mRFP1 or rsGFP using primer pair #2691 
(CGGAGATCTATGGCCTCCTCCGAGGAC)/ #2631 
(GGACTCGAGTTAGGCGCCGGTGGAGTGG) or #4568 
(GGCAGATCTGGTAAAGGAGAAGAACTTTTCACT)/ #3721 
(GCCGAGATCTCGGATAACAATTTCACACAG) were digested with BglII/XhoI and 
inserted into BglII/SalI digested pRS315-Vps34-mRFP1, or pRS315-Vps34-GFP. 
 
PI3K inhibitor AS604850. AS604850 was obtained from Selleck Chemicals, dissolved in 
DMSO in concentration of 5mM. 
 
Split-Ubiquitin based Y2H assay. For pray constructs pPR3N-Vps34 or pPR3C-Vps34, 
VPS34 was amplified from genomic DNA using primer pair #5104/#5105, digested with 
BglII, and inserted into BamHI/SmaI digested pPR-N-RE or pPR-C-RE (99). Bait 
construct pGAD-BT3-N-His33 or pGAD-BT3-N-His92 (110) together with pray 
construct were co-transformed into yeast NMY51 [MATahis3∆ 200 trp1-901 leu2-3, 112 
ade2 LYS2::(lexAop)4-HIS3 ura3::(lexAop)8-lacZ ade2::(lexAop)8-ADE2 
GAL4] (Dualsystems), and plated onto Trp−/Leu− synthetic minimal medium plates. 
Transformed colonies were picked, re-suspended in water, diluted 4 times with 10 fold 
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dilution each time, and spotted onto TLHA− (Trp−/Leu−/His−/Ade−) plates to test bait 
and pray interaction. 
 
6.3 Results 
 
VPS34 deletion affects PE enrichment in peroxisomal membrane and dramatically 
reduces TBSV replication in yeast. To test the role of VPS34 in TBSV replication, we 
utilized vps34∆ deletion yeast strain. Plasmids (9) (pESC-T33/DI72, pYES-T92) 
expressing viral replication components together with empty vector or pRS315-VPS34-
CFlag were transformed into wild type or vps34∆ deletion yeast strain. Cells were grown 
in SC media containing 2% galactose to induce TBSV replication, and harvested at 1 day 
post induction. Total RNA and protein were extracted and subjected for RNA and protein 
blot analysis. In vps34∆ strain, we observed a reduction by 90% of repRNA accumulation 
compared to that from wild type. However, a plasmid expressing Vps34p-Flag 
complemented TBSV replication caused by deletion of VPS34. Viral protein p33 and p92 
accumulation was reduced comparing to that in wild type yeast, while p92 also showed 
less accumulation level. 
 This reduction of p33/p92 protein level was also observed in TBSV replicating 
cells where TLG2 or other tSNAREs in endocytic pathways were deleted (In Chapter 5). 
Since TLG2 deletion could affect virus driven enrichment of PE in peroxisomal 
membrane during TBSV replication, we also tested the PE localization in vps34∆ strain 
(Fig. 6.1B). Surprisingly, PE was not enriched at the site of replication, however TBSV 
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p33/p92 still localized to peroxisome, as shown by co-localization of peroxisome marker 
Pex13p-GFP and mRFP-p33/p92.  
 
PI3K inhibitor AS604850 inhibits (+)RNA virus replication in yeast and in plant. 
AS604850 is a specific PI3K inhibitor, with higher specificity toward Class I PI3K 
isoform γ (PI3Kγ /p110γ) comparing to isoform α/β (303, 304). We tested its effect on 
TBSV replication in yeast and in plants (Fig. 6.2A/B). 
 At the concentration of 4µM, AS604850 inhibited TBSV replication in yeast as 
the repRNA accumulation was reduced to ~13% comparing to that in wild type. Similarly 
to deletion of VPS34, we observed an reduction in p33 accumulation level (Fig. 6.2A, 
lower panel). In Nicotiana benthamiana protoplast transfected with TBSV full length 
genomic RNA, 0.5 µM AS604850 inhibited TBSV genomic replication by 80% 
comparing to that of adding the solvent only. At concentration of 2.5 or 5 µM, TBSV 
replication is close to detection limit (Fig. 6.2B). 
 CIRV replication proteins or CNV replication proteins could also replicate DI-72 
repRNA in yeast mitochondria outer (9) or peroxisome membranes (10), respectively. 
Different concentrations of AS604850 were also added to growth media of yeast 
transformed with pESC-C36/DI72 and pYES-C95, or pESC-HisCNVp33-DI72 and 
pYES-CNVp92 (9). Interestingly, 4µM AS604850 could also effectively inhibit repRNA 
replication by CIRV or CNV replication proteins (Fig. 6.2C upper & middle panels).  
 AS604850 was also used to test its effect on Nodamura virus (NoV), a unrelated 
positive strand RNA virus replication using the mitochondrial outer membrane (109, 224, 
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305). At concentration of 4µM,  AS604850 inhibited Nov replication, similar to the 
results obtained with TBSV, CIRV and CNV. 
 
Deletion of genes encoding components of different Vps34p complexes reveals a role 
for vacuole targeting complexes in viral replication. We have tested single gene 
encoding deletions encoding protein components of different Vps34p complexes (Fig. 
6.3A) for their effects on supporting tombusvirus replication.  
 Deletion of VPS15 dramatically reduced repRNA accumulation in yeast cells 
expressing TBSV p33, p92 and DI72 to ~5% of wild type yeast strain. While VPS30 and 
VPS38 deletion also reduced repRNA accumulation to ~48% and ~27% respectively. 
However, deletion of ATG14, which is responsible for autophagy or pheromone 
signaling did not affect TBSV replication (Fig. 6.3B Upper panel). TBSV p33 
accumulation in vps15∆ and vps38∆ reduced significantly, similar to that in vps34∆ strain 
(Fig. 6.3B lower panel).  
 RepRNA DI-72 replication by CNV replication proteins was also tested (Fig. 
6.4C). In VPS15 deletion strain, repRNA was reduced to ~42%, however replication was 
not significantly affected in vps30∆, atg14∆ or vps38∆  strains. The above results 
suggested involvement of different Vps34p complexes controlling vacuole protein 
targeting are involved in TBSV or CNV replication in yeast. 
 
Vps34p is co-localized with TBSV p33 in yeast. To observe the localization of Vps34p 
during TBSV replication, we utilized a plasmid-borne C-terminal mRFP1 tagged Vps34p 
and GFP-tagged p33. Plasmids pESC-GFP-T33/DI72, pYES-T92 (9) and pRS315-
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Vps34-mRFP1 were transformed into vps34∆ yeast strain. Yeast cells were induced to 
support repRNA replication in growth media containing 2% galactose for 4, 6 or 24 hours 
and subjected to confocal microscope analysis (Fig. 6.4A).  We observed Vps34p-mRFP1 
showed punctuate structures in yeast, and some of Vps34p-mRFP1 containing punctuates 
co-localized with GFP-p33 after 4, 6 or 24 hours induction of viral replication. These co-
localized Vps34p-p33 structures may represent Vps34p complexes responsible for TBSV 
replication (Fig. 6.3). 
 Pex13p tagged with mRFP on its C-terminal end was also used to test Vps34p 
localization during TBSV repRNA replication in yeast. Plasmids pESC-T33/DI72, 
pYES-T92, pRS315-pex13-mRFP and pRS314-Vps34-GFP were transformed to diploid 
Sc1 yeast strain. RepRNA replication was induced in growth media containing 2% 
galactose for 24hours. Yeast cells were collected and subjected to confocal laser 
microscope analysis. Vps34p-GFP forms many punctuate structures similar to  the 
observation using Vps34p-mRFP1, and some of the Vps34p-GFP punctuate structures 
were co-localized with peroxisome marker Pex13p-mRFP (Fig. 6.4B). Thus these 
observations supported that some of the Vps34p localized to peroxisome in TBSV 
replicating yeast. 
 
Vps34p does not interact with tombusvirus replication proteins in Split- Ubiquitin 
based yeast two hybrid assay. To test if Vps34p interacts with TBSV replication proteins, 
we utilized a split-ubiquitin based yeast two hybrid assay, designed for testing the 
interaction of a pray protein with a membrane bait protein (110). 
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 Vps34p was tagged with N-terminal half of ubiquitin (NubG) on its N-terminal or 
C-terminal and expressed from a plasmid which was co-transformed into yeast strain 
NMY51 (110) together with a plasmid expressing C-terminal Cub (C-terminal half of 
ubiquitin)-tagged CNV p33 or p92. Transformed yeast cells were spotted on Trp-/Leu-
/His-/Ade- (TLHA-) or Trp-/Leu- (TL-) media with 10X dilution sequentially for 5 times 
(Fig. 6.5 A&B right panels). Growing of the yeast cells from TLHA- media suggested 
interaction between bait and prey proteins. A known interacting protein Ssa1p (101) was 
used as positive control, while an empty plasmid was used as negative control.  
 Yeasts transformed with plasmids containing Cub-tagged p33 or p92 with NubG 
tagged Ssa1p grown in TLHA- media suggested an interaction between viral proteins and 
Ssa1p. However, yeast co-expressing N or C terminal NubG tagged  Vps34p and viral 
proteins did not show growth, suggesting lack of interaction between viral proteins and 
Vps34p. 
 
TBSV replication does not induce pexophagy. Pexophagy is selective macro-autophagy 
for peroxisome, which is controlled by VPS34 (306). The pexophagy event is usually 
monitored by vacuolar degradation of peroxisome matrix protein Pot1p (306), or 
visualization of vacuolar localization of peroxisomal matrix targeted BFP-SKL (307), or 
free GFP caused by vacuolar degradation GFP-tagged peroxisome membrane proteins, 
including Pex11p-GFP(283). 
 Since minor amount of free GFP was detected from yeast cells expressing GFP-
p33/p92 (Chapter 5, Fig. 5.5C&D) , it could be possible that pexophagy was also 
involved besides previously identified COP-II dependent secretion and endocytic 
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pathway that transfers p33 from ER to TGN/endosome/vacuole (Chapter 5, Fig. 5.5 & 
5.6). To test if pexophagy contributes to TBSV replication, we utilized GFP-tagged 
p33/p92 expressed in wild type or vps34∆ deletion yeast strain. GFP-p33/p92 
accumulation was dramatically reduced in vps34∆ yeast strain (Fig. 6.6A), in which 
pexophagy did not occur due to deletion of VPS34. The reduced GFP-p33/p92 
accumulation level in pexophagy-free vps34∆ yeast strain was contrary to the vacuolar 
degradation of pexophagic cargo proteins, suggesting pexophagy is not involved in 
targeting GPF-p33/p92 to vacuole. 
 To test if TBSV viral protein expression induces pexophagic degradation of 
peroxisomal matrix protein Pot1p/Fox3p, we detected Pot1p protein level by protein blot 
using anti-Pot1p antibody (kindly provided by Daniel J. Klionsky from University of 
Michigan) between samples with or without TBSV replication, in wild type or vps34∆ 
deletion strain (Fig. 6.6B). We found that Pot1p level was not significantly different 
between different samples described above.  Total protein, mitochondria membrane 
protein Porin, ER membrane protein Sec61p and cytosolic protein PGK were used as 
control to show equal loading between samples. Thus, our data suggest that TBSV 
replication in yeast does not induce pexophagy, and the role of Vps34p function in TBSV 
replication is not related to pexophagy-like event. This finding supported the previous 
finding that ATG14 deletion did not affect TBSV replication in yeast (Fig. 6.3). 
 
6.4 Discussion 
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VPS34 is involved in RNA viruses replication. Based on genetic study on model host 
yeast for TBSV replication, as well as utilizing a PI3K inhibitor AS604850 in yeast and 
plant cells, we identified VPS34/PI3K as a host factor important for TBSV replication 
(Fig. 6.1A, 6.2A&B). In plant protoplast cells transfected with TBSV full genomic RNA, 
TBSV replication was almost eliminated by adding 5 µM AS604850 into the incubation 
media (Fig. 6.2B). In yeast, either deletion of VPS34 or 4 µM AS604850 could reduce 
repRNA accumulation to ~11%. Interestingly, the accumulation of plasmid driven viral 
protein was also reduced dramatically. Such reduced level of repRNA as well as lower 
viral protein accumulation as also observed when tSNAREs from endocytic pathway or 
TGN were deleted. It could be interesting if PE distribution was affected during TBSV 
replication, since deletion of TGN tSNARE TLG2 abolished PE enrichment in 
peroxisome at the presence of TBSV replication. Interestingly, PE also did not 
accumulate in peroxisome in vps34∆ when mRFP tagged p33/p92 were expressed (Fig. 
6.1B). 
 PI3K inhibitor AS604850 was also tested for its effect on DI-72 replication using 
CIRV or CNV replication proteins in yeast, and Nodamura virus genomic RNA1 
replication in yeast. Results showed that at concentration of 4 µM, it inhibited viral 
replication in all these three cases (Fig. 6.2C). It is notable that PE was also enriched at 
site of CIRV, CNV or Nov replication (Chapter 4). 
 
Identifying a vacuolar protein targeting function of VPS34 in TBSV replication. As 
TBSV driven PE enrichment in peroxisome was affected in tlg2∆ or vps34∆ deletion 
strains, we wonder if these two gene have common functions? Vps34p in yeast is known 
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to function in distinct complexes (Fig. 6.3A), containing additional proteins including 
Vps15p, Vps30p, Vps38p or Atg14p (292, 295). We used single gene deletion yeast 
strains of vps15∆, vps30∆, vps38∆ or atg14∆ to dissect different functions of VPS34 in 
tombusvirus replication. Deletion of VPS15 reduced TBSV repRNA and proteins 
accumulation to similar level comparing to VPS34 deletion, while deletion of VPS30 or 
VPS38 also reduced TBSV replication (Fig. 6.3B). In case where DI-72 was replicated by 
CNV p33 and p92 (Fig. 6.3C), repRNA accumulation was only reduced in VPS15 
deletion strain, and did not change in VPS30, VPS38 or ATG14 deletions. 
 Based on Jonathan M. BACKER's model of four Vps34p complexes (292), I 
demonstrated that vacuole protein targeting function of VPS34 seems to be involved in 
TBSV replication. This results agreed with the finding that PE was not enriched in 
peroxisome in yeast deletion strain of TGN tSNARE TLG2, which is involved in 
vesicle/protein transportation. 
 
Vps34p localized at site of TBSV replication, but does not interact with p33/p92. In 
vps34∆ yeast expressing Vps34p-mRFP1, GFP-p33/p92, of which fluorescence under 
confocal laser microscope, co-localized with some of the punctuate-like structures of 
Vps34p-mRFP1, suggesting a direct involvement of Vps34p in TBSV replication. This 
result was confirmed by co-localization of Vps34p-GFP and a peroxisome marker 
Pex13p-mRFP in a diploid yeast cell when TBSV replication (Fig. 6.4). 
 We asked if Vps34p directly interacts with TBSV replication proteins. In a split 
ubiquitin based yeast membrane protein two hybrid system, Vps34p does not show 
interaction with p33 or p92 (Fig. 6.5). However other components of the Vps34p 
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complexes were not tested for their interaction with TBSV p33/p92 yet. Besides direct 
interaction, an existing function of Vps34p on peroxisome may be co-opted by TBSV to 
aid its replication. 
 
Pexophagy pathway is not co-opted for TBSV replication. A known function of VPS34 
in peroxisome regulation involves pexophagy during nutrition stressed environment 
(306). We tested degradation pattern of TBSV viral proteins GFP-p33/p92 and 
peroxisomal matrix protein Pot1p accumulation in wild type as well as pexophagy-free 
vps34∆ yeast strains (306). Pot1p level was similar in samples with or without TBSV in 
both WT and vps34∆ yeast strains, suggesting TBSV replication does not induce 
detectable pexophagy. GFP-p33/p92 accumulation reduced, not increased, in pexophagy 
free yeast strain suggesting that pexophagy does not play a role in stability of TBSV 
protein. Pexophagy is a selective macro-autophagy event, which is controlled by VPS15, 
VPS30 and ATG14, but not VPS38 (306). Absence of involvement of pexophagy in 
TBSV replication agreed with previously identified non-autophagy function of VPS34 
(Fig. 6.3). 
 
Summary: In this chapter, we show evidence that VPS34 is involved in TBSV replication 
in yeast and in plant, and possibly in CIRV, CNV and NoV replication in yeast. I 
identified a role in the vacuole protein targeting of Vps34 in TBSV replication. Co-
localization of Vps34p and TBSV p33/p92 suggests involvement of cellular functions of 
Vps34p in peroxisome that might be co-opted for TBSV replication. However this 
cellular function is not pexophagy, instead a non-autophagic function, possibly 
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vesicle/protein transport function of Vps34p, is involved in TBSV replication. 
Importantly I discovered that VPS34's function correlates to PE enrichment in 
peroxisome during TBSV replication.  
(Copyright © Kai Xu 2014)  
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Fig. 6.1 
  
A  TBSV replication in vps34∆ yeast strain
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Fig. 6.1 VPS34 is required for efficient TBSV replication in yeast and is involved in PE 
enrichment at the site of replication.  
 
(A) TBSV replication in WT or vps34∆ strain was induced by expression of TBSV His6-
p33 and His6-p92 under the galactose-inducible GAL1 promoter and DI-72 (+)repRNA 
from the galactose-inducible GAL10 promoter at 23°C for 24 hours. Northern blot 
analysis of DI-72 accumulation or 18S rRNA accumulation was shown in upper panels. 
DI-72 accumulation data was normalized based on 18S rRNA. Each experiment was 
repeated three times. Lower panels: Western blot of TBSV p33, p92 or Flag-tagged 
Vps34p was performed using anti-HIS or anti-Flag antibodies. Total protein was shown 
as loading control. (B) Confocal microscope images showed that PE was not enriched at 
sites of replication in vps34∆ yeast. See further description of yeast growth condition in 
Fig. 5.2, PE detection method in Fig. 5.3. 
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Fig. 6.2 
  
A  VPS34/PI3K inhibitor (AS604850) in yeast inhibit TBSV replication
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C  CIRV+DI72, CNV+DI72 and NoV RNA1 replication in the presence ofAS604850
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Fig. 6.2 PI3K inhibitor AS604850 inhibits positive strand RNA viruses replication. 
 
(A) AS604850 inhibited TBSV repliation in yeast at different concentrations. Notably at 
4µM, AS604850 inhibited TBSV repRNA accumulation to ~13% comparing to that of 
adding solvent DMSO alone. See further detail of RNA and protein blot in Fig. 6.1A (B) 
Genome replication of TBSV in plant protoplasts was inhibited by AS604850, as shown 
by RNA blot analysis of genomic TBSV RNA as well two sub-genomic RNA generated 
during TBSV genomic RNA replication (Upper panel). Lower panel: ribosomal RNA 
stained by ethidium bromide was shown as a loading control. 
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Fig. 6.3 
  
WT vps15∆ vps30∆ atg14∆ atg38∆
WT vps15∆ vps30∆ atg14∆ atg38∆
repRNA
rRNA
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A. Vps34p complexs in yeast (adapted from Biochem. J. (2008) 410, 1–17)
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Fig. 6.3 Dissecting the function of different Vps34p complexes in tombusvirus 
replication.  
 
(A) A cartoon illustration of Vps34p complexes as proposed by Jonathan M. Backer 
(292).(B) TBSV repRNA replication in wild type, vps15∆, vps30∆, atg14∆ or vps38∆. 
Upper panel: RNA blot of repRNA accumulation and 18S rRNA accumulation. Lower 
panel: Protein analysis of TBSV p33, p92 See further detail about growth condition and 
RNA or protein blot on Fig. 6.1A. (C) DI-72 replication by CNV His6-p33 and His6-p92 
driven under the galactose-inducible GAL1 promoter. 
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Fig. 6.4 
 
  
A  Vps34p-mRFP co-localizes with TBSV replicase complex
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Fig. 6.4 Confocal laser microscope analysis of Vps34p localization during TBSV 
replication in yeast.  
 
(A): Vps34p-mRFP is localized to site of TBSV replication visualized by GFP-tagged 
p33 expression in vps34∆ yeast strain. (B) Vps34p-GFP is localized to peroxisome during 
TBSV replication in yeast. 
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Fig. 6.5 
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Fig. 6.5 Split-ubiquitin based Y2H assay to test viral protein interaction with Vps34p.  
 
(A) Bait protein TBSV p33 was used to test the interaction with Vps34p tagged with N-
terminal half of ubiquitin (NubG) on its N-terminal or C-terminal. (B) Bait protein TBSV 
p92 was used to test the interaction with Vps34p. 
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Fig. 6.6 
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Fig. 6.6 GFP-p33/p92 and a peroxisomal matrix protein Pot1p were analyzed for 
accumulation during TBSV repRNA replication in wild type and vps34∆ yeast strains. 
 
(A) Western blot analysis of GFP-p33/p92 of yeast cells with or without induction 
repRNA replication Both anti-HIS and anti-GFP antibody were used. Note that: free GFP 
was detected when using anti-GFP antibody in wild type yeast with repRNA replication. 
(B) Western blot analysis of Pot1p, mitochondria porin, ER membrane protein Sec61p 
and cytosolic protein PGK of samples prepared as in Fig. 6.6A. No significant change of 
Pot1p accumulation was observed in wild type cells with viral protein expression. 
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Chapter 7 
CONCLUSION AND PERSPECTIVE 
  
7.1  Conclusion 
 
(+)RNA virus replication can take place on alternative organellar membranes. In 
Chapter 2, we demonstrated that in a cell-free environment, peroxisome/ER-based 
tombusvirus TBSV could utilize mitochondrial membrane to assemble replicase 
complexes, supporting asymmetric replication of (+)repRNA. While mitochondria-based 
CIRV could use ER membrane for assembly of replicase complexes only inefficiently. 
The ability of using ER or mitochondria membranes depended on the p33/p36 region of 
TBSV/CIRV replicase protein. Despite the C-terminal RdRp region coming from TBSV 
p92 or CIRV p95, p33 prefers ER and p36 prefers mitochondria to assemble the replicase 
complexes. The difference might come from co-evolution of TBSV or CIRV with 
different cellular membrane environments, however, it was surprising that TBSV or 
CIRV have the potential to explore alternative sub-cellular membranes for viral 
replication. Thus these viruses are more flexible in exploiting various membranes as 
previously anticipated. 
 Cymbidium ringspot virus (CymRSV) is a tombusvirus closely related with 
TBSV, replicating on peroxisome membrane. Previous study using chimeric viruses 
made between CymRSV and CIRV also suggested swapping a small N-terminal region of 
CIRV p36/p95 with CymRSV p33/p92 could led to a recombinant CymRSV (majority of 
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genome from CymRSV which replicates on peroxisomal membrane ) to replicate on 
mitochondrial outer membrane (114). While replacing the N-terminal region of CIRV 
p36/p95 with CymRSV p33/p92 could make a recombinant CIRV replicating on 
peroxisome (114). Although this study suggested that recombination event could change 
the sub-cellular replication site, it was still not answered if a non-modified tombusvirus 
could explore an alternative sub-cellular membrane for replication. Later studies on the 
N-terminal region of CymRSV (8) or CIRV (19) replication proteins proposed that this 
region contains perixosome or mitochondria targeting sequences as well as two trans-
membrane domains. 
 Similar study of changing sub-cellular replication site by modifying replicase 
protein was shown with an animal virus, Flock house virus (FHV). By replacing 
mitochondria targeting domain in FHV RdRp Protein A with three different types of ER 
targeting sequences, the replication of FHV was re-targeted from mitochondrial outer 
membrane to ER membrane (308). Surprisingly the replication of FHV increased when 
FHV was replicating on ER membrane. 
 Are the sites of replication of (+)RNA viruses simply decided by the organelle 
targeting sequence in their replication proteins? Or are other motifs in (+)RNA virus 
replication proteins also important for choosing the replication sites? In my studies in 
Chapter 2, when TBSV or CIRV replicase proteins were simply mixed with purified 
organellar membranes without a cellular targeting event, the wild type viral replicase 
proteins could utilize different organelles for viral replication, suggesting that the native 
replicase proteins have the ability of using an alternative membrane. However, their 
preference in using the native organellar membranes also suggested that non-organelle 
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targeting motifs of the replicase proteins could be co-evolved within the native membrane 
environment and contribute to selectivity of (+)RNA virus replication sites. It is also 
possible that viruses use the alternative membranes when the original membranes are 
becoming saturated with viral proteins during late infection. 
 Studies of TBSV or CymRSV also showed that genetic modification of a host cell 
could also lead to change in viral replication site. Pex3p is a peroxisomal membrane 
protein which controls peroxisome biogenesis (309). Deletion of PEX3 abolishes 
peroxisome biogenesis and relocates replication site of TBSV or CymRSV from 
peroxisome to ER (15, 32) in yeast model host. Recent study also showed that in the 
absence of an important lipid biogenesis gene, PAH1 (phosphatidic acid 
phosphohydrolase), TBSV replication switched from peroxisome to ER (310). 
 These studies discussed above including my study in chapter 2 suggest an 
emerging picture that (+)RNA viruses have the ability of using alternative replication 
sites in host cell (Summarized in Fig. 7.1). Such event could be observed in cell-free 
environment (9), viral protein recombination/modification (114, 308) or genetically 
altered host cell (15, 32, 310). 
 
TPR domain containing protein Sti1p inhibits CIRV replication. Previous work showed 
that some members of TPR-containing protein family act as cell-intrinsic negative 
regulators of tombusviruses replication (109, 150). Study on Sti1p which inhibited CIRV, 
not TBSV, replication provided a more detailed picture on how these TRP-containing 
proteins, often Heat shock protein 70 co-chaperones, affect tombusviruses replication. 
Specificity of Sti1p's inhibition of CIRV replication could provide more information on 
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CIRV replication protein targeting and replicase assembly process on mitochondria outer 
membrane, and emphasize importance of further analysis of more proteins from this 
TPR-containing proteins family. 
 
PE is required for TBSV replication. Utilizing a novel artificial vesicle-based cell-free 
replication system, different phospholipids showed different effects in three steps of 
TBSV replication: 1) viral replication protein association with membranes, 2) viral RNA 
recruitment by viral replication proteins to membranes, 3) asymmetric viral RNA 
replication. PE was the only phospholipid capable of supporting all three processes. 
These findings suggested that sub-cellular membrane is not simply a bilayer platform that 
functions as a scaffold, different head groups of different lipids may directly interact with 
viral replication proteins to stimulate their RdRp activity, or may introduce membrane 
curvature (For example, negative membrane curvature introduced by PE) which is 
favored for viral RdRp activity. 
 
Finding pathway for PE re-localization to the site of viral replication. Building up of 
PE enriched micro-environment by TBSV replication protein p33 was a surprising 
finding, suggesting that heavy modification of phospholipid transportation could be 
achieved by a single viral protein expression in a host cell. Finding the exact pathway of 
p33 induced PE enrichment to peroxisome could pioneeringly contribute to 
understanding of the cell biology of virus infected cell. 
 To hijack an PE synthesis pathway to build up PE enriched micro-environment, 
could require recruitment of PE synthesis enzyme/s to peroxisome, and also need PS or 
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CDP-ethanolamine, the precursors of PE synthesis in two different pathways, to be 
funneling to peroxisome. By deleting different PE synthesis genes, we concluded that no 
single PE synthesis pathway directly contribute to the virus-driven PE enrichment in 
peroxisomes. I have demonstrated that vesicle transport pathway is involved in PE 
enrichment in peroxisome driven by TBSV p33. 
 I provide multiple evidence supporting that TBSV p33/p92 are indeed targeted to 
post-Golgi compartment. Inhibition of p33/p92 secretion from ER to golgi inhibited 
TBSV replication suggesting post-Golgi p33 is essential for efficient viral replication. 
TGN localization of p33 as well as abolishment of PE enrichment in tlg2∆ yeast strain 
suggested that post-golgi p33 may directly induce PE enrichment in peroxisome through 
vesicle transport pathway. 
 
7.2  Perspective 
 
PE source for TBSV replication. PE is an important lipid for autophagy pathway. 
Lipidation of LC3 (Atg8p) requires covalently linking its molecule with PE, and serves as 
marker for autophagy event (247, 298). However membrane source of pre-
autophagosomal structure (PAS) was extensively studied and still remains unclear (244, 
246, 247, 249, 251). By studying the role of VPS34 and associated components in TBSV 
replication, we learned that autophagy is unlikely required for TBSV replication.  
 By utilizing yeast genetics as well as cell biology tools, we were able to narrow 
down certain pathway/s affecting PE enrichment in peroxisome. Current results 
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suggested vesicle transport pathway is involved in PE enrichment. Next question is 
WHY? 
 Aminophospholipid flippase could be involved in PE enrichment at peroxisome. 
Aminophospholipid flippases belong to P4 subfamily of P-type ATPases, which 
introduce phospholipid asymmetry on different sides of membrane bilayer (282). There 
are five P4 ATPase in yeast with overlapping functions, namely Drs2p, Dnf1p, Dnf2p, 
Dnf3p, and Neo1p (282). Dnf1p and Dnf2p are localized primarily at plasma membrane 
(311), Drs2p and Dnf3p are mostly localized at TGN (312), while Neo1p is mainly 
localized at endosomes (313). Nele Alder-Baerens and co-workers showed that 
phospholipid asymmetry exists on post-Golgi vesicles, including up to 80% of PE on the 
cytosolic leaflet of the total post-Golgi vesicles, while deletion of Drs2p and Dnf3p could 
abolish most of the PE asymmetry (282). 
 PE is the pro-fusion kind of phospholipid, which facilitates vesicle fusion into 
membrane bilayer (57, 314, 315). It could be that by hijacking post-Golgi vesicles 
generated from TGN or endosomes with enriched PE at cytosolic leaflets, TBSV might 
build up PE enriched micro-environment on peroxisomal membranes. This hypothesis 
fits to the current results that vesicle transport rather single PE synthesis pathway is 
required for PE enrichment in peroxisome. However since the asymmetric distribution 
could not change the overall PE content on post-golgi vesicles, this hypothesis could not 
directly explain why PE is enriched in peroxisome as observed under the confocal laser 
microscope, unless other cellular host factors also contribute to this hypothetic pathway. 
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Role of Vps34p during TBSV replication. Vps34p forms complexes with Vps15p, 
Vps30p and Vps38p at late golgi, late endosome and vacuole to regulate vesicle transport 
(295, 297, 298). A major organizer of endosomal and vaclular membrane/protein sorting 
is phosphoinositide phosphatidylinositol-3-phosphate (PI3P), a product of Vps34p, 
serving as a molecular signal (316). PI3P is predominantly localized at late endosome or 
in multivesicle bodies (MVB), and recruits many effectors containing PI3P binding 
domains, such as PX (Phox homology) and FYVE (Fab1, YOTB, Vac1, EEA1) domains 
(317). These effectors facilitates various membrane rearrangement events as the 
retromer-coated tubules budding (SNX1,2,6,27), the fusion of endosomes (EEA1) and the 
ESCRT-dependent intraluminal sorting of ubiquitinated cargos in multivesicular 
endosomes (Hrs) (316).  
 The accumulation of Vps34p at peroxisome was especially interesting, since one 
role of Vps34p on peroxisome is to induce pexophagy. However no macro-autophagy 
events was induced upon TBSV replication (Fig. 6.6). If PI3P on peroxisome membrane 
does not facilitate autophagy, it might instead recruits those effectors which have PI3P 
binding modules and introduce various endosome/ multivesicle bodies (MVB) -like 
events. One of the ESCRT-I component Vps23p was recruited to peroxisome upon TBSV 
replication (81). ESCRT factors, including Vps23p, Vps24p, Snf7p and Vps4p have been 
shown to help TBSV assemble replication complexes by introducing membrane 
invagination (81). CIRV could also recruit Vps23p to mitochondria upon infection (318). 
Very interestingly, these invaginated peroxisomes or mitochondria upon tombusvirus 
infections possessed MVB-like morphology, and were once called MVB by scientists 
(114). Vps23p has been shown to bind to p33 or p36, however the binding sites between 
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Vps23p and these viral replication proteins were quite different (81, 86, 318). N-terminal 
ubiquitin E2 domain of Vps23p was shown to bind to p33 depending on ubiquitination of 
two lysine sites N-terminals of p33 and a "late domain" between two trans-membrane 
domains (86). However, Vps23p C-terminal steadiness box domain showed ability to 
bind to N-terminal 16 amino-acid long sequence in CIRV p36 (318). Lack of conserving 
binding domain of vps23p to two related tombusviruses replication proteins may 
suggested a possibility that this binding maybe a result rather than a cause of vps23p 
recruitment. 
 ESCRT-I components are involved in ubiquitin-dependent sorting of proteins into 
the endosome/MVB (319), and Vps34p/PI3P controls ESCRT-I dependent intraluminal 
sorting into MVB (316). It is possible that Vps34p/PI3P controls the ESCRT-I 
recruitment to viral replication sites. 
 Since CIRV replication on mitochondria also led to PE enrichment (Chapter 4) 
and required Vps34p (Fig. 6.2), it is possible that PI3P serves as molecular signal on 
peroxisome or mitochondria to recruit ESCRT factors and other effectors which leads to 
PE enrichment and membrane invagination. It is quite interesting that PE possesses a 
physical property which favors negative curvature during formation of virus-induced 
spherules in peroxisomes or mitochondria, suggesting that membrane invagination 
introduced by ESCRT might be accompanied with PE enrichment. 
 PE was also shown to be enriched at site of Nodamura virus (NoV) replication 
(Chapter 4). At early stage of NoV infected muscle cells of suckling mouse, membrane 
invagination on mitochondria outer membrane (or vesiculation of mitochondria outter 
membrane) was observed (224), suggesting PE might play a common role for membrane 
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invagination. Interestingly, PI3P inhibitor also inhibited NoV replication (Fig. 6.2C), 
suggesting function of Vps34p during NoV replication could also be similar to its 
function in TBSV or CIRV replication. 
 In summary, we found that p33 was transported to TGN through COP-II 
dependent vesicle transport from ER, and peroxisome possibly via pex19p mediated 
proxisomal protein targeting (107).  We hypothesize that TGN localized p33 as well as 
peroxisome localized Vps34p may induce vesicle transport from TGN and endocytic 
pathway to peroxisome, lead to a MVB-like peroxisome in TBSV replicating cells as well 
as PE enrichment in peroxisome ( Summarized in Fig. 7.2).  
 
Role of secretory pathway. Current studies (235, 236) on trans-membrane protein sorting 
through early secretory and endocytic pathways shed a light on our understanding of 
(+)RNA virus RdRp function. Most of the (+)RNA virus RdRp or their auxiliary proteins 
are membrane associated, and their function depends on their sub-cellular association 
with membrane (20).  
 Membrane proteins accounts for 20-30% of the total protein products produced 
from eukaryotic genome (320). Their sorting were believed to be contributed by motifs 
residing on cytosolic part of the protein (321), however trans-membrane domain of these 
proteins also received attentions for their functions in determining protein localization 
and transport (235, 236). TMDs were shown to function in ER retention, golgi or plasma 
membrane localization and sorting through endocytic pathways [reviewed in (235)]. The 
sorting function of TMDs together with cytosolic organellar targeting signals on viral 
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replication proteins could explain various sub-cellular locations of (+)RNA viruses 
replication sites. 
 Current progress showed that early secretory pathways are involved in (+)RNA 
virus replication (33, 72, 226-228, 232, 322). Despite that other viral factors may join and 
modify ER membranes as well as early secretory pathway, TMDs within viral replication 
proteins could be a driving force of (+)RNA viruses to find the replication site on cellular 
membranes during evolution. 
(Copyright © Kai Xu 2014) 
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Fig. 7.1 Alternative replication sites found for different (+)RNA viruses. 
Solid lines show original replication sites for TBSV, CymRSV, CIRV and FHV. Dotted 
lines show alternative replication sites of these (+)RNA viruses in different experimental 
systems.  
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Fig. 7.2 Working Model for sub-cellular transport of TBSV replicase proteins. 
Portion of TBSV p33 and p92 molecules translated on ER or in cytoplasm are transported 
directly to peroxisome, while part of p33/p92 are transported to TGN and beyond through 
COP-II dependent early secretory pathway. Dotted lines suggest a proposed role played 
by p33, in which p33 induces vesicle transportation from TGN or early endosome (EE) to 
peroxisome, and thus produce MVB-like structures as well as PE enriched micro-
environment. See text for further detail and possible role of Vps34p in this model. 
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